pathwayRes	pathway	pathwayTitle	TotalGenesinPW	GenesInPWs.rectum_Ensembl_BridgeDb_CD	probabilities.rectum_Ensembl_BridgeDb_CD	GenesInPWs.rectum_Ensembl_Hs_CD	probabilities.rectum_Ensembl_Hs_CD	GenesInPWs.rectum_Ensembl_PriID_BridgeDb_CD	probabilities.rectum_Ensembl_PriID_BridgeDb_CD	GenesInPWs.rectum_ENTREZ_BridgeDb_CD	probabilities.rectum_ENTREZ_BridgeDb_CD	GenesInPWs.rectum_ENTREZ_Hs_CD	probabilities.rectum_ENTREZ_Hs_CD	GenesInPWs.rectum_ENTREZ_PriID_BridgeDb_CD	probabilities.rectum_ENTREZ_PriID_BridgeDb_CD	GenesInPWs.rectum_HGNC_CD	probabilities.rectum_HGNC_CD	GenesInPWs.rectum_HGNC_PriID_BridgeDb_CD	probabilities.rectum_HGNC_PriID_BridgeDb_CD
<https://identifiers.org/wikipathways/WP100_r107114>	WP100	Glutathione metabolism	37	3	3.28011902889582e-63	3	6.4731609531969e-63	3	6.18101124029635e-64	3	3.44259329976608e-62	3	3.28011902889582e-63	3	6.29066719498081e-63	3	7.22268525218576e-65	3	7.22268525218576e-65
<https://identifiers.org/wikipathways/WP106_r114258>	WP106	Alanine and aspartate metabolism	40	2	2.53619186135765e-70	2	5.41499478113622e-70	2	3.93883171291269e-71	2	3.49437489934737e-69	2	2.53619186135765e-70	2	5.24493709379484e-70	2	3.58828008174474e-72	2	3.58828008174474e-72
<https://identifiers.org/wikipathways/WP107_r117851>	WP107	Translation factors	50	1	1.79008269548222e-87	1	4.73952660826039e-87	1	1.63856805765084e-88	1	5.18863303736319e-86	1	1.79008269548222e-87	1	4.54932447574204e-87	1	7.55639481747852e-90	1	7.55639481747852e-90
<https://identifiers.org/wikipathways/WP117_r117743>	WP117	GPCRs, other	114	8	3.94973773619078e-147	8	3.09506937579375e-146	11	6.38631774725547e-143	8	4.85860029549039e-144	8	3.94973773619078e-147	11	5.9704130362267e-140	8	3.70466052246899e-152	11	1.12671634423637e-145
<https://identifiers.org/wikipathways/WP12_r116896>	WP12	Osteoclast signaling	16	4	9.63262294215634e-26	4	1.22715595305679e-25	4	5.31681063260993e-26	4	2.22582365842296e-25	4	9.63262294215634e-26	4	1.21471856164065e-25	4	2.47640161913702e-26	4	2.47640161913702e-26
<https://identifiers.org/wikipathways/WP127_r120669>	WP127	IL-5 signaling pathway	40	5	7.90428683060742e-63	5	1.59091617456679e-62	5	1.41909506709825e-63	5	8.88063232420076e-62	5	7.90428683060742e-63	5	1.5447835597285e-62	5	1.55808144741473e-64	5	1.55808144741473e-64
<https://identifiers.org/wikipathways/WP129_r117774>	WP129	Matrix metalloproteinases	31	12	4.96610796719448e-34	12	7.27822527604016e-34	12	1.94321844311266e-34	12	1.86304293718728e-33	12	4.96610796719448e-34	12	7.16211588876492e-34	12	5.81467943586772e-35	12	5.81467943586772e-35
<https://identifiers.org/wikipathways/WP134_r118339>	WP134	Pentose phosphate metabolism	7	2	1.02121683002659e-12	2	1.12995625797539e-12	2	7.96660455362328e-13	2	1.44922699662088e-12	2	1.02121683002659e-12	2	1.12515610394831e-12	2	5.78947479253297e-13	2	5.78947479253297e-13
<https://identifiers.org/wikipathways/WP138_r122133>	WP138	Androgen receptor signaling pathway	88	5	3.38220671963448e-125	5	1.72071567970584e-124	5	6.21533886893278e-127	5	9.36195082260607e-123	5	3.38220671963448e-125	5	1.60691535985269e-124	5	3.61803397646885e-129	5	3.61803397646885e-129
<https://identifiers.org/wikipathways/WP1403_r121114>	WP1403	AMP-activated protein kinase (AMPK) signaling	68	2	1.57802672954986e-108	2	5.8044977891467e-108	2	6.43795038838199e-110	2	1.42462675315999e-106	2	1.57802672954986e-108	2	5.49504960329548e-108	2	1.04803110211091e-111	2	1.04803110211091e-111
<https://identifiers.org/wikipathways/WP1422_r118359>	WP1422	Sphingolipid pathway	36	1	4.32448125101619e-67	1	8.70399482748012e-67	1	7.76395156526037e-68	1	4.85864554338592e-66	1	4.32448125101619e-67	1	8.45160061127313e-67	1	8.52435412744685e-69	1	8.52435412744685e-69
<https://identifiers.org/wikipathways/WP1423_r117518>	WP1423	Ganglio sphingolipid metabolism	18	1	2.72741899262395e-37	1	3.84070123759073e-37	1	1.17721951280935e-37	1	8.91159449230089e-37	1	2.72741899262395e-37	1	3.78578793141823e-37	1	3.99633245654225e-38	1	3.99633245654225e-38
<https://identifiers.org/wikipathways/WP143_r116506>	WP143	Fatty acid beta-oxidation	34	2	3.18558236797802e-61	2	6.04336639261088e-61	2	6.61380135165845e-62	2	2.91702405600181e-60	2	3.18558236797802e-61	2	5.88274535892017e-61	2	8.75532604885219e-63	2	8.75532604885219e-63
<https://identifiers.org/wikipathways/WP1433_r122867>	WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	41	11	2.72058607164649e-51	11	4.96121009394601e-51	11	6.22420882479349e-52	11	2.17304496783079e-50	11	2.72058607164649e-51	11	4.83738621472934e-51	11	9.33617415442872e-53	11	9.33617415442872e-53
<https://identifiers.org/wikipathways/WP1434_r117813>	WP1434	Osteopontin signaling	13	3	1.66924411009121e-22	3	2.04278515725596e-22	3	1.01687547889088e-22	3	3.35662157060388e-22	3	1.66924411009121e-22	3	2.02550271091708e-22	3	5.37688701555125e-23	3	5.37688701555125e-23
<https://identifiers.org/wikipathways/WP1455_r117827>	WP1455	Serotonin transporter activity	11	2	3.86815221665368e-21	2	4.63947936676791e-21	2	2.47570068514584e-21	2	7.25546662568996e-21	2	3.86815221665368e-21	2	4.60412346981535e-21	2	1.39488857384204e-21	2	1.39488857384204e-21
<https://identifiers.org/wikipathways/WP1471_r120934>	WP1471	Target of rapamycin (TOR) signaling	36	1	4.32448125101619e-67	1	8.70399482748012e-67	1	7.76395156526037e-68	1	4.85864554338592e-66	1	4.32448125101619e-67	1	8.45160061127313e-67	1	8.52435412744685e-69	1	8.52435412744685e-69
<https://identifiers.org/wikipathways/WP15_r121694>	WP15	Selenium micronutrient network	89	16	1.93700282346775e-103	16	8.14726617383168e-103	16	5.68319022381654e-105	16	2.77900477982768e-101	16	1.93700282346775e-103	16	7.66955498452242e-103	16	6.04847736352768e-107	16	6.04847736352768e-107
<https://identifiers.org/wikipathways/WP1528_r121714>	WP1528	Physiological and pathological hypertrophy of the heart	24	2	4.99121865644148e-45	2	7.76583042480324e-45	2	1.68632029985075e-45	2	2.30264234239817e-44	2	4.99121865644148e-45	2	7.62274142200117e-45	2	4.17734319277944e-46	2	4.17734319277944e-46
<https://identifiers.org/wikipathways/WP1530_r118120>	WP1530	miRNA regulation of DNA damage response	96	5	2.47066622823424e-134	5	1.46203069848181e-133	5	3.13065978695632e-136	5	1.15252365617273e-131	5	2.47066622823424e-134	5	1.35669040270833e-133	5	1.12815894478852e-138	5	1.12815894478852e-138
<https://identifiers.org/wikipathways/WP1531_r118354>	WP1531	Vitamin D metabolism	11	2	3.86815221665368e-21	2	4.63947936676791e-21	2	2.47570068514584e-21	2	7.25546662568996e-21	2	3.86815221665368e-21	2	4.60412346981535e-21	2	1.39488857384204e-21	2	1.39488857384204e-21
<https://identifiers.org/wikipathways/WP1533_r121695>	WP1533	Vitamin B12 metabolism	57	15	8.26876647952723e-66	15	1.90956312006521e-65	15	1.05902667073942e-66	15	1.49425071684543e-64	15	8.26876647952723e-66	15	1.84349915709758e-65	15	7.52712270494903e-68	15	7.52712270494903e-68
<https://identifiers.org/wikipathways/WP1539_r118358>	WP1539	Angiogenesis	24	2	4.99121865644148e-45	2	7.76583042480324e-45	2	1.68632029985075e-45	2	2.30264234239817e-44	2	4.99121865644148e-45	2	7.62274142200117e-45	2	4.17734319277944e-46	2	4.17734319277944e-46
<https://identifiers.org/wikipathways/WP1544_r121713>	WP1544	MicroRNAs in cardiomyocyte hypertrophy	104	5	3.33565094578016e-143	5	2.29374818842266e-142	5	2.92104052212907e-145	5	2.61357047397411e-140	5	3.33565094578016e-143	5	2.11508487555565e-142	5	6.5342450359827e-148	5	6.5342450359827e-148
<https://identifiers.org/wikipathways/WP1545_r118363>	WP1545	miRNAs involved in DNA damage response	69	2	8.62787990007413e-110	2	3.23514012480715e-109	2	3.35766120028993e-111	2	8.32339085250156e-108	2	8.62787990007413e-110	2	3.06019711563679e-109	2	5.14325363055863e-113	2	5.14325363055863e-113
<https://identifiers.org/wikipathways/WP1559_r117836>	WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP1584_r122869>	WP1584	Type II diabetes mellitus	22	3	5.41934369184043e-39	3	7.94247819380062e-39	3	2.12056779295109e-39	3	2.03307500682014e-38	3	5.41934369184043e-39	3	7.81577199255606e-39	3	6.34536069876172e-40	3	6.34536069876172e-40
<https://identifiers.org/wikipathways/WP1589_r122870>	WP1589	Folate-alcohol and cancer pathway hypotheses	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP1591_r118366>	WP1591	Heart development	47	3	7.49757974551156e-78	3	1.80057564476127e-77	3	8.72221347757458e-79	3	1.55115026786018e-76	3	7.49757974551156e-78	3	1.73542323656269e-77	3	5.47735753362704e-80	3	5.47735753362704e-80
<https://identifiers.org/wikipathways/WP1600_r119518>	WP1600	Nicotine metabolism in liver cells	6	4	2.09553985297692e-05	4	2.18220542408977e-05	4	1.89716601340917e-05	4	2.41091663050289e-05	4	2.09553985297692e-05	4	2.17848786800106e-05	4	1.66950482486891e-05	4	1.66950482486891e-05
<https://identifiers.org/wikipathways/WP1601_r120496>	WP1601	Fluoropyrimidine activity	34	2	3.18558236797802e-61	2	6.04336639261088e-61	2	6.61380135165845e-62	2	2.91702405600181e-60	2	3.18558236797802e-61	2	5.88274535892017e-61	2	8.75532604885219e-63	2	8.75532604885219e-63
<https://identifiers.org/wikipathways/WP1603_r117164>	WP1603	Nicotine effect on chromaffin cells	4	1	1.39935883337357e-08	1	1.48702243549559e-08	1	1.20550660105429e-08	1	1.72670841933958e-08	1	1.39935883337357e-08	1	1.48322578246882e-08	1	9.9523387473559e-09	1	9.9523387473559e-09
<https://identifiers.org/wikipathways/WP1604_r118374>	WP1604	Codeine and morphine metabolism	17	4	1.35558435444253e-27	4	1.76196378394977e-27	4	7.12259895621513e-28	4	3.35749797632566e-27	4	1.35558435444253e-27	4	1.74263422345074e-27	4	3.11381860394446e-28	4	3.11381860394446e-28
<https://identifiers.org/wikipathways/WP167_r120547>	WP167	Eicosanoid synthesis	28	4	1.37660552460482e-46	4	2.22879218894818e-46	4	4.21806686613612e-47	4	7.28748486529965e-46	4	1.37660552460482e-46	4	2.18406726207967e-46	4	9.21469784865575e-48	4	9.21469784865575e-48
<https://identifiers.org/wikipathways/WP170_r116552>	WP170	Nuclear receptors	38	1	4.00913405776155e-70	1	8.39324191076137e-70	1	6.53442081603714e-71	1	5.16092292826698e-69	1	4.00913405776155e-70	1	8.13637677370728e-70	1	6.33469445200312e-72	1	6.33469445200312e-72
<https://identifiers.org/wikipathways/WP1742_r116592>	WP1742	TP53 network	22	1	2.20083808148162e-44	1	3.35675206405441e-44	1	7.80839617104804e-45	1	9.47754239479835e-44	1	2.20083808148162e-44	1	3.29766422386575e-44	1	2.05991452368579e-45	1	2.05991452368579e-45
<https://identifiers.org/wikipathways/WP176_r121696>	WP176	Folate metabolism	75	13	1.27588007895806e-92	13	4.34548681176025e-92	13	6.28932624770364e-94	13	8.82921637029876e-91	13	1.27588007895806e-92	13	4.12715603191486e-92	13	1.30655226266786e-95	13	1.30655226266786e-95
<https://identifiers.org/wikipathways/WP1772_r120736>	WP1772	Apoptosis modulation and signaling	97	12	2.68412678781945e-120	12	1.41827074076676e-119	12	4.49380919162169e-122	12	8.46786151367444e-118	12	2.68412678781945e-120	12	1.32236540030118e-119	12	2.31974978969734e-124	12	2.31974978969734e-124
<https://identifiers.org/wikipathways/WP179_r122978>	WP179	Cell cycle	120	5	3.15775541847809e-160	5	2.92399935424255e-159	5	1.3295145691274e-162	5	6.91172164787616e-157	5	3.15775541847809e-160	5	2.66272513066979e-159	5	1.15540376299333e-165	5	1.15540376299333e-165
<https://identifiers.org/wikipathways/WP183_r117060>	WP183	Proteasome degradation	65	13	4.02990039646099e-80	13	1.13108880516039e-79	13	3.19604614466929e-81	13	1.42906033663627e-78	14	3.58948985313343e-78	13	1.08303601278428e-79	13	1.22530873809547e-82	13	1.22530873809547e-82
<https://identifiers.org/wikipathways/WP185_r116785>	WP185	Integrin-mediated cell adhesion	101	4	2.55395163145075e-142	4	1.69164936561314e-141	4	2.45241977786258e-144	4	1.75831590452702e-139	4	2.55395163145075e-142	4	1.56234283412026e-141	4	6.17888823045455e-147	4	6.17888823045455e-147
<https://identifiers.org/wikipathways/WP1946_r122878>	WP1946	Cori cycle	23	4	3.11612262280828e-38	4	4.56692496143529e-38	4	1.21932648094689e-38	4	1.16901812892158e-37	4	3.11612262280828e-38	4	4.49406889571975e-38	4	3.64858240178799e-39	4	3.64858240178799e-39
<https://identifiers.org/wikipathways/WP195_r120702>	WP195	IL-1 signaling pathway	55	4	2.00715216171864e-86	4	5.52513244197555e-86	4	1.66970718829384e-87	4	6.65531549256313e-85	4	2.00715216171864e-86	4	5.29473035322621e-86	4	6.80757120221219e-89	4	6.80757120221219e-89
<https://identifiers.org/wikipathways/WP197_r120482>	WP197	Cholesterol biosynthesis pathway	15	9	1.21593677513573e-12	9	1.37284405174578e-12	9	9.02713511226724e-13	9	1.85035232604273e-12	9	1.21593677513573e-12	9	1.36585163722078e-12	9	6.15535238165215e-13	9	6.15535238165215e-13
<https://identifiers.org/wikipathways/WP1971_r117762>	WP1971	Integrated cancer pathway	49	4	3.5553039438394e-78	4	8.70673091381306e-78	4	3.9420918714941e-79	4	7.86951128129243e-77	4	3.5553039438394e-78	4	8.38478934345833e-78	4	2.32708542613632e-80	4	2.32708542613632e-80
<https://identifiers.org/wikipathways/WP1982_r116442>	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	69	12	3.56176884581031e-87	12	1.10145280128259e-86	12	2.22597837037122e-88	12	1.76562997334263e-85	12	3.56176884581031e-87	12	1.05036833450218e-86	12	6.27845626365594e-90	12	6.27845626365594e-90
<https://identifiers.org/wikipathways/WP1995_r116455>	WP1995	Effects of nitric oxide	8	2	6.8024434972629e-15	2	7.68024644333305e-15	2	5.05014551735233e-15	2	1.03516214044349e-14	2	6.8024434972629e-15	2	7.64112804039599e-15	2	3.44355377994527e-15	2	3.44355377994527e-15
<https://identifiers.org/wikipathways/WP2011_r118441>	WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	18	3	6.6718668881366e-32	3	9.02664649065984e-32	3	3.17703293238933e-32	3	1.89821418483255e-31	3	6.6718668881366e-32	3	8.91257766390336e-32	3	1.22379688816691e-32	3	1.22379688816691e-32
<https://identifiers.org/wikipathways/WP2018_r120672>	WP2018	RANKL/RANK signaling pathway	55	7	1.84445802751576e-79	7	4.78927857009502e-79	7	1.77112942488478e-80	7	4.99813489929578e-78	7	1.84445802751576e-79	7	4.60084793782918e-79	7	8.68719179266805e-82	7	8.68719179266805e-82
<https://identifiers.org/wikipathways/WP2023_r117676>	WP2023	Cell differentiation - expanded index	68	2	1.57802672954986e-108	2	5.8044977891467e-108	2	6.43795038838199e-110	2	1.42462675315999e-106	2	1.57802672954986e-108	2	5.49504960329548e-108	2	1.04803110211091e-111	2	1.04803110211091e-111
<https://identifiers.org/wikipathways/WP2029_r120346>	WP2029	Cell differentiation - index	58	2	1.46703886668009e-95	2	4.44975212073031e-95	2	9.6151757360989e-97	2	6.80186719215408e-94	2	1.46703886668009e-95	2	4.24683182857974e-95	2	2.88343291468867e-98	2	2.88343291468867e-98
<https://identifiers.org/wikipathways/WP2032_r122774>	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	64	4	2.67306193577839e-98	4	8.75964424557203e-98	4	1.44870365803973e-99	4	1.61898041895655e-96	4	2.67306193577839e-98	4	8.33303819465104e-98	4	3.4006912603292e-101	4	3.4006912603292e-101
<https://identifiers.org/wikipathways/WP2034_r120670>	WP2034	Leptin signaling pathway	76	6	1.30761219133396e-108	6	5.19330875275779e-108	6	4.41779240941643e-110	6	1.53872916412944e-106	6	1.30761219133396e-108	6	4.90061019181331e-108	6	5.63957031524025e-112	6	5.63957031524025e-112
<https://identifiers.org/wikipathways/WP2036_r120940>	WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	42	6	1.84283535368343e-63	6	3.78287441674128e-63	6	3.15232418155733e-64	6	2.21629693656142e-62	6	1.84283535368343e-63	6	3.67013974869263e-63	6	3.25214091205834e-65	6	3.25214091205834e-65
<https://identifiers.org/wikipathways/WP2037_r122570>	WP2037	Prolactin signaling pathway	76	7	2.36304203148201e-106	7	9.20699451738924e-106	7	8.36856104983753e-108	7	2.60265047189898e-104	7	2.36304203148201e-106	7	8.69508265461729e-106	7	1.1351649391677e-109	7	1.1351649391677e-109
<https://identifiers.org/wikipathways/WP2038_r117173>	WP2038	Microtubule cytoskeleton regulation	46	2	4.78568919926284e-79	2	1.14930360303913e-78	2	5.56737030483492e-80	2	9.90095915655449e-78	2	4.78568919926284e-79	2	1.10771695950811e-78	2	3.49618565976207e-81	2	3.49618565976207e-81
<https://identifiers.org/wikipathways/WP205_r120718>	WP205	IL-7 signaling pathway	25	3	4.15934888036791e-44	3	6.4715253540027e-44	3	1.40526691654231e-44	3	1.91886861866512e-43	3	4.15934888036791e-44	3	6.35228451833438e-44	3	3.48111932731617e-45	3	3.48111932731617e-45
<https://identifiers.org/wikipathways/WP2059_r119468>	WP2059	Alzheimer's disease and miRNA effects	280	21	1.10135118285065e-263	21	1.27269849209014e-261	21	9.19730768462061e-269	21	1.45073260108666e-256	21	1.10135118285065e-263	21	1.04234984816895e-261	21	2.53297809675962e-275	21	2.53297809675962e-275
<https://identifiers.org/wikipathways/WP206_r117723>	WP206	Fatty acid omega-oxidation	15	2	5.98051921077587e-29	2	7.77336963507248e-29	2	3.14232306891842e-29	2	1.48124910720249e-28	2	5.98051921077587e-29	2	7.68809216228266e-29	2	1.37374350174021e-29	2	1.37374350174021e-29
<https://identifiers.org/wikipathways/WP2064_r117162>	WP2064	Neural crest differentiation	101	5	6.59941101566876e-140	5	4.29002279119496e-139	5	6.63624791889601e-142	5	4.25864112076467e-137	5	6.59941101566876e-140	5	3.96522611299723e-139	5	1.77457669978655e-144	5	1.77457669978655e-144
<https://identifiers.org/wikipathways/WP2112_r117960>	WP2112	IL-17 signaling pathway	32	4	5.33663223723615e-53	4	9.35403887768288e-53	4	1.3455986717835e-53	4	3.71730560772709e-52	4	5.33663223723615e-53	4	9.13577797053705e-53	4	2.287419338134e-54	4	2.287419338134e-54
<https://identifiers.org/wikipathways/WP2113_r105848>	WP2113	Type III interferon signaling	10	2	4.23386842622816e-19	2	4.97689604798731e-19	2	2.84705578791774e-19	2	7.40717183695431e-19	2	4.23386842622816e-19	2	4.94315437986536e-19	2	1.70937254321734e-19	2	1.70937254321734e-19
<https://identifiers.org/wikipathways/WP2118_r119252>	WP2118	Arrhythmogenic right ventricular cardiomyopathy	74	3	2.17446111471511e-113	3	8.80296423893187e-113	3	7.00875327714522e-115	3	2.73369604997455e-111	3	2.17446111471511e-113	3	8.30014005472906e-113	3	8.42041107165414e-117	3	8.42041107165414e-117
<https://identifiers.org/wikipathways/WP2197_r117710>	WP2197	Endothelin pathways	33	3	4.6981156150138e-57	3	8.56739614109177e-57	3	1.07484387190047e-57	3	3.75257985839593e-56	3	4.6981156150138e-57	3	8.35356761843552e-57	3	1.61224178997824e-58	3	1.61224178997824e-58
<https://identifiers.org/wikipathways/WP22_r120719>	WP22	IL-9 signaling pathway	17	2	1.11197781468943e-32	2	1.50444108177663e-32	2	5.29505488731549e-33	2	3.16369030805419e-32	2	1.11197781468943e-32	2	1.48542961065056e-32	2	2.03966148027819e-33	2	2.03966148027819e-33
<https://identifiers.org/wikipathways/WP2203_r120724>	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	47	9	4.43069188645514e-64	9	9.45992052396786e-64	10	8.90412293804338e-63	9	6.10462431910925e-63	9	4.43069188645514e-64	10	1.10870268540901e-61	9	6.26867536591019e-66	10	8.63196597885846e-64
<https://identifiers.org/wikipathways/WP2249_r107453>	WP2249	Metastatic brain tumor	22	1	2.20083808148162e-44	1	3.35675206405441e-44	1	7.80839617104804e-45	1	9.47754239479835e-44	1	2.20083808148162e-44	1	3.29766422386575e-44	1	2.05991452368579e-45	1	2.05991452368579e-45
<https://identifiers.org/wikipathways/WP2261_r118379>	WP2261	Glioblastoma signaling pathways	83	3	2.99642892953959e-124	3	1.44010268593697e-123	3	6.33379958937343e-126	3	6.81382536641454e-122	3	2.99642892953959e-124	3	1.34808334498245e-123	3	4.41657965483428e-128	3	4.41657965483428e-128
<https://identifiers.org/wikipathways/WP2267_r117179>	WP2267	Synaptic vesicle pathway	51	3	1.89283344220288e-83	3	4.91488909276579e-83	3	1.81758161794917e-84	3	5.12922318908542e-82	3	1.89283344220288e-83	3	4.72151640714887e-83	3	8.91503460566096e-86	3	8.91503460566096e-86
<https://identifiers.org/wikipathways/WP2272_r118427>	WP2272	Pathogenic Escherichia coli infection	71	3	1.13171187921269e-109	3	4.3257052516254e-109	3	4.20130316350482e-111	3	1.16658918603867e-107	3	1.13171187921269e-109	3	4.08848915718147e-109	3	6.055903943112e-113	3	6.055903943112e-113
<https://identifiers.org/wikipathways/WP2276_r117054>	WP2276	Glial cell differentiation	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP2289_r120498>	WP2289	Drug induction of bile acid pathway	17	4	1.35558435444253e-27	4	1.76196378394977e-27	4	7.12259895621513e-28	4	3.35749797632566e-27	4	1.35558435444253e-27	4	1.74263422345074e-27	4	3.11381860394446e-28	4	3.11381860394446e-28
<https://identifiers.org/wikipathways/WP229_r116612>	WP229	Irinotecan pathway	13	2	4.15234853256522e-25	2	5.1847339016649e-25	2	2.40775567219621e-25	2	8.95099085494371e-25	2	4.15234853256522e-25	2	5.13652420350907e-25	2	1.1948637812336e-25	2	1.1948637812336e-25
<https://identifiers.org/wikipathways/WP2291_r117696>	WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	16	1	1.30820919375229e-33	1	1.7699306844431e-33	1	6.22947633801837e-34	1	3.72198859771085e-33	1	1.30820919375229e-33	1	1.74756424782419e-33	1	2.39960174150376e-34	1	2.39960174150376e-34
<https://identifiers.org/wikipathways/WP23_r120701>	WP23	B cell receptor signaling pathway	97	2	5.216750014529e-143	2	3.32816478164796e-142	2	5.49373744701861e-145	2	3.15518638973601e-140	2	5.216750014529e-143	2	3.07861809320559e-142	2	1.55924831107226e-147	2	1.55924831107226e-147
<https://identifiers.org/wikipathways/WP231_r120699>	WP231	TNF-alpha signaling pathway	93	11	8.10403324930771e-118	11	4.04554340356671e-117	11	1.56032691978463e-119	11	2.10102257205466e-115	11	8.10403324930771e-118	11	3.78100228786306e-117	11	9.64589321290847e-122	11	9.64589321290847e-122
<https://identifiers.org/wikipathways/WP2324_r120674>	WP2324	AGE/RAGE pathway	66	11	2.12949100213309e-85	11	6.33515523552095e-85	11	1.46375348153996e-86	11	9.23402167262503e-84	11	2.12949100213309e-85	11	6.05118332194822e-85	11	4.66724865326928e-88	11	4.66724865326928e-88
<https://identifiers.org/wikipathways/WP2328_r120805>	WP2328	Allograft rejection	102	25	5.84033936579543e-102	25	2.65124160975246e-101	26	7.28267212776703e-102	25	1.09053123774165e-99	25	5.84033936579543e-102	26	1.1950981410115e-99	25	1.18697242481421e-105	26	6.4644344366804e-104
<https://identifiers.org/wikipathways/WP2332_r120725>	WP2332	Interleukin-11 signaling pathway	44	7	4.04295511267288e-64	7	8.46404729952054e-64	8	1.06503524134044e-62	7	5.20446047408976e-63	7	4.04295511267288e-64	8	1.23998292937976e-61	7	6.38813393440039e-66	8	1.09875903671686e-63
<https://identifiers.org/wikipathways/WP2355_r120664>	WP2355	Corticotropin-releasing hormone signaling pathway	92	4	3.28766503377284e-132	4	1.8385093467877e-131	5	1.28695820477582e-131	4	1.26151777247139e-129	4	3.28766503377284e-132	5	4.30946590887027e-129	4	2.06457720825904e-136	5	5.8923033523713e-134
<https://identifiers.org/wikipathways/WP2359_r119918>	WP2359	Parkin-ubiquitin proteasomal system pathway	73	4	1.17647896304226e-109	4	4.58385217793215e-109	4	4.16642442026065e-111	4	1.29577192768794e-107	4	1.17647896304226e-109	4	4.32898851936834e-109	4	5.65160353781897e-113	4	5.65160353781897e-113
<https://identifiers.org/wikipathways/WP236_r105873>	WP236	Adipogenesis	131	16	2.29356338008785e-148	16	2.12378001255208e-147	16	9.65662480127688e-151	16	5.02017083785726e-145	16	2.29356338008785e-148	16	1.93400945975999e-147	16	8.39201080777332e-154	16	8.39201080777332e-154
<https://identifiers.org/wikipathways/WP2361_r117731>	WP2361	Gastric cancer network 1	29	2	2.63173436537895e-53	2	4.52237605417007e-53	2	6.96672860713736e-54	2	1.71175927581623e-52	2	2.63173436537895e-53	2	4.42053772767913e-53	2	1.26084767549563e-54	2	1.26084767549563e-54
<https://identifiers.org/wikipathways/WP2363_r117737>	WP2363	Gastric cancer network 2	32	1	6.96739672996269e-61	1	1.2959304403406e-60	1	1.51846277022035e-61	1	5.95884058498765e-60	1	6.96739672996269e-61	1	1.26253572408911e-60	1	2.13967059054837e-62	1	2.13967059054837e-62
<https://identifiers.org/wikipathways/WP2369_r118380>	WP2369	Histone modifications	67	1	4.64125508691094e-110	1	1.70720523210199e-109	1	1.89351482011229e-111	1	4.19007868576466e-108	1	4.64125508691094e-110	1	1.61619105979283e-109	1	3.08244441797322e-113	1	3.08244441797322e-113
<https://identifiers.org/wikipathways/WP2371_r119919>	WP2371	Parkinson's disease pathway	47	4	2.32237532617232e-75	4	5.4692485209626e-75	4	2.83471938021177e-76	4	4.49058002545524e-74	4	2.32237532617232e-75	4	5.27568663915071e-75	4	1.8937963672516e-77	4	1.8937963672516e-77
<https://identifiers.org/wikipathways/WP2374_r120781>	WP2374	Oncostatin M signaling pathway	65	14	3.58948985313343e-78	14	9.88086863365104e-78	14	2.98602025516245e-79	14	1.19020310894131e-76	14	3.58948985313343e-78	14	9.46882914034252e-78	14	1.21743175335055e-80	14	1.21743175335055e-80
<https://identifiers.org/wikipathways/WP2380_r120727>	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	144	8	2.2547478834311e-177	8	3.0684568637203e-176	8	3.67870187520865e-180	8	1.86389930933771e-173	8	2.2547478834311e-177	8	2.74941241917464e-176	8	9.39300204379455e-184	8	9.39300204379455e-184
<https://identifiers.org/wikipathways/WP24_r113974>	WP24	Peptide GPCRs	75	13	1.27588007895806e-92	13	4.34548681176025e-92	13	6.28932624770364e-94	13	8.82921637029876e-91	13	1.27588007895806e-92	13	4.12715603191486e-92	13	1.30655226266786e-95	13	1.30655226266786e-95
<https://identifiers.org/wikipathways/WP2406_r119249>	WP2406	Cardiac progenitor differentiation	53	3	3.36823110235866e-86	3	9.09321460484089e-86	3	2.93913440417528e-87	3	1.04423468671196e-84	3	3.36823110235866e-86	3	8.72115181413532e-86	3	1.27441400283838e-88	3	1.27441400283838e-88
<https://identifiers.org/wikipathways/WP241_r120901>	WP241	One-carbon metabolism	29	2	2.63173436537895e-53	2	4.52237605417007e-53	2	6.96672860713736e-54	2	1.71175927581623e-52	2	2.63173436537895e-53	2	4.42053772767913e-53	2	1.26084767549563e-54	2	1.26084767549563e-54
<https://identifiers.org/wikipathways/WP2431_r120812>	WP2431	Spinal cord injury	117	19	1.64130528384247e-128	19	1.10770458308999e-127	20	1.01891988685662e-128	19	1.20550636867964e-125	19	1.64130528384247e-128	20	6.49114885690771e-126	19	3.57296527749422e-133	20	2.56717555187951e-131
<https://identifiers.org/wikipathways/WP2435_r120750>	WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	17	2	1.11197781468943e-32	2	1.50444108177663e-32	2	5.29505488731549e-33	2	3.16369030805419e-32	2	1.11197781468943e-32	2	1.48542961065056e-32	2	2.03966148027819e-33	2	2.03966148027819e-33
<https://identifiers.org/wikipathways/WP2436_r107129>	WP2436	Dopamine metabolism	13	1	6.88044495868306e-28	1	8.76539966469129e-28	1	3.7977218804357e-28	1	1.58987404173068e-27	1	6.88044495868306e-28	1	8.67656115457625e-28	1	1.76885829938359e-28	1	1.76885829938359e-28
<https://identifiers.org/wikipathways/WP244_r120686>	WP244	Alpha 6 beta 4 signaling pathway	33	1	1.87387198116355e-62	1	3.55492140741808e-62	1	3.89047138332856e-63	1	1.71589650353045e-61	1	1.87387198116355e-62	1	3.46043844642363e-62	1	5.15019179344245e-64	1	5.15019179344245e-64
<https://identifiers.org/wikipathways/WP2446_r116593>	WP2446	Retinoblastoma gene in cancer	90	5	1.65482529223702e-127	5	8.74396210980527e-127	5	2.77053570737773e-129	5	5.22062946786987e-125	5	1.65482529223702e-127	5	8.15268384462337e-127	5	1.43017857467587e-131	5	1.43017857467587e-131
<https://identifiers.org/wikipathways/WP2447_r113794>	WP2447	Amyotrophic lateral sclerosis (ALS)	38	4	3.11611307745094e-62	4	6.14950290553714e-62	4	5.8719606782817e-63	4	3.27046363477775e-61	4	3.11611307745094e-62	4	5.97613383523173e-62	4	6.86155098957642e-64	4	6.86155098957642e-64
<https://identifiers.org/wikipathways/WP2456_r119185>	WP2456	HIF1A and PPARG regulation of glycolysis	8	2	6.8024434972629e-15	2	7.68024644333305e-15	2	5.05014551735233e-15	2	1.03516214044349e-14	2	6.8024434972629e-15	2	7.64112804039599e-15	2	3.44355377994527e-15	2	3.44355377994527e-15
<https://identifiers.org/wikipathways/WP247_r118104>	WP247	Small ligand GPCRs	19	3	1.04678340936909e-33	3	1.44487180558162e-33	3	4.74556805938655e-34	3	3.19168756741756e-33	3	1.04678340936909e-33	3	1.42541225264451e-33	3	1.71602515683919e-34	3	1.71602515683919e-34
<https://identifiers.org/wikipathways/WP2485_r117161>	WP2485	NAD biosynthesis II (from tryptophan)	8	2	6.8024434972629e-15	2	7.68024644333305e-15	2	5.05014551735233e-15	2	1.03516214044349e-14	2	6.8024434972629e-15	2	7.64112804039599e-15	2	3.44355377994527e-15	2	3.44355377994527e-15
<https://identifiers.org/wikipathways/WP2491_r117698>	WP2491	Diclofenac metabolic pathway	5	2	3.49839708343393e-08	2	3.71755608873899e-08	2	3.01376650263572e-08	2	4.31677104834896e-08	2	3.49839708343393e-08	2	3.70806445617204e-08	2	2.48808468683897e-08	2	2.48808468683897e-08
<https://identifiers.org/wikipathways/WP2507_r110715>	WP2507	Nanomaterial induced apoptosis	21	3	2.99049238267922e-37	3	4.29615865937391e-37	3	1.22896542546029e-37	3	1.04703362851237e-36	3	2.99049238267922e-37	3	4.23117474687918e-37	3	3.91681810405387e-38	3	3.91681810405387e-38
<https://identifiers.org/wikipathways/WP2513_r119820>	WP2513	Nanoparticle triggered regulated necrosis	14	2	4.81631147107814e-27	2	6.13577976528392e-27	2	2.65840531630502e-27	2	1.11291182921147e-26	2	4.81631147107814e-27	2	6.07359280820331e-27	2	1.23820080956851e-27	2	1.23820080956851e-27
<https://identifiers.org/wikipathways/WP2516_r116808>	WP2516	ATM signaling pathway	41	2	8.42656939348989e-72	2	1.8348329423685e-71	2	1.24704324501484e-72	2	1.24257910557888e-70	2	8.42656939348989e-72	2	1.77574253381993e-71	2	1.06763050327672e-73	2	1.06763050327672e-73
<https://identifiers.org/wikipathways/WP2525_r116582>	WP2525	Trans-sulfuration and one-carbon metabolism	31	2	1.63499762170229e-56	2	2.92313714927592e-56	2	3.92684437290914e-57	2	1.21958845397869e-55	2	1.63499762170229e-56	2	2.85255348788625e-56	2	6.27033809795505e-58	2	6.27033809795505e-58
<https://identifiers.org/wikipathways/WP2526_r121697>	WP2526	PDGF pathway	41	3	3.46612887718893e-69	3	7.40049286755302e-69	3	5.38307000764725e-70	3	4.77564569577482e-68	3	3.46612887718893e-69	3	7.16808069485303e-69	3	4.90398277838449e-71	3	4.90398277838449e-71
<https://identifiers.org/wikipathways/WP2533_r120261>	WP2533	Glycerophospholipid biosynthetic pathway	44	4	4.5182787468575e-71	4	1.00332483438186e-70	4	6.3718521361791e-72	4	7.13029361970831e-70	4	4.5182787468575e-71	4	9.70211803544177e-71	4	5.12679419340022e-73	4	5.12679419340022e-73
<https://identifiers.org/wikipathways/WP2536_r117685>	WP2536	Colchicine metabolic pathway	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
<https://identifiers.org/wikipathways/WP254_r118382>	WP254	Apoptosis	87	14	5.93565727313933e-105	14	2.49660863345196e-104	14	1.74152917992337e-106	14	8.51584712919592e-103	14	5.93565727313933e-105	14	2.3502211392817e-104	14	1.85346599495225e-108	14	1.85346599495225e-108
<https://identifiers.org/wikipathways/WP2572_r119251>	WP2572	Primary focal segmental glomerulosclerosis (FSGS)	73	4	1.17647896304226e-109	4	4.58385217793215e-109	4	4.16642442026065e-111	4	1.29577192768794e-107	4	1.17647896304226e-109	4	4.32898851936834e-109	4	5.65160353781897e-113	4	5.65160353781897e-113
<https://identifiers.org/wikipathways/WP2583_r117181>	WP2583	T cell receptor and co-stimulatory signaling	32	1	6.96739672996269e-61	1	1.2959304403406e-60	1	1.51846277022035e-61	1	5.95884058498765e-60	1	6.96739672996269e-61	1	1.26253572408911e-60	1	2.13967059054837e-62	1	2.13967059054837e-62
<https://identifiers.org/wikipathways/WP2586_r121728>	WP2586	Aryl hydrocarbon receptor pathway	48	3	2.90228893374645e-79	3	7.10753543984714e-79	3	3.21803418081149e-80	3	6.42409084187123e-78	3	2.90228893374645e-79	3	6.84472599465976e-79	3	1.89966157235624e-81	3	1.89966157235624e-81
<https://identifiers.org/wikipathways/WP2597_r117821>	WP2597	Secretion of hydrochloric acid in parietal cells	5	1	5.83552474300908e-11	1	6.32775504466212e-11	1	4.78375635338997e-11	1	7.7223095677084e-11	1	5.83552474300908e-11	1	6.30623206831977e-11	1	3.70526386722106e-11	1	3.70526386722106e-11
<https://identifiers.org/wikipathways/WP26_r118660>	WP26	S1P receptor signal transduction	25	2	1.02447016757832e-46	2	1.62601139547809e-46	2	3.29616946804295e-47	2	5.06297788566005e-46	2	1.02447016757832e-46	2	1.59471577866131e-46	2	7.66766371655566e-48	2	7.66766371655566e-48
<https://identifiers.org/wikipathways/WP262_r116630>	WP262	Ebstein-Barr virus LMP1 signaling	24	3	2.02477103496315e-42	3	3.0882118989301e-42	4	2.29340403939849e-40	3	8.71933900321451e-42	3	2.02477103496315e-42	4	9.04846086386517e-40	3	1.89512136179094e-43	4	6.44341263008922e-41
<https://identifiers.org/wikipathways/WP2637_r117962>	WP2637	Interleukin-1 (IL-1) structural pathway	51	4	5.88197992164537e-81	4	1.49781245102044e-80	4	5.92531607451424e-82	4	1.49003933642932e-79	4	5.88197992164537e-81	4	1.44006250418039e-80	4	3.0912882495131e-83	4	3.0912882495131e-83
<https://identifiers.org/wikipathways/WP2640_r117652>	WP2640	Aripiprazole metabolic pathway	2	1	0.00167224080267564	1	0.00170648464163818	1	0.00159108989657917	1	0.00179372197309415	1	0.00167224080267564	1	0.00170502983802214	1	0.00149253731343287	1	0.00149253731343287
<https://identifiers.org/wikipathways/WP2643_r110709>	WP2643	Nanoparticle-mediated activation of receptor signaling	28	3	4.51346073640926e-49	3	7.45415447808768e-49	3	1.31711689809092e-49	3	2.55925719589106e-48	3	4.51346073640926e-49	3	7.29847038288947e-49	3	2.70225743362341e-50	3	2.70225743362341e-50
<https://identifiers.org/wikipathways/WP2646_r106722>	WP2646	Lidocaine metabolism	2	1	0.00167224080267564	1	0.00170648464163818	1	0.00159108989657917	1	0.00179372197309415	1	0.00167224080267564	1	0.00170502983802214	1	0.00149253731343287	1	0.00149253731343287
<https://identifiers.org/wikipathways/WP268_r117167>	WP268	Notch signaling	46	3	1.97648963929551e-76	3	4.65467959230847e-76	3	2.41252713209502e-77	3	3.82177023442999e-75	3	1.97648963929551e-76	3	4.48994607587281e-76	3	1.61174158915029e-78	3	1.61174158915029e-78
<https://identifiers.org/wikipathways/WP272_r120902>	WP272	Blood clotting cascade	23	4	3.11612262280828e-38	4	4.56692496143529e-38	4	1.21932648094689e-38	4	1.16901812892158e-37	4	3.11612262280828e-38	4	4.49406889571975e-38	4	3.64858240178799e-39	4	3.64858240178799e-39
<https://identifiers.org/wikipathways/WP2795_r117670>	WP2795	Cardiac hypertrophic response	54	2	3.51182123505478e-90	2	9.85677385025037e-90	2	2.78516628572798e-91	2	1.24534205380881e-88	2	3.51182123505478e-90	2	9.43802202001087e-90	2	1.06778451639166e-92	2	1.06778451639166e-92
<https://identifiers.org/wikipathways/WP2806_r116569>	WP2806	Complement system	136	22	2.41567269444369e-142	22	2.19586960129805e-141	22	1.06443430124502e-144	22	4.96051112762032e-139	22	2.41567269444369e-142	22	2.00121242046749e-141	22	9.81039490645926e-148	22	9.81039490645926e-148
<https://identifiers.org/wikipathways/WP2813_r102405>	WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	20	2	4.27213197525603e-38	2	6.13736951339127e-38	2	1.75566489351474e-38	2	1.49576232644626e-37	2	4.27213197525603e-38	2	6.04453535268457e-38	2	5.59545443436273e-39	2	5.59545443436273e-39
<https://identifiers.org/wikipathways/WP2814_r102407>	WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	14	2	4.81631147107814e-27	2	6.13577976528392e-27	2	2.65840531630502e-27	2	1.11291182921147e-26	2	4.81631147107814e-27	2	6.07359280820331e-27	2	1.23820080956851e-27	2	1.23820080956851e-27
<https://identifiers.org/wikipathways/WP2815_r102408>	WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	12	4	4.65725526885105e-18	4	5.47458565278608e-18	4	3.13176136670955e-18	4	8.14788902064975e-18	4	4.65725526885105e-18	4	5.43746981785196e-18	4	1.88030979753908e-18	4	1.88030979753908e-18
<https://identifiers.org/wikipathways/WP2816_r117724>	WP2816	Felbamate metabolism	4	1	1.39935883337357e-08	1	1.48702243549559e-08	1	1.20550660105429e-08	1	1.72670841933958e-08	1	1.39935883337357e-08	1	1.48322578246882e-08	1	9.9523387473559e-09	1	9.9523387473559e-09
<https://identifiers.org/wikipathways/WP2817_r102410>	WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	38	2	2.46962657958111e-67	2	5.06951811409979e-67	2	4.22450305756807e-68	2	2.97011114521763e-66	2	2.46962657958111e-67	2	4.91843975970617e-67	2	4.35826978297812e-69	2	4.35826978297812e-69
<https://identifiers.org/wikipathways/WP2826_r106727>	WP2826	Cocaine metabolism	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP2828_r119245>	WP2828	Bladder cancer	40	4	3.21051455345541e-65	4	6.59037354832971e-65	5	1.41909506709825e-63	4	3.86114448878291e-64	4	3.21051455345541e-65	5	1.5447835597285e-62	4	5.66575071787158e-67	5	1.55808144741473e-64
<https://identifiers.org/wikipathways/WP2839_r117746>	WP2839	Hair follicle development: organogenesis - part 2 of 3	32	4	5.33663223723615e-53	4	9.35403887768288e-53	4	1.3455986717835e-53	4	3.71730560772709e-52	4	5.33663223723615e-53	4	9.13577797053705e-53	4	2.287419338134e-54	4	2.287419338134e-54
<https://identifiers.org/wikipathways/WP2840_r120866>	WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	88	10	3.7832966813641e-114	10	1.75044144851636e-113	10	8.78089626757189e-116	10	7.54436296503242e-112	10	3.7832966813641e-114	10	1.64121390212891e-113	10	6.90766868422162e-118	10	6.90766868422162e-118
<https://identifiers.org/wikipathways/WP2846_r116729>	WP2846	PCSK9-mediated LDL receptor degradation	2	2	1	2	1	2	1	2	1	2	1	2	1	2	1	2	1
<https://identifiers.org/wikipathways/WP2848_r120814>	WP2848	Pluripotent stem cell differentiation pathway	50	9	2.76616628458503e-68	9	6.26415760871907e-68	9	3.71748690165515e-69	9	4.67142266842699e-67	9	2.76616628458503e-68	9	6.05242598303277e-68	9	2.81119214938103e-70	9	2.81119214938103e-70
<https://identifiers.org/wikipathways/WP2849_r117150>	WP2849	Hematopoietic stem cell differentiation	94	9	4.005072526589e-123	9	2.11624771411213e-122	9	6.70535826205055e-125	9	1.26351704626181e-120	9	4.005072526589e-123	9	1.9731442489573e-122	9	3.46137380448616e-127	9	3.46137380448616e-127
<https://identifiers.org/wikipathways/WP2853_r116557>	WP2853	Endoderm differentiation	145	7	1.47306395561738e-180	7	2.07888574390635e-179	7	2.19754963341072e-183	7	1.38044401464872e-176	7	1.47306395561738e-180	7	1.85988861973911e-179	7	4.99799196111009e-187	7	4.99799196111009e-187
<https://identifiers.org/wikipathways/WP2855_r117704>	WP2855	Dopaminergic neurogenesis	30	2	6.45560351278569e-55	2	1.13153696101003e-54	2	1.62774032877039e-55	2	4.49674065450855e-54	2	6.45560351278569e-55	2	1.1051344319198e-54	2	2.76703952193629e-56	2	2.76703952193629e-56
<https://identifiers.org/wikipathways/WP2857_r118395>	WP2857	Mesodermal commitment pathway	153	8	6.0108593496098e-186	8	9.62969379632218e-185	8	6.56180040988048e-189	8	8.72421960222708e-182	8	6.0108593496098e-186	8	8.5694769394762e-185	8	9.96653802699658e-193	8	9.96653802699658e-193
<https://identifiers.org/wikipathways/WP2858_r116763>	WP2858	Ectoderm differentiation	142	14	4.88407913955645e-163	14	5.74402842736624e-162	14	1.14148596919003e-165	14	2.43988008486446e-159	14	4.88407913955645e-163	14	5.17846255144104e-162	14	4.63762873379231e-169	14	4.63762873379231e-169
<https://identifiers.org/wikipathways/WP286_r120663>	WP286	IL-3 signaling pathway	49	6	1.82074225571906e-73	6	4.28789084043468e-73	7	4.12417653188245e-72	6	3.5206147399569e-72	6	1.82074225571906e-73	7	7.17915437855608e-71	6	1.48473635192522e-75	7	2.93129376908664e-73
<https://identifiers.org/wikipathways/WP2864_r108133>	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	53	5	2.60832448335566e-81	5	6.7727171698316e-81	5	2.50462746953397e-82	5	7.06806955455976e-80	5	2.60832448335566e-81	5	6.50624960905114e-81	5	1.22849176866015e-83	5	1.22849176866015e-83
<https://identifiers.org/wikipathways/WP2865_r120807>	WP2865	IL1 and megakaryocytes in obesity	24	10	1.29355711996132e-26	10	1.7153944120398e-26	10	6.4702361919734e-27	10	3.43393463238244e-26	10	1.29355711996132e-26	10	1.69514523685551e-26	10	2.65509996082681e-27	10	2.65509996082681e-27
<https://identifiers.org/wikipathways/WP2868_r117183>	WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	5	1	5.83552474300908e-11	1	6.32775504466212e-11	1	4.78375635338997e-11	1	7.7223095677084e-11	1	5.83552474300908e-11	1	6.30623206831977e-11	1	3.70526386722106e-11	1	3.70526386722106e-11
<https://identifiers.org/wikipathways/WP2870_r106411>	WP2870	Extracellular vesicle-mediated signaling in recipient cells	30	2	6.45560351278569e-55	2	1.13153696101003e-54	2	1.62774032877039e-55	2	4.49674065450855e-54	2	6.45560351278569e-55	2	1.1051344319198e-54	2	2.76703952193629e-56	2	2.76703952193629e-56
<https://identifiers.org/wikipathways/WP2873_r120645>	WP2873	Aryl hydrocarbon receptor pathway	46	7	5.50035890590652e-67	7	1.19766885480161e-66	7	8.13995007750976e-68	7	8.11081085375534e-66	7	5.50035890590652e-67	7	1.15909818152558e-66	7	6.96885134708865e-69	7	6.96885134708865e-69
<https://identifiers.org/wikipathways/WP2874_r116465>	WP2874	Liver X receptor pathway	10	5	1.2254601960319e-11	5	1.35594750957046e-11	5	9.55992546434793e-12	5	1.73907239594505e-11	5	1.2254601960319e-11	5	1.35018732473796e-11	5	6.9473697510396e-12	5	6.9473697510396e-12
<https://identifiers.org/wikipathways/WP2875_r117690>	WP2875	Constitutive androstane receptor pathway	32	8	7.07181923782713e-44	8	1.14496238735109e-43	9	3.08178660584141e-42	8	3.74368508223116e-43	8	7.07181923782713e-44	9	1.4909954644172e-41	8	4.73372192339524e-45	9	7.16895886843066e-43
<https://identifiers.org/wikipathways/WP2876_r116466>	WP2876	Pregnane X receptor pathway	33	8	1.91286913810076e-45	8	3.15917715573462e-45	8	5.58212957366616e-46	8	1.0846497604357e-44	8	1.91286913810076e-45	8	3.09319601213114e-45	8	1.14525530404723e-46	8	1.14525530404723e-46
<https://identifiers.org/wikipathways/WP2877_r119905>	WP2877	Vitamin D receptor pathway	186	30	1.32918103481186e-174	30	2.59543515610587e-173	30	8.91107409908311e-178	30	3.81835039761034e-170	30	1.32918103481186e-174	30	2.29054970102124e-173	30	7.20503640039521e-182	30	7.20503640039521e-182
<https://identifiers.org/wikipathways/WP2878_r116507>	WP2878	PPAR-alpha pathway	26	2	2.18508813429337e-48	2	3.53776537928285e-48	2	6.69534423196219e-49	2	1.15674362941265e-47	2	2.18508813429337e-48	2	3.46677343187244e-48	2	1.4626504521676e-49	2	1.4626504521676e-49
<https://identifiers.org/wikipathways/WP2879_r116462>	WP2879	Farnesoid X receptor pathway	19	3	1.04678340936909e-33	3	1.44487180558162e-33	3	4.74556805938655e-34	3	3.19168756741756e-33	3	1.04678340936909e-33	3	1.42541225264451e-33	3	1.71602515683919e-34	3	1.71602515683919e-34
<https://identifiers.org/wikipathways/WP288_r118398>	WP288	Nod-like receptor (NLR) signaling pathway	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP2880_r117734>	WP2880	Glucocorticoid receptor pathway	71	16	6.34747689196229e-82	16	1.88835038157864e-81	16	4.36308084434147e-83	16	2.7524295302565e-80	16	6.34747689196229e-82	16	1.80370549894868e-81	16	1.39118939436663e-84	16	1.39118939436663e-84
<https://identifiers.org/wikipathways/WP2881_r117716>	WP2881	Estrogen receptor pathway	13	3	1.66924411009121e-22	3	2.04278515725596e-22	3	1.01687547889088e-22	3	3.35662157060388e-22	3	1.66924411009121e-22	3	2.02550271091708e-22	3	5.37688701555125e-23	3	5.37688701555125e-23
<https://identifiers.org/wikipathways/WP2882_r120815>	WP2882	Nuclear receptors meta-pathway	318	54	4.58837750965734e-237	54	5.76136899028692e-235	55	8.62608541637287e-241	54	8.04500658318333e-230	54	4.58837750965734e-237	55	1.22769535574845e-233	54	6.58727322995961e-249	55	1.91989072502277e-247
<https://identifiers.org/wikipathways/WP2884_r106658>	WP2884	NRF2 pathway	143	20	1.00673532759688e-152	20	1.08027653511731e-151	20	2.94869211558157e-155	20	3.66517966522131e-149	20	1.00673532759688e-152	20	9.77671119040541e-152	20	1.60362516382941e-158	20	1.60362516382941e-158
<https://identifiers.org/wikipathways/WP289_r122789>	WP289	Myometrial relaxation and contraction pathways	156	11	2.26088456336624e-182	11	3.62204882658966e-181	11	2.46811186083623e-185	11	3.28146979971776e-178	11	2.26088456336624e-182	11	3.22326592616803e-181	11	3.74874716988742e-189	11	3.74874716988742e-189
<https://identifiers.org/wikipathways/WP2895_r118446>	WP2895	Differentiation of white and brown adipocyte	25	2	1.02447016757832e-46	2	1.62601139547809e-46	2	3.29616946804295e-47	2	5.06297788566005e-46	2	1.02447016757832e-46	2	1.59471577866131e-46	2	7.66766371655566e-48	2	7.66766371655566e-48
<https://identifiers.org/wikipathways/WP2911_r120808>	WP2911	miRNA targets in ECM and membrane receptors	41	7	9.4907901158936e-60	7	1.8729628849436e-59	7	1.78843145229947e-60	7	9.96089781335169e-59	7	9.4907901158936e-60	7	1.82015961953058e-59	7	2.08983238711098e-61	7	2.08983238711098e-61
<https://identifiers.org/wikipathways/WP299_r117807>	WP299	Nuclear receptors in lipid metabolism and toxicity	35	8	1.52561641161019e-48	8	2.62162139860242e-48	8	4.03861257355748e-49	8	9.92306852190682e-48	8	1.52561641161019e-48	8	2.56258572073561e-48	8	7.30913397484812e-50	8	7.30913397484812e-50
<https://identifiers.org/wikipathways/WP3_r120028>	WP3	Transcriptional activation by NRF2 in response to phytochemicals	15	3	2.40815573553907e-26	3	3.06788988264195e-26	3	1.32920265815249e-26	3	5.56455914605738e-26	3	2.40815573553907e-26	3	3.03679640410163e-26	3	6.1910040478426e-27	3	6.1910040478426e-27
<https://identifiers.org/wikipathways/WP304_r120696>	WP304	Kit receptor signaling pathway	58	7	1.76950534577114e-83	7	4.87095676084564e-83	7	1.4720138571999e-84	7	5.86732613824381e-82	7	1.76950534577114e-83	7	4.66783427940405e-83	7	6.00155477187017e-86	7	6.00155477187017e-86
<https://identifiers.org/wikipathways/WP306_r116784>	WP306	Focal adhesion	198	20	4.1509789277039e-202	20	1.19833792192307e-200	20	1.06176065694712e-205	20	4.59250343700575e-197	20	4.1509789277039e-202	20	1.04033484777317e-200	20	2.46755001981256e-210	20	2.46755001981256e-210
<https://identifiers.org/wikipathways/WP313_r118735>	WP313	Hepatocyte growth factor receptor signaling	34	2	3.18558236797802e-61	2	6.04336639261088e-61	2	6.61380135165845e-62	2	2.91702405600181e-60	2	3.18558236797802e-61	2	5.88274535892017e-61	2	8.75532604885219e-63	2	8.75532604885219e-63
<https://identifiers.org/wikipathways/WP314_r121827>	WP314	Fas ligand pathway and stress induction of heat shock proteins	43	5	3.12991437610147e-67	5	6.68264505940034e-67	5	4.86091221690568e-68	5	4.31240806328476e-66	5	3.12991437610147e-67	5	6.4727768674522e-67	5	4.42829644888117e-69	5	4.42829644888117e-69
<https://identifiers.org/wikipathways/WP322_r117584>	WP322	Osteoblast signaling	14	3	1.93776264853043e-24	3	2.41954248744363e-24	3	1.12361931369157e-24	3	4.17712906564039e-24	3	1.93776264853043e-24	3	2.39704462830424e-24	3	5.5760309790902e-25	3	5.5760309790902e-25
<https://identifiers.org/wikipathways/WP325_r116669>	WP325	Triacylglyceride synthesis	24	3	2.02477103496315e-42	3	3.0882118989301e-42	3	7.18372447736427e-43	3	8.71933900321451e-42	3	2.02477103496315e-42	3	3.03385108595649e-42	3	1.89512136179094e-43	3	1.89512136179094e-43
<https://identifiers.org/wikipathways/WP3286_r106367>	WP3286	Copper homeostasis	55	3	6.43833893093359e-89	3	1.80707520587918e-88	3	5.10613819050115e-90	3	2.28312709864939e-87	3	6.43833893093359e-89	3	1.73030403700196e-88	3	1.95760494671804e-91	3	1.95760494671804e-91
<https://identifiers.org/wikipathways/WP3287_r121705>	WP3287	Overview of nanoparticle effects	22	5	3.99021398620888e-34	5	5.61894591059518e-34	6	3.65408740572762e-32	5	1.30376627422363e-33	5	3.99021398620888e-34	6	1.09756743453627e-31	5	5.84663438392126e-35	6	1.32133937076618e-32
<https://identifiers.org/wikipathways/WP3297_r106734>	WP3297	EV release from cardiac cells and their functional effects	12	2	3.85210179251818e-23	2	4.71411959366764e-23	2	2.34663572051742e-23	2	7.74604977831665e-23	2	3.85210179251818e-23	2	4.67423702519325e-23	2	1.24082008051183e-23	2	1.24082008051183e-23
<https://identifiers.org/wikipathways/WP3298_r120642>	WP3298	Melatonin metabolism and effects	40	3	1.04237485501801e-67	3	2.18224289679797e-67	3	1.69894941216969e-68	3	1.34183996134941e-66	3	1.04237485501801e-67	3	2.11545796116397e-67	3	1.64702055752086e-69	3	1.64702055752086e-69
<https://identifiers.org/wikipathways/WP3303_r120561>	WP3303	RAC1/PAK1/p38/MMP2 pathway	68	9	4.33652609275228e-92	9	1.3939068038036e-91	9	2.46447639297665e-93	9	2.45696465811029e-90	9	4.33652609275228e-92	9	1.32709892287393e-91	9	6.14998612842616e-95	9	6.14998612842616e-95
<https://identifiers.org/wikipathways/WP334_r117741>	WP334	GPCRs, class B secretin-like	23	NA	NA	NA	NA	3	3.82234006566423e-41	NA	NA	NA	NA	3	1.50807681064421e-40	NA	NA	3	1.07390210501487e-41
<https://identifiers.org/wikipathways/WP34_r116553>	WP34	Ovarian infertility	32	3	1.74399746314906e-55	3	3.11801295922765e-55	3	4.18863399776977e-56	3	1.30089435091059e-54	3	1.74399746314906e-55	3	3.04272372041197e-55	3	6.68836063781861e-57	3	6.68836063781861e-57
<https://identifiers.org/wikipathways/WP3408_r118453>	WP3408	Evolocumab mechanism to reduce LDL cholesterol	2	2	1	2	1	2	1	2	1	2	1	2	1	2	1	2	1
<https://identifiers.org/wikipathways/WP3413_r116601>	WP3413	NOTCH1 regulation of endothelial cell calcification	17	6	6.58839300500343e-23	6	8.22644445730827e-23	6	3.82030566655132e-23	6	1.42022388231773e-22	6	6.58839300500343e-23	6	8.14995173623443e-23	6	1.89585053289067e-23	6	1.89585053289067e-23
<https://identifiers.org/wikipathways/WP35_r117729>	WP35	G protein signaling pathways	92	3	1.02419471457093e-134	3	5.83653760884946e-134	3	1.42387834658322e-136	3	4.19457280954759e-132	3	1.02419471457093e-134	3	5.42460117174621e-134	3	5.78312943489932e-139	3	5.78312943489932e-139
<https://identifiers.org/wikipathways/WP3527_r120810>	WP3527	Pre-implantation embryo	59	3	2.88517643780422e-94	3	8.75117917076962e-94	3	1.89098456143276e-95	3	1.33770054779028e-92	3	2.88517643780422e-94	3	8.3521025962072e-94	3	5.67075139888801e-97	3	5.67075139888801e-97
<https://identifiers.org/wikipathways/WP3529_r120882>	WP3529	Zinc homeostasis	37	1	1.29980346293743e-68	1	2.66816742847361e-68	1	2.22342266187794e-69	1	1.56321639221983e-67	1	1.29980346293743e-68	1	2.58865250510843e-68	1	2.29382620156746e-70	1	2.29382620156746e-70
<https://identifiers.org/wikipathways/WP357_r121828>	WP357	Fatty acid biosynthesis	23	3	1.02588399104799e-40	3	1.53381190980192e-40	3	3.82234006566423e-41	3	4.12352073693678e-40	3	1.02588399104799e-40	3	1.50807681064421e-40	3	1.07390210501487e-41	3	1.07390210501487e-41
<https://identifiers.org/wikipathways/WP3580_r120915>	WP3580	Methionine de novo and salvage pathway	22	4	1.64477081047357e-36	4	2.36288726265565e-36	4	6.75930984003172e-37	4	5.7586849568181e-36	4	1.64477081047357e-36	4	2.32714611078356e-36	4	2.15424995722963e-37	4	2.15424995722963e-37
<https://identifiers.org/wikipathways/WP3584_r117155>	WP3584	MECP2 and associated Rett syndrome	73	3	3.72009158274236e-112	3	1.47747048442611e-111	3	1.25683994577996e-113	3	4.37760786381039e-110	3	3.72009158274236e-112	3	1.39419920108483e-111	3	1.6044296771665e-115	3	1.6044296771665e-115
<https://identifiers.org/wikipathways/WP3591_r88424>	WP3591	Sleep regulation	39	3	3.21051455345549e-66	3	6.59037354832987e-66	3	5.49185397483849e-67	3	3.86114448878298e-65	3	3.21051455345549e-66	3	6.39397168761802e-66	3	5.6657507178718e-68	3	5.6657507178718e-68
<https://identifiers.org/wikipathways/WP3593_r117786>	WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP3594_r117682>	WP3594	Circadian rhythm genes	209	22	1.2753524140906e-207	22	4.31255063438566e-206	22	2.20902968473931e-211	22	2.43395882488615e-202	22	1.2753524140906e-207	22	3.71913858977163e-206	22	3.0992420383419e-216	22	3.0992420383419e-216
<https://identifiers.org/wikipathways/WP3595_r89883>	WP3595	mir-124 predicted interactions with cell cycle and differentiation 	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP3599_r105845>	WP3599	Transcription factor regulation in adipogenesis	22	5	3.99021398620888e-34	5	5.61894591059518e-34	5	1.72227214724004e-34	5	1.30376627422363e-33	5	3.99021398620888e-34	5	5.53860774366482e-34	5	5.84663438392126e-35	5	5.84663438392126e-35
<https://identifiers.org/wikipathways/WP3601_r117687>	WP3601	Lipid particles composition	11	4	4.66889840702315e-16	4	5.37878040386231e-16	4	3.2987886396007e-16	4	7.6182762343076e-16	4	4.66889840702315e-16	4	5.34684532088774e-16	4	2.11064774773761e-16	4	2.11064774773761e-16
<https://identifiers.org/wikipathways/WP3611_r120501>	WP3611	Photodynamic therapy-induced AP-1 survival signaling	50	9	2.76616628458503e-68	9	6.26415760871907e-68	9	3.71748690165515e-69	9	4.67142266842699e-67	9	2.76616628458503e-68	9	6.05242598303277e-68	9	2.81119214938103e-70	9	2.81119214938103e-70
<https://identifiers.org/wikipathways/WP3612_r106540>	WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	23	3	1.02588399104799e-40	3	1.53381190980192e-40	3	3.82234006566423e-41	3	4.12352073693678e-40	3	1.02588399104799e-40	3	1.50807681064421e-40	3	1.07390210501487e-41	3	1.07390210501487e-41
<https://identifiers.org/wikipathways/WP3613_r106539>	WP3613	Photodynamic therapy-induced unfolded protein response	27	4	5.99315048033311e-45	4	9.51216666354672e-45	5	4.9324868770634e-43	4	2.96184206311115e-44	4	5.99315048033311e-45	5	2.22965186593537e-42	4	4.48558327418498e-46	5	1.22187288388797e-43
<https://identifiers.org/wikipathways/WP3614_r106542>	WP3614	Photodynamic therapy-induced HIF-1 survival signaling	37	12	2.55223115607806e-43	12	4.21510818687873e-43	12	7.44791409480382e-44	12	1.44718572581769e-42	12	2.55223115607806e-43	12	4.12707334588295e-43	12	1.52804821324849e-44	12	1.52804821324849e-44
<https://identifiers.org/wikipathways/WP3617_r106541>	WP3617	Photodynamic therapy-induced NF-kB survival signaling	35	16	1.42871106133135e-32	16	2.09388942556846e-32	17	4.19286748687007e-31	16	5.35983121929259e-32	16	1.42871106133135e-32	17	1.44355200398015e-30	16	1.67283854539579e-33	17	1.33630279096911e-31
<https://identifiers.org/wikipathways/WP3624_r122572>	WP3624	Lung fibrosis	64	19	1.46320570002388e-67	19	3.58330497276898e-67	20	1.05536501170376e-66	19	3.23874243808091e-66	19	1.46320570002388e-67	20	2.09981671404262e-65	19	9.57725334810076e-70	20	6.62745931688555e-68
<https://identifiers.org/wikipathways/WP363_r120695>	WP363	Wnt signaling pathway	51	1	7.33286887306001e-89	1	1.97965484865908e-88	1	6.39869609036695e-90	1	2.27337014523651e-87	1	7.33286887306001e-89	1	1.89865424110347e-88	1	2.77448621808068e-91	1	2.77448621808068e-91
<https://identifiers.org/wikipathways/WP3630_r121716>	WP3630	NAD metabolism, sirtuins and aging	11	2	3.86815221665368e-21	2	4.63947936676791e-21	2	2.47570068514584e-21	2	7.25546662568996e-21	2	3.86815221665368e-21	2	4.60412346981535e-21	2	1.39488857384204e-21	2	1.39488857384204e-21
<https://identifiers.org/wikipathways/WP364_r121718>	WP364	IL6 signaling pathway	44	10	1.04746686912411e-57	10	2.06712670401606e-57	10	1.97383217952115e-58	10	1.0993510886669e-56	10	1.04746686912411e-57	10	2.00884950008854e-57	10	2.30647834457477e-59	10	2.30647834457477e-59
<https://identifiers.org/wikipathways/WP3640_r122579>	WP3640	Imatinib and chronic myeloid leukemia	20	2	4.27213197525603e-38	2	6.13736951339127e-38	2	1.75566489351474e-38	2	1.49576232644626e-37	2	4.27213197525603e-38	2	6.04453535268457e-38	2	5.59545443436273e-39	2	5.59545443436273e-39
<https://identifiers.org/wikipathways/WP3644_r118983>	WP3644	NAD+ metabolism	16	2	7.91466562220127e-31	2	1.04956889587477e-30	2	3.95883221281062e-31	2	2.10106256340779e-30	2	7.91466562220127e-31	2	1.03717938108367e-30	2	1.62453037899804e-31	2	1.62453037899804e-31
<https://identifiers.org/wikipathways/WP3645_r118940>	WP3645	NAD+ biosynthetic pathways	22	3	5.41934369184043e-39	3	7.94247819380062e-39	3	2.12056779295109e-39	3	2.03307500682014e-38	3	5.41934369184043e-39	3	7.81577199255606e-39	3	6.34536069876172e-40	3	6.34536069876172e-40
<https://identifiers.org/wikipathways/WP3646_r116732>	WP3646	Hepatitis C and hepatocellular carcinoma	56	10	2.21471084304318e-74	10	5.53065569989351e-74	11	2.77042332544865e-73	10	5.24447297594256e-73	10	2.21471084304318e-74	11	5.89266225479561e-72	10	1.29889675477121e-76	11	1.63542909578011e-74
<https://identifiers.org/wikipathways/WP3651_r122573>	WP3651	Pathways affected in adenoid cystic carcinoma	66	6	3.82247856816311e-96	6	1.25262912711677e-95	6	2.0716462309968e-97	6	2.31514199910785e-94	6	3.82247856816311e-96	6	1.19162446183515e-95	6	4.86298850227087e-99	6	4.86298850227087e-99
<https://identifiers.org/wikipathways/WP3656_r117955>	WP3656	Interleukin-1 induced activation of NF-kB	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP3657_r120797>	WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	20	1	7.03810869070189e-41	1	1.03149067451954e-40	1	2.7539841466897e-41	1	2.64035715171446e-40	1	7.03810869070189e-41	1	1.01503532370858e-40	1	8.24072818020991e-42	1	8.24072818020991e-42
<https://identifiers.org/wikipathways/WP3658_r116670>	WP3658	Wnt/beta-catenin signaling pathway in leukemia	27	1	7.92113151352982e-53	1	1.33443510169847e-52	1	2.20155487757565e-53	1	4.81063382686287e-52	1	7.92113151352982e-53	1	1.30547407278014e-52	1	4.24216237617488e-54	1	4.24216237617488e-54
<https://identifiers.org/wikipathways/WP366_r120697>	WP366	TGF-beta signaling pathway	132	9	1.95822140122935e-163	9	2.10126790261971e-162	9	5.73556112325088e-166	9	7.12921565682893e-160	9	1.95822140122935e-163	9	1.9016880168882e-162	9	3.11924398526522e-169	9	3.11924398526522e-169
<https://identifiers.org/wikipathways/WP3668_r117756>	WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	25	3	4.15934888036791e-44	3	6.4715253540027e-44	3	1.40526691654231e-44	3	1.91886861866512e-43	3	4.15934888036791e-44	3	6.35228451833438e-44	3	3.48111932731617e-45	3	3.48111932731617e-45
<https://identifiers.org/wikipathways/WP3672_r117771>	WP3672	lncRNA-mediated mechanisms of therapeutic resistance	7	1	1.70061087431572e-15	1	1.92006161083328e-15	1	1.26253637933808e-15	1	2.58790535110871e-15	1	1.70061087431572e-15	1	1.91028201009899e-15	1	8.60888444986317e-16	1	8.60888444986317e-16
<https://identifiers.org/wikipathways/WP3674_r117841>	WP3674	Tgif disruption of Shh signaling	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP3678_r117647>	WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	17	2	1.11197781468943e-32	2	1.50444108177663e-32	2	5.29505488731549e-33	2	3.16369030805419e-32	2	1.11197781468943e-32	2	1.48542961065056e-32	2	2.03966148027819e-33	2	2.03966148027819e-33
<https://identifiers.org/wikipathways/WP368_r117795>	WP368	Mitochondrial long chain fatty acid beta-oxidation	17	2	1.11197781468943e-32	2	1.50444108177663e-32	2	5.29505488731549e-33	2	3.16369030805419e-32	2	1.11197781468943e-32	2	1.48542961065056e-32	2	2.03966148027819e-33	2	2.03966148027819e-33
<https://identifiers.org/wikipathways/WP382_r119087>	WP382	MAPK signaling pathway	249	21	6.73914341809457e-241	21	4.62339002826073e-239	21	2.03847192206394e-245	21	1.47313501190894e-234	21	6.73914341809457e-241	21	3.87043793794412e-239	21	2.98111839846144e-251	21	2.98111839846144e-251
<https://identifiers.org/wikipathways/WP384_r121706>	WP384	Apoptosis modulation by HSP70	20	3	1.72736536199518e-35	3	2.43244411714078e-35	3	7.45572358112573e-36	3	5.64400984512382e-35	3	1.72736536199518e-35	3	2.39766568989821e-35	3	2.53101055581004e-36	3	2.53101055581004e-36
<https://identifiers.org/wikipathways/WP3844_r107714>	WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	30	2	6.45560351278569e-55	2	1.13153696101003e-54	2	1.62774032877039e-55	2	4.49674065450855e-54	2	6.45560351278569e-55	2	1.1051344319198e-54	2	2.76703952193629e-56	2	2.76703952193629e-56
<https://identifiers.org/wikipathways/WP3845_r116460>	WP3845	Canonical and non-canonical Notch signaling	29	3	1.07199313149767e-50	3	1.80593550429858e-50	3	2.97943760098567e-51	3	6.51039111235449e-50	3	1.07199313149767e-50	3	1.76674157849581e-50	3	5.74105974909e-52	3	5.74105974909e-52
<https://identifiers.org/wikipathways/WP3850_r121711>	WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	39	3	3.21051455345549e-66	3	6.59037354832987e-66	3	5.49185397483849e-67	3	3.86114448878298e-65	3	3.21051455345549e-66	3	6.39397168761802e-66	3	5.6657507178718e-68	3	5.6657507178718e-68
<https://identifiers.org/wikipathways/WP3851_r121712>	WP3851	TLR4 signaling and tolerance	29	2	2.63173436537895e-53	2	4.52237605417007e-53	3	2.97943760098567e-51	2	1.71175927581623e-52	2	2.63173436537895e-53	3	1.76674157849581e-50	2	1.26084767549563e-54	3	5.74105974909e-52
<https://identifiers.org/wikipathways/WP3858_r117850>	WP3858	Toll-like receptor signaling related to MyD88	31	2	1.63499762170229e-56	2	2.92313714927592e-56	2	3.92684437290914e-57	2	1.21958845397869e-55	2	1.63499762170229e-56	2	2.85255348788625e-56	2	6.27033809795505e-58	2	6.27033809795505e-58
<https://identifiers.org/wikipathways/WP3859_r117840>	WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	19	2	2.59104804299277e-36	2	3.64866617571116e-36	2	1.11835853716887e-36	2	8.46601476768587e-36	2	2.59104804299277e-36	2	3.59649853484725e-36	2	3.79651583371506e-37	2	3.79651583371506e-37
<https://identifiers.org/wikipathways/WP3863_r121717>	WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	66	7	6.85315800434966e-94	7	2.20283779354393e-93	7	3.89469491427397e-95	7	3.88282386707527e-92	7	6.85315800434966e-94	7	2.09725905282978e-93	7	9.71902987810995e-97	7	9.71902987810995e-97
<https://identifiers.org/wikipathways/WP3865_r106524>	WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	60	9	8.70006795004144e-82	9	2.39488707408251e-81	10	9.459283714188e-81	9	2.88476868463652e-80	9	8.70006795004144e-82	10	2.80680765082476e-79	9	2.95076442950286e-84	10	4.10156255700911e-82
<https://identifiers.org/wikipathways/WP3869_r118463>	WP3869	Cannabinoid receptor signaling	31	5	4.98476806146425e-49	5	8.39760009498834e-49	5	1.38543848445835e-49	5	3.0273318672448e-48	5	4.98476806146425e-49	5	8.21534834000527e-49	5	2.66959278332682e-50	5	2.66959278332682e-50
<https://identifiers.org/wikipathways/WP3871_r106754>	WP3871	Valproic acid pathway	13	2	4.15234853256522e-25	2	5.1847339016649e-25	2	2.40775567219621e-25	2	8.95099085494371e-25	2	4.15234853256522e-25	2	5.13652420350907e-25	2	1.1948637812336e-25	2	1.1948637812336e-25
<https://identifiers.org/wikipathways/WP3872_r116648>	WP3872	Regulation of apoptosis by parathyroid hormone-related protein	22	2	1.33810955354085e-41	2	2.00062423017644e-41	2	4.98566095521432e-42	2	5.378505309048e-41	2	1.33810955354085e-41	2	1.96705670953592e-41	2	1.40074187610636e-42	2	1.40074187610636e-42
<https://identifiers.org/wikipathways/WP3874_r116461>	WP3874	Canonical and non-canonical TGF-B signaling	17	1	1.83646212170015e-35	1	2.53486281680987e-35	1	8.3255579989238e-36	1	5.59945187266235e-35	1	1.83646212170015e-35	1	2.50072325025348e-35	1	3.01057045059511e-36	1	3.01057045059511e-36
<https://identifiers.org/wikipathways/WP3877_r117828>	WP3877	MYD88 distinct input-output pathway	18	3	6.6718668881366e-32	3	9.02664649065984e-32	3	3.17703293238933e-32	3	1.89821418483255e-31	3	6.6718668881366e-32	3	8.91257766390336e-32	3	1.22379688816691e-32	3	1.22379688816691e-32
<https://identifiers.org/wikipathways/WP3878_r117656>	WP3878	ATM signaling in development and disease 	46	1	7.71885354719821e-82	1	1.89030197868283e-81	2	5.56737030483492e-80	1	1.70853479837002e-80	1	7.71885354719821e-82	2	1.10771695950811e-78	1	5.05229141584095e-84	2	3.49618565976207e-81
<https://identifiers.org/wikipathways/WP3888_r116782>	WP3888	VEGFA-VEGFR2 signaling pathway	435	40	0	40	0	41	0	40	5.01115962607401e-319	40	0	41	0	40	0	41	0
<https://identifiers.org/wikipathways/WP3890_r116457>	WP3890	Nanomaterial-induced inflammasome activation	10	3	1.69778123891752e-16	3	1.95592014685904e-16	3	1.19955950530935e-16	3	2.77028226702094e-16	3	1.69778123891752e-16	3	1.94430738941373e-16	3	7.67508271904583e-17	3	7.67508271904583e-17
<https://identifiers.org/wikipathways/WP3891_r106161>	WP3891	Benzene metabolism	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP3892_r120069>	WP3892	Development of pulmonary dendritic cells and macrophage subsets	13	4	5.02859788164979e-20	4	6.03132317679825e-20	4	3.21841089068964e-20	4	9.43210661339703e-20	4	5.02859788164979e-20	4	5.98536051075996e-20	4	1.81335514599467e-20	4	1.81335514599467e-20
<https://identifiers.org/wikipathways/WP3893_r118859>	WP3893	Development and heterogeneity of the ILC family	32	10	1.16664744875665e-39	10	1.81518520349354e-39	10	3.94160506887115e-40	10	5.38219621112153e-39	10	1.16664744875665e-39	10	1.78173957997858e-39	10	9.76412197880288e-41	10	9.76412197880288e-41
<https://identifiers.org/wikipathways/WP3915_r122574>	WP3915	Angiopoietin-like protein 8 regulatory pathway	134	11	3.17267471024608e-161	11	3.40443605095324e-160	12	1.06788057497643e-161	11	1.1550625585091e-157	11	3.17267471024608e-161	12	3.32499920976451e-158	11	5.05374239139997e-167	12	6.15714281352185e-165
<https://identifiers.org/wikipathways/WP3925_r117062>	WP3925	Amino acid metabolism	94	6	9.58025590841395e-130	6	5.35741623653916e-129	7	2.67871157765457e-129	6	3.67606278898154e-127	6	9.58025590841395e-130	7	8.96984547031971e-127	6	6.01617798486662e-134	7	1.22644085491494e-131
<https://identifiers.org/wikipathways/WP3926_r106298>	WP3926	ApoE and miR-146 in inflammation and atherosclerosis	9	2	5.09334371675252e-17	2	5.86776044057711e-17	2	3.59867851592803e-17	2	8.31084680106283e-17	2	5.09334371675252e-17	2	5.83292216824115e-17	2	2.30252481571377e-17	2	2.30252481571377e-17
<https://identifiers.org/wikipathways/WP3927_r117666>	WP3927	BMP signaling in eyelid development	20	2	4.27213197525603e-38	2	6.13736951339127e-38	2	1.75566489351474e-38	2	1.49576232644626e-37	2	4.27213197525603e-38	2	6.04453535268457e-38	2	5.59545443436273e-39	2	5.59545443436273e-39
<https://identifiers.org/wikipathways/WP3929_r119247>	WP3929	Chemokine signaling pathway	166	28	2.72425624710077e-160	28	3.84465145131602e-159	28	4.06410617428001e-163	28	2.55296670340671e-156	28	2.72425624710077e-160	28	3.43964236713162e-159	28	9.24319054246848e-167	28	9.24319054246848e-167
<https://identifiers.org/wikipathways/WP3930_r116431>	WP3930	EDA signaling in hair follicle development	13	1	6.88044495868306e-28	1	8.76539966469129e-28	1	3.7977218804357e-28	1	1.58987404173068e-27	1	6.88044495868306e-28	1	8.67656115457625e-28	1	1.76885829938359e-28	1	1.76885829938359e-28
<https://identifiers.org/wikipathways/WP3931_r117717>	WP3931	Embryonic stem cell pluripotency pathways	116	8	3.10576569730876e-149	8	2.52595040586331e-148	8	1.79952207951329e-151	8	4.34390313149485e-146	8	3.10576569730876e-149	8	2.31282334036856e-148	8	2.36193217854916e-154	8	2.36193217854916e-154
<https://identifiers.org/wikipathways/WP3932_r120304>	WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	302	33	2.45095817052695e-258	33	3.34306572435406e-256	33	1.35908581445059e-263	33	5.71441469232819e-251	33	2.45095817052695e-258	33	2.71899585631016e-256	33	2.19984164356329e-270	33	2.19984164356329e-270
<https://identifiers.org/wikipathways/WP3935_r118425>	WP3935	Leptin-insulin signaling overlap	17	5	3.27509180033313e-25	5	4.17233024039302e-25	5	1.80771561508741e-25	5	7.56780043863799e-25	5	3.27509180033313e-25	5	4.13004310957823e-25	5	8.41976550506588e-26	5	8.41976550506588e-26
<https://identifiers.org/wikipathways/WP3937_r120792>	WP3937	Microglia pathogen phagocytosis pathway	40	7	2.84492220791057e-58	7	5.50468360087066e-58	7	5.62701603284465e-59	7	2.7890513877385e-57	7	2.84492220791057e-58	7	5.35393292964366e-58	7	6.99838992074013e-60	7	6.99838992074013e-60
<https://identifiers.org/wikipathways/WP3940_r119248>	WP3940	One-carbon metabolism and related pathways	52	3	7.9121655140314e-85	3	2.09487076085104e-84	3	7.24247081481683e-86	3	2.29337580251459e-83	3	7.9121655140314e-85	3	2.01080141827793e-84	3	3.33992650932557e-87	3	3.33992650932557e-87
<https://identifiers.org/wikipathways/WP3941_r117040>	WP3941	Oxidative damage response	40	4	3.21051455345541e-65	4	6.59037354832971e-65	4	5.49185397483843e-66	4	3.86114448878291e-64	4	3.21051455345541e-65	4	6.39397168761791e-65	4	5.66575071787158e-67	4	5.66575071787158e-67
<https://identifiers.org/wikipathways/WP3942_r106517>	WP3942	PPAR signaling pathway	68	10	5.4380037203114e-90	10	1.71450536867844e-89	10	3.24078645676443e-91	10	2.88201954396338e-88	10	5.4380037203114e-90	10	1.63365877405782e-89	10	8.59768060753981e-93	10	8.59768060753981e-93
<https://identifiers.org/wikipathways/WP3943_r117818>	WP3943	Robo4 and VEGF signaling pathways crosstalk	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP3944_r120596>	WP3944	Serotonin and anxiety-related events	13	2	4.15234853256522e-25	2	5.1847339016649e-25	2	2.40775567219621e-25	2	8.95099085494371e-25	2	4.15234853256522e-25	2	5.13652420350907e-25	2	1.1948637812336e-25	2	1.1948637812336e-25
<https://identifiers.org/wikipathways/WP3945_r116679>	WP3945	TYROBP causal network in microglia	60	10	1.08402846657519e-79	10	2.92655200452878e-79	10	9.459283714188e-81	10	3.36075551760162e-78	10	1.08402846657519e-79	10	2.80680765082476e-79	10	4.10156255700911e-82	10	4.10156255700911e-82
<https://identifiers.org/wikipathways/WP3947_r106483>	WP3947	Serotonin and anxiety	17	1	1.83646212170015e-35	1	2.53486281680987e-35	1	8.3255579989238e-36	1	5.59945187266235e-35	1	1.83646212170015e-35	1	2.50072325025348e-35	1	3.01057045059511e-36	1	3.01057045059511e-36
<https://identifiers.org/wikipathways/WP395_r120704>	WP395	IL-4 signaling pathway	53	9	2.04911353638087e-72	9	4.92103325632066e-72	9	2.38381001746609e-73	9	4.23934538707086e-71	9	2.04911353638087e-72	9	4.74296955296703e-72	9	1.49698007179874e-74	9	1.49698007179874e-74
<https://identifiers.org/wikipathways/WP3953_r106206>	WP3953	mRNA, protein, and metabolite inducation pathway by cyclosporin A	8	3	2.7232448800709e-12	3	3.01321668793437e-12	3	2.12442788096621e-12	3	3.86460532432234e-12	3	2.7232448800709e-12	3	3.00041627719549e-12	3	1.54385994467547e-12	3	1.54385994467547e-12
<https://identifiers.org/wikipathways/WP3959_r118468>	WP3959	DNA IR-double strand breaks and cellular response via ATM	57	2	3.16425107278758e-94	2	9.41352733126907e-94	2	2.17501906306238e-95	2	1.37210079565864e-92	2	3.16425107278758e-94	2	8.9915680784414e-94	2	6.93515330343238e-97	2	6.93515330343238e-97
<https://identifiers.org/wikipathways/WP3963_r107557>	WP3963	Mevalonate pathway	7	5	2.93375579416769e-05	5	3.05508759372568e-05	5	2.65603241877284e-05	5	3.37528328270405e-05	5	2.93375579416769e-05	5	3.04988301520149e-05	5	2.33730675481648e-05	5	2.33730675481648e-05
<https://identifiers.org/wikipathways/WP3967_r108139>	WP3967	miR-509-3p alteration of YAP1/ECM axis	18	4	2.01823973366131e-29	4	2.67640068448066e-29	4	1.0095022142667e-29	4	5.3577095366899e-29	4	2.01823973366131e-29	4	2.64480742176335e-29	4	4.142552466445e-30	4	4.142552466445e-30
<https://identifiers.org/wikipathways/WP3969_r106437>	WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	15	1	9.8933320277515e-32	1	1.31196111984346e-31	1	4.94854026601329e-32	1	2.62632820425974e-31	1	9.8933320277515e-32	1	1.29647422635458e-31	1	2.03066297374753e-32	1	2.03066297374753e-32
<https://identifiers.org/wikipathways/WP3971_r117820>	WP3971	OSX and miRNAs in tooth development	36	3	1.08953142878727e-61	3	2.10815106718978e-61	3	2.15500121621144e-62	3	1.06813435354904e-60	3	1.08953142878727e-61	3	2.05041746949914e-61	3	2.68020185168943e-63	3	2.68020185168943e-63
<https://identifiers.org/wikipathways/WP3972_r108157>	WP3972	PDGFR-beta pathway	29	4	3.27225903389671e-48	4	5.40426199661349e-48	4	9.54909751115912e-49	4	1.85546146702101e-47	4	3.27225903389671e-48	4	5.29139102759483e-48	4	1.95913663937698e-49	4	1.95913663937698e-49
<https://identifiers.org/wikipathways/WP3981_r108114>	WP3981	miRNA regulation of prostate cancer signaling pathways	35	1	1.4775310940972e-65	1	2.91583826720587e-65	1	2.78423929743081e-66	1	1.55071770259734e-64	1	1.4775310940972e-65	1	2.83363387161291e-65	1	3.25346182530885e-67	1	3.25346182530885e-67
<https://identifiers.org/wikipathways/WP3982_r108115>	WP3982	miRNA regulation of p53 pathway in prostate cancer	34	4	3.99339827276175e-56	4	7.28228671992796e-56	4	9.13617291115387e-57	4	3.18969287963657e-55	4	3.99339827276175e-56	4	7.10053247567015e-56	4	1.37040552148146e-57	4	1.37040552148146e-57
<https://identifiers.org/wikipathways/WP399_r119242>	WP399	Wnt signaling pathway and pluripotency	101	6	1.41997327020474e-137	6	9.05909812740653e-137	7	2.88605997827511e-137	6	8.5882595935417e-135	6	1.41997327020474e-137	7	1.51675185790288e-134	6	4.24419594032302e-142	7	8.69453854060454e-140
<https://identifiers.org/wikipathways/WP3995_r119304>	WP3995	Prion disease pathway	33	3	4.6981156150138e-57	3	8.56739614109177e-57	3	1.07484387190047e-57	3	3.75257985839593e-56	3	4.6981156150138e-57	3	8.35356761843552e-57	3	1.61224178997824e-58	3	1.61224178997824e-58
<https://identifiers.org/wikipathways/WP3996_r107156>	WP3996	Ethanol effects on histone modifications	31	1	2.66938387216694e-59	1	4.86783871652947e-59	1	6.10706745397997e-60	1	2.13214764681587e-58	1	2.66938387216694e-59	1	4.74634523774754e-59	1	9.1604647157851e-61	1	9.1604647157851e-61
<https://identifiers.org/wikipathways/WP3998_r119303>	WP3998	Prader-Willi and Angelman syndrome	74	2	5.14868456522926e-116	2	2.12460922902615e-115	2	1.58330269815032e-117	2	6.91491412303836e-114	2	5.14868456522926e-116	2	2.00164149229794e-115	2	1.79030710240699e-119	2	1.79030710240699e-119
<https://identifiers.org/wikipathways/WP400_r116725>	WP400	p38 MAPK signaling pathway	34	1	5.18824489898692e-64	1	1.00388146056658e-63	1	1.02619105533878e-64	1	5.08635406451927e-63	1	5.18824489898692e-64	1	9.76389271190069e-64	1	1.27628659604261e-65	1	1.27628659604261e-65
<https://identifiers.org/wikipathways/WP4008_r117805>	WP4008	NO/cGMP/PKG mediated neuroprotection	47	7	2.09325399657985e-68	7	4.64826062557191e-68	7	2.95198806823275e-69	7	3.30336317267344e-67	7	2.09325399657985e-68	7	4.49485268413392e-68	7	2.37517050988526e-70	7	2.37517050988526e-70
<https://identifiers.org/wikipathways/WP4016_r120667>	WP4016	DNA IR-damage and cellular response via ATR	83	1	1.10335091658039e-129	1	5.50794139791107e-129	1	2.12435966653585e-131	1	2.86050798326966e-127	1	1.10335091658039e-129	1	5.14777298114186e-129	1	1.3132726372524e-133	1	1.3132726372524e-133
<https://identifiers.org/wikipathways/WP4018_r117168>	WP4018	Clear cell renal cell carcinoma pathways	86	12	9.78496620301403e-108	12	4.19501242937973e-107	12	2.7392473489417e-109	12	1.4995589782051e-105	12	9.78496620301403e-108	12	3.9458704391919e-107	12	2.74406627361138e-111	12	2.74406627361138e-111
<https://identifiers.org/wikipathways/WP4022_r120306>	WP4022	Pyrimidine metabolism	99	3	1.30681406250868e-142	3	8.49509463602973e-142	3	1.31410849879131e-144	3	8.43295271438547e-140	3	1.30681406250868e-142	3	7.85193289702421e-142	3	3.51401326690406e-147	3	3.51401326690406e-147
<https://identifiers.org/wikipathways/WP4030_r93221>	WP4030	SCFA and skeletal muscle substrate metabolism	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP408_r116900>	WP408	Oxidative stress response	33	2	1.14962046044382e-59	2	2.13828522656201e-59	2	2.50546357086358e-60	2	9.83208696522963e-59	2	1.14962046044382e-59	2	2.08318394474701e-59	2	3.53045647440485e-61	2	3.53045647440485e-61
<https://identifiers.org/wikipathways/WP410_r117108>	WP410	Exercise-induced circadian regulation	48	5	2.22948031312537e-74	5	5.25047858012393e-74	5	2.72133060500331e-75	5	4.31095682443713e-73	5	2.22948031312537e-74	5	5.06465917358458e-74	5	1.81804451256149e-76	5	1.81804451256149e-76
<https://identifiers.org/wikipathways/WP411_r122796>	WP411	mRNA processing	127	4	7.97673794508049e-170	4	8.55943224861236e-169	4	2.3363582902036e-172	4	2.9040579891933e-166	4	7.97673794508049e-170	4	7.74645142499928e-169	4	1.27061178279487e-175	4	1.27061178279487e-175
<https://identifiers.org/wikipathways/WP4136_r120387>	WP4136	Fibrin complement receptor 3 signaling pathway	43	7	1.1320274315484e-62	7	2.32376571314108e-62	7	1.93642771152803e-63	7	1.36143954674483e-61	7	1.1320274315484e-62	7	2.25451441705409e-62	7	1.99774370312159e-64	7	1.99774370312159e-64
<https://identifiers.org/wikipathways/WP4141_r122432>	WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	22	4	1.64477081047357e-36	4	2.36288726265565e-36	4	6.75930984003172e-37	4	5.7586849568181e-36	4	1.64477081047357e-36	4	2.32714611078356e-36	4	2.15424995722963e-37	4	2.15424995722963e-37
<https://identifiers.org/wikipathways/WP4142_r119292>	WP4142	Metabolism of spingolipids in ER and Golgi apparatus	31	1	2.66938387216694e-59	1	4.86783871652947e-59	1	6.10706745397997e-60	1	2.13214764681587e-58	1	2.66938387216694e-59	1	4.74634523774754e-59	1	9.1604647157851e-61	1	9.1604647157851e-61
<https://identifiers.org/wikipathways/WP4146_r107552>	WP4146	Macrophage markers	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP4147_r94394>	WP4147	PTF1A related regulatory pathway	11	1	6.42016965419703e-24	1	7.85686598944609e-24	1	3.91105953419566e-24	1	1.29100829638612e-23	1	6.42016965419703e-24	1	7.79039504198873e-24	1	2.06803346751973e-24	1	2.06803346751973e-24
<https://identifiers.org/wikipathways/WP4148_r110682>	WP4148	Splicing factor NOVA regulated synaptic proteins	42	4	3.63943532104829e-68	4	7.77051751093071e-68	4	5.65222350802968e-69	4	5.01442798056355e-67	4	3.63943532104829e-68	4	7.52648472959561e-68	4	5.14918191730385e-70	4	5.14918191730385e-70
<https://identifiers.org/wikipathways/WP4149_r107159>	WP4149	White fat cell differentiation	32	2	4.27101419546713e-58	2	7.78854194644705e-58	2	9.77130792636792e-59	2	3.41143623490541e-57	2	4.27101419546713e-58	2	7.59415238039599e-58	2	1.46567435452564e-59	2	1.46567435452564e-59
<https://identifiers.org/wikipathways/WP4150_r116677>	WP4150	Wnt signaling in kidney disease	37	2	8.00029031438006e-66	2	1.61023904308386e-65	2	1.43633103957314e-66	2	8.98849425526395e-65	2	8.00029031438006e-66	2	1.56354611308553e-65	2	1.57700551357768e-67	2	1.57700551357768e-67
<https://identifiers.org/wikipathways/WP4155_r119086>	WP4155	Endometrial cancer	63	1	6.34914685352385e-105	1	2.16243943086321e-104	1	3.12974993613847e-106	1	4.39367243529231e-103	1	6.34914685352385e-105	1	2.05379174470963e-104	1	6.50178047631012e-108	1	6.50178047631012e-108
<https://identifiers.org/wikipathways/WP4157_r120415>	WP4157	GABA metabolism (aka GHB)	12	2	3.85210179251818e-23	2	4.71411959366764e-23	2	2.34663572051742e-23	2	7.74604977831665e-23	2	3.85210179251818e-23	2	4.67423702519325e-23	2	1.24082008051183e-23	2	1.24082008051183e-23
<https://identifiers.org/wikipathways/WP4172_r122580>	WP4172	PI3K-Akt signaling pathway	340	30	1.34094035464178e-288	30	3.56749150039782e-286	31	7.2094528165111e-293	30	3.11778096893159e-280	30	1.34094035464178e-288	31	1.34874194789241e-284	30	2.70638515658303e-302	31	1.43962229780845e-300
<https://identifiers.org/wikipathways/WP4174_r117157>	WP4174	Metabolism of tetrahydrocannabinol (THC)	4	2	8.38215941190768e-06	2	8.72882169635909e-06	2	7.58866405363668e-06	2	9.6436665220116e-06	2	8.38215941190768e-06	2	8.71395147200427e-06	2	6.67801929947566e-06	2	6.67801929947566e-06
<https://identifiers.org/wikipathways/WP4189_r120000>	WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP4190_r118431>	WP4190	Mevalonate arm of cholesterol biosynthesis pathway	13	7	4.16892608617965e-13	7	4.70689389169985e-13	7	3.09501775277734e-13	7	6.3440651178608e-13	7	4.16892608617965e-13	7	4.68291989904267e-13	7	2.11040653085218e-13	7	2.11040653085218e-13
<https://identifiers.org/wikipathways/WP4191_r106347>	WP4191	Caloric restriction and aging	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP4197_r120647>	WP4197	Immune response to tuberculosis	23	10	6.51629399180518e-25	10	8.46975990944642e-25	10	3.42383331825261e-25	10	1.61394927721973e-24	10	6.51629399180518e-25	10	8.37684271212763e-25	10	1.49681260291609e-25	10	1.49681260291609e-25
<https://identifiers.org/wikipathways/WP4204_r108297>	WP4204	Tumor suppressor activity of SMARCB1	31	2	1.63499762170229e-56	2	2.92313714927592e-56	2	3.92684437290914e-57	2	1.21958845397869e-55	2	1.63499762170229e-56	2	2.85255348788625e-56	2	6.27033809795505e-58	2	6.27033809795505e-58
<https://identifiers.org/wikipathways/WP4205_r118937>	WP4205	MET in type 1 papillary renal cell carcinoma	59	4	9.02338930923264e-92	4	2.68442421063362e-91	4	6.20242936149969e-93	4	3.91277410228658e-90	4	9.02338930923264e-92	4	2.56409549703549e-91	4	1.97767455036218e-94	4	1.97767455036218e-94
<https://identifiers.org/wikipathways/WP4206_r119286>	WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	20	2	4.27213197525603e-38	2	6.13736951339127e-38	2	1.75566489351474e-38	2	1.49576232644626e-37	2	4.27213197525603e-38	2	6.04453535268457e-38	2	5.59545443436273e-39	2	5.59545443436273e-39
<https://identifiers.org/wikipathways/WP4210_r95880>	WP4210	Tryptophan catabolism leading to NAD+ production	16	5	2.32531517823652e-23	5	2.90345098493233e-23	5	1.34834317642989e-23	5	5.01255487876845e-23	5	2.32531517823652e-23	5	2.87645355396508e-23	5	6.69123717490819e-24	5	6.69123717490819e-24
<https://identifiers.org/wikipathways/WP4211_r107570>	WP4211	Transcriptional cascade regulating adipogenesis	13	2	4.15234853256522e-25	2	5.1847339016649e-25	2	2.40775567219621e-25	2	8.95099085494371e-25	2	4.15234853256522e-25	2	5.13652420350907e-25	2	1.1948637812336e-25	2	1.1948637812336e-25
<https://identifiers.org/wikipathways/WP4216_r119088>	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	73	3	3.72009158274236e-112	3	1.47747048442611e-111	3	1.25683994577996e-113	3	4.37760786381039e-110	3	3.72009158274236e-112	3	1.39419920108483e-111	3	1.6044296771665e-115	3	1.6044296771665e-115
<https://identifiers.org/wikipathways/WP4217_r120623>	WP4217	Ebola virus infection in host	140	14	4.2664487661365e-161	14	4.83718800291611e-160	14	1.0912427989309e-163	14	1.87825434630095e-157	14	4.2664487661365e-161	14	4.36763046180114e-160	14	4.98141363636286e-167	14	4.98141363636286e-167
<https://identifiers.org/wikipathways/WP422_r116723>	WP422	MAPK cascade	33	1	1.87387198116355e-62	1	3.55492140741808e-62	1	3.89047138332856e-63	1	1.71589650353045e-61	1	1.87387198116355e-62	1	3.46043844642363e-62	1	5.15019179344245e-64	1	5.15019179344245e-64
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	52	2	1.90654590699555e-87	2	5.14710260651361e-87	2	1.66366098349542e-88	2	5.91076237761503e-86	2	1.90654590699555e-87	2	4.93650102686913e-87	2	7.21366416700978e-90	2	7.21366416700978e-90
<https://identifiers.org/wikipathways/WP4223_r119284>	WP4223	Ras signaling	184	10	1.10733624585143e-209	10	2.97879157520949e-208	10	3.37093934881045e-213	10	9.60344801916589e-205	10	1.10733624585143e-209	10	2.59371747856268e-208	10	9.81376313276914e-218	10	9.81376313276914e-218
<https://identifiers.org/wikipathways/WP4224_r120400>	WP4224	Purine metabolism and related disorders	24	3	2.02477103496315e-42	3	3.0882118989301e-42	3	7.18372447736427e-43	3	8.71933900321451e-42	3	2.02477103496315e-42	3	3.03385108595649e-42	3	1.89512136179094e-43	3	1.89512136179094e-43
<https://identifiers.org/wikipathways/WP4225_r120401>	WP4225	Pyrimidine metabolism and related diseases	24	4	6.1553039462878e-40	4	9.2028714588116e-40	4	2.29340403939849e-40	4	2.47411244216211e-39	4	6.1553039462878e-40	4	9.04846086386517e-40	4	6.44341263008922e-41	4	6.44341263008922e-41
<https://identifiers.org/wikipathways/WP4239_r118997>	WP4239	Epithelial to mesenchymal transition in colorectal cancer	161	19	1.80959212088368e-171	19	2.74594685080669e-170	19	2.25792516420175e-174	19	2.17806521820863e-167	19	1.80959212088368e-171	19	2.44920069189145e-170	19	4.07633835891894e-178	19	4.07633835891894e-178
<https://identifiers.org/wikipathways/WP4241_r106520>	WP4241	Type 2 papillary renal cell carcinoma	34	6	1.9959004567263e-51	6	3.49841054025333e-51	6	5.03253903247039e-52	6	1.39027229728992e-50	6	1.9959004567263e-51	6	3.4167809609808e-51	6	8.55494832462097e-53	6	8.55494832462097e-53
<https://identifiers.org/wikipathways/WP4249_r117749>	WP4249	Hedgehog signaling pathway	43	2	9.96972362501678e-75	2	2.25770664802403e-74	2	1.33984414442681e-75	2	1.68365846982486e-73	2	9.96972362501678e-75	2	2.18139504656565e-74	2	1.01320043347825e-76	2	1.01320043347825e-76
<https://identifiers.org/wikipathways/WP4255_r119279>	WP4255	Non-small cell lung cancer	72	7	1.94969589350178e-101	7	7.03512445711794e-101	7	8.33904881108974e-103	7	1.64710216544053e-99	7	1.94969589350178e-101	7	6.66545340642037e-101	7	1.44273952775684e-104	7	1.44273952775684e-104
<https://identifiers.org/wikipathways/WP4258_r117770>	WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	98	10	1.64793175299265e-125	10	9.21547024901173e-125	10	2.39986514328626e-127	10	6.32331813875364e-123	10	1.64793175299265e-125	10	8.57185010463672e-125	10	1.03486282910353e-129	10	1.03486282910353e-129
<https://identifiers.org/wikipathways/WP4262_r108103>	WP4262	Breast cancer pathway	156	8	9.2609657250031e-189	8	1.56618663749845e-187	8	8.84763588157363e-192	8	1.62016266350761e-184	8	9.2609657250031e-189	8	1.39058389329429e-187	8	1.13100653393802e-195	8	1.13100653393802e-195
<https://identifiers.org/wikipathways/WP4263_r105482>	WP4263	Pancreatic adenocarcinoma pathway	89	5	2.35352930451493e-126	5	1.22026848999057e-125	5	4.12809820399274e-128	5	6.95503859108437e-124	5	2.35352930451493e-126	5	1.13865817696571e-125	5	2.26286032259817e-130	5	2.26286032259817e-130
<https://identifiers.org/wikipathways/WP4269_r117715>	WP4269	Ethanol metabolism production of ROS by CYP2E1	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP4271_r120408>	WP4271	Vitamin B12 disorders	16	2	7.91466562220127e-31	2	1.04956889587477e-30	2	3.95883221281062e-31	2	2.10106256340779e-30	2	7.91466562220127e-31	2	1.03717938108367e-30	2	1.62453037899804e-31	2	1.62453037899804e-31
<https://identifiers.org/wikipathways/WP428_r116549>	WP428	Wnt signaling	116	7	1.90537772841036e-151	7	1.57871900366458e-150	7	1.05466495502615e-153	7	2.84147383908074e-148	7	1.90537772841036e-151	7	1.44438616104204e-150	7	1.3049349052758e-156	7	1.3049349052758e-156
<https://identifiers.org/wikipathways/WP4288_r120407>	WP4288	MTHFR deficiency	27	1	7.92113151352982e-53	1	1.33443510169847e-52	1	2.20155487757565e-53	1	4.81063382686287e-52	1	7.92113151352982e-53	1	1.30547407278014e-52	1	4.24216237617488e-54	1	4.24216237617488e-54
<https://identifiers.org/wikipathways/WP4290_r118611>	WP4290	Metabolic reprogramming in colon cancer	42	8	4.98266481084408e-59	8	9.83305514595394e-59	8	9.38926512457242e-60	8	5.22947135200969e-58	8	4.98266481084408e-59	8	9.55583800253578e-59	8	1.09716200323328e-60	8	1.09716200323328e-60
<https://identifiers.org/wikipathways/WP4297_r120409>	WP4297	Thiamine metabolic pathways	10	2	4.23386842622816e-19	2	4.97689604798731e-19	2	2.84705578791774e-19	2	7.40717183695431e-19	2	4.23386842622816e-19	2	4.94315437986536e-19	2	1.70937254321734e-19	2	1.70937254321734e-19
<https://identifiers.org/wikipathways/WP4298_r121698>	WP4298	Acute viral myocarditis	98	18	6.70931195912792e-110	18	3.22453774153533e-109	18	1.41820274503319e-111	18	1.52568544401674e-107	18	6.70931195912792e-110	18	3.01849699127756e-109	18	9.88917521270033e-114	18	9.88917521270033e-114
<https://identifiers.org/wikipathways/WP43_r122562>	WP43	Oxidation by cytochrome P450	64	11	7.74980845473245e-83	11	2.21782118658898e-82	11	5.85982486417588e-84	11	2.93894156634703e-81	11	7.74980845473245e-83	11	2.12186647402629e-82	11	2.11260127257838e-85	11	2.11260127257838e-85
<https://identifiers.org/wikipathways/WP430_r122069>	WP430	Statin inhibition of cholesterol production	31	10	4.43690607855262e-38	10	6.76723733677425e-38	10	1.57417852438043e-38	10	1.91067965494814e-37	10	4.43690607855262e-38	10	6.64811580779508e-38	10	4.15280312910948e-39	10	4.15280312910948e-39
<https://identifiers.org/wikipathways/WP4300_r105311>	WP4300	Extracellular vesicles in the crosstalk of cardiac cells	25	5	3.07765197314393e-39	5	4.60143572940591e-39	5	1.14670201969927e-39	5	1.23705622108106e-38	5	3.07765197314393e-39	5	4.52423043193262e-39	5	3.22170631504464e-40	5	3.22170631504464e-40
<https://identifiers.org/wikipathways/WP4301_r97800>	WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	18	1	2.72741899262395e-37	1	3.84070123759073e-37	1	1.17721951280935e-37	1	8.91159449230089e-37	1	2.72741899262395e-37	1	3.78578793141823e-37	1	3.99633245654225e-38	1	3.99633245654225e-38
<https://identifiers.org/wikipathways/WP4304_r119229>	WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	31	6	1.01440030050798e-46	6	1.67532121895021e-46	6	2.96022022845938e-47	6	5.75193054776506e-46	6	1.01440030050798e-46	6	1.64033121855438e-46	6	6.07332358206867e-48	6	6.07332358206867e-48
<https://identifiers.org/wikipathways/WP4312_r119230>	WP4312	Rett syndrome causing genes	49	3	1.14594808826413e-80	3	2.86170284759669e-80	3	1.21108813256351e-81	3	2.71362457975611e-79	3	1.14594808826413e-80	3	2.75362540015051e-80	3	6.72082433541205e-83	3	6.72082433541205e-83
<https://identifiers.org/wikipathways/WP4313_r120500>	WP4313	Ferroptosis	65	6	7.26850091370388e-95	6	2.33634311436467e-94	6	4.13073703029058e-96	6	4.11814652568572e-93	6	7.26850091370388e-95	6	2.22436566209218e-94	6	1.03080619919349e-97	6	1.03080619919349e-97
<https://identifiers.org/wikipathways/WP4321_r106178>	WP4321	Thermogenesis	108	9	1.41873573851398e-138	9	9.75588448240809e-138	9	1.2423915600746e-140	9	1.11161686184307e-135	9	1.41873573851398e-138	9	8.99598474695693e-138	9	2.77917776992922e-143	9	2.77917776992922e-143
<https://identifiers.org/wikipathways/WP4329_r101725>	WP4329	miRNAs involvement in the immune response in sepsis	66	11	2.12949100213309e-85	11	6.33515523552095e-85	12	1.59915067858235e-84	11	9.23402167262503e-84	11	2.12949100213309e-85	12	6.18733494669188e-83	11	4.66724865326928e-88	12	5.42178718554766e-86
<https://identifiers.org/wikipathways/WP4331_r107654>	WP4331	Neovascularisation processes	41	4	1.06843422639344e-66	4	2.23679896921786e-66	4	1.74142314747388e-67	4	1.37538596038315e-65	4	1.06843422639344e-66	4	2.16834441019301e-66	4	1.68819607145887e-68	4	1.68819607145887e-68
<https://identifiers.org/wikipathways/WP4336_r108198>	WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	93	7	2.39478151971051e-126	7	1.28954311528695e-125	7	3.827137924245e-128	7	8.06500242294767e-124	7	2.39478151971051e-126	7	1.20138674969497e-125	7	1.8605368713923e-130	7	1.8605368713923e-130
<https://identifiers.org/wikipathways/WP4337_r108190>	WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	18	4	2.01823973366131e-29	4	2.67640068448066e-29	4	1.0095022142667e-29	4	5.3577095366899e-29	4	2.01823973366131e-29	4	2.64480742176335e-29	4	4.142552466445e-30	4	4.142552466445e-30
<https://identifiers.org/wikipathways/WP4341_r122900>	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	93	16	5.20939065356891e-108	16	2.36482032929191e-107	17	9.93491207012078e-108	16	9.7271800172911e-106	16	5.20939065356891e-108	17	1.6303349564295e-105	16	1.0587403691102e-111	17	8.81868448623575e-110
<https://identifiers.org/wikipathways/WP4352_r102218>	WP4352	Ciliary landscape	214	4	1.2299454179989e-248	4	6.20104076743014e-247	4	7.95504880938445e-253	4	9.30118617882663e-243	4	1.2299454179989e-248	4	5.25876973909458e-247	4	3.11558080795454e-258	4	3.11558080795454e-258
<https://identifiers.org/wikipathways/WP4357_r98705>	WP4357	NRF2-ARE regulation	23	3	1.02588399104799e-40	3	1.53381190980192e-40	3	3.82234006566423e-41	3	4.12352073693678e-40	3	1.02588399104799e-40	3	1.50807681064421e-40	3	1.07390210501487e-41	3	1.07390210501487e-41
<https://identifiers.org/wikipathways/WP437_r120689>	WP437	EGF/EGFR signaling pathway	162	9	3.83357887755206e-192	9	7.09348587891806e-191	9	2.93447273308864e-195	9	9.14701890269691e-188	9	3.83357887755206e-192	9	6.27438901893681e-191	9	2.81648198301779e-199	9	2.81648198301779e-199
<https://identifiers.org/wikipathways/WP4389_r116629>	WP4389	Bile acids synthesis and enterohepatic circulation 	13	4	5.02859788164979e-20	4	6.03132317679825e-20	4	3.21841089068964e-20	4	9.43210661339703e-20	4	5.02859788164979e-20	4	5.98536051075996e-20	4	1.81335514599467e-20	4	1.81335514599467e-20
<https://identifiers.org/wikipathways/WP4396_r98945>	WP4396	Nonalcoholic fatty liver disease	155	14	2.1299727746404e-175	14	3.17408681833513e-174	15	2.58811643507994e-176	14	2.40836588992107e-171	14	2.1299727746404e-175	15	2.48001983405894e-172	14	5.31480374860368e-182	15	5.2439396986222e-180
<https://identifiers.org/wikipathways/WP4462_r102079>	WP4462	Platelet-mediated interactions with vascular and circulating cells	19	8	4.0236257280557e-22	8	5.02400715071333e-22	8	2.33311524635815e-22	8	8.6735101384404e-22	8	4.0236257280557e-22	8	4.97729195320029e-22	8	1.15782300401537e-22	8	1.15782300401537e-22
<https://identifiers.org/wikipathways/WP4478_r121699>	WP4478	LTF danger signal response pathway	19	6	1.54536616406447e-26	6	2.00863871370272e-26	7	1.47199700085688e-24	6	3.82754769301126e-26	6	1.54536616406447e-26	7	3.36303510351369e-24	6	3.54975320849673e-27	7	6.85609476841072e-25
<https://identifiers.org/wikipathways/WP4479_r121700>	WP4479	Supression of HMGB1 mediated inflammation by THBD	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP4480_r121701>	WP4480	Altered glycosylation of MUC1 in tumor microenvironment	9	2	5.09334371675252e-17	2	5.86776044057711e-17	2	3.59867851592803e-17	2	8.31084680106283e-17	2	5.09334371675252e-17	2	5.83292216824115e-17	2	2.30252481571377e-17	2	2.30252481571377e-17
<https://identifiers.org/wikipathways/WP4481_r121702>	WP4481	Resistin as a regulator of inflammation	33	2	1.14962046044382e-59	2	2.13828522656201e-59	3	1.07484387190047e-57	2	9.83208696522963e-59	2	1.14962046044382e-59	3	8.35356761843552e-57	2	3.53045647440485e-61	3	1.61224178997824e-58
<https://identifiers.org/wikipathways/WP4482_r121703>	WP4482	Vitamin D in inflammatory diseases	22	2	1.33810955354085e-41	2	2.00062423017644e-41	2	4.98566095521432e-42	2	5.378505309048e-41	2	1.33810955354085e-41	2	1.96705670953592e-41	2	1.40074187610636e-42	2	1.40074187610636e-42
<https://identifiers.org/wikipathways/WP4483_r107927>	WP4483	Relationship between inflammation, COX-2 and EGFR	26	3	8.87874145234531e-46	3	1.40920987608102e-45	3	2.85668020563716e-46	3	4.38791416757199e-45	3	8.87874145234531e-46	3	1.38208700817317e-45	3	6.64530855434816e-47	3	6.64530855434816e-47
<https://identifiers.org/wikipathways/WP4484_r107333>	WP4484	Control of immune tolerance by vasoactive intestinal peptide	15	3	2.40815573553907e-26	3	3.06788988264195e-26	3	1.32920265815249e-26	3	5.56455914605738e-26	3	2.40815573553907e-26	3	3.03679640410163e-26	3	6.1910040478426e-27	3	6.1910040478426e-27
<https://identifiers.org/wikipathways/WP4493_r120800>	WP4493	Cells and molecules involved in local acute inflammatory response 	17	5	3.27509180033313e-25	5	4.17233024039302e-25	6	3.82030566655132e-23	5	7.56780043863799e-25	5	3.27509180033313e-25	6	8.14995173623443e-23	5	8.41976550506588e-26	6	1.89585053289067e-23
<https://identifiers.org/wikipathways/WP4494_r103559>	WP4494	Selective expression of chemokine receptors during T-cell polarization	29	11	7.77916783506345e-33	11	1.11755975206294e-32	11	3.19690776124986e-33	11	2.72364857784923e-32	11	7.77916783506345e-33	11	1.10065548690569e-32	11	1.01888189340753e-33	11	1.01888189340753e-33
<https://identifiers.org/wikipathways/WP4495_r117759>	WP4495	IL-10 anti-inflammatory signaling pathway 	13	6	2.42782717165205e-15	6	2.79696581000841e-15	6	1.71537009259237e-15	6	3.96150364183994e-15	6	2.42782717165205e-15	6	2.78035956686164e-15	6	1.09753682882357e-15	6	1.09753682882357e-15
<https://identifiers.org/wikipathways/WP4496_r102693>	WP4496	Signal transduction through IL1R	33	6	7.17937134875381e-50	6	1.23370418757758e-49	6	1.90052356402704e-50	6	4.66967930442668e-49	6	7.17937134875381e-50	6	1.20592269211089e-49	6	3.43959245875208e-51	6	3.43959245875208e-51
<https://identifiers.org/wikipathways/WP45_r106424>	WP45	G1 to S cell cycle control	66	5	1.82602479370844e-98	5	6.10046652816607e-98	5	9.43802383142027e-100	5	1.18220016975714e-96	5	1.82602479370844e-98	5	5.79865918167928e-98	5	2.08413792954456e-101	5	2.08413792954456e-101
<https://identifiers.org/wikipathways/WP4507_r119314>	WP4507	Molybdenum cofactor (Moco) biosynthesis	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP4518_r122628>	WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	6	1	2.91776237150454e-13	1	3.22844645135826e-13	1	2.27617272960665e-13	1	4.14064856177393e-13	1	2.91776237150454e-13	1	3.21473172556658e-13	1	1.65413565500943e-13	1	1.65413565500943e-13
<https://identifiers.org/wikipathways/WP4521_r119311>	WP4521	Glycosylation and related congenital defects	25	1	1.68083702637952e-49	1	2.72135798406373e-49	1	5.15026479381707e-50	1	8.89802791855898e-49	1	1.68083702637952e-49	1	2.66674879374807e-49	1	1.1251157324366e-50	1	1.1251157324366e-50
<https://identifiers.org/wikipathways/WP4522_r119310>	WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	20	6	2.55643699597098e-28	6	3.39010753367545e-28	6	1.27870280473782e-28	6	6.78643207980717e-28	6	2.55643699597098e-28	6	3.3500894009002e-28	6	5.24723312416365e-29	6	5.24723312416365e-29
<https://identifiers.org/wikipathways/WP4523_r121849>	WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	25	2	1.02447016757832e-46	2	1.62601139547809e-46	2	3.29616946804295e-47	2	5.06297788566005e-46	2	1.02447016757832e-46	2	1.59471577866131e-46	2	7.66766371655566e-48	2	7.66766371655566e-48
<https://identifiers.org/wikipathways/WP453_r116780>	WP453	Inflammatory response pathway	33	8	1.91286913810076e-45	8	3.15917715573462e-45	8	5.58212957366616e-46	8	1.0846497604357e-44	9	2.59300038720322e-43	8	3.09319601213114e-45	8	1.14525530404723e-46	8	1.14525530404723e-46
<https://identifiers.org/wikipathways/WP4532_r103287>	WP4532	Intraflagellar transport proteins binding to dynein	27	1	7.92113151352982e-53	1	1.33443510169847e-52	1	2.20155487757565e-53	1	4.81063382686287e-52	1	7.92113151352982e-53	1	1.30547407278014e-52	1	4.24216237617488e-54	1	4.24216237617488e-54
<https://identifiers.org/wikipathways/WP4533_r103380>	WP4533	Transcription co-factors SKI and SKIL protein partners	18	1	2.72741899262395e-37	1	3.84070123759073e-37	1	1.17721951280935e-37	1	8.91159449230089e-37	1	2.72741899262395e-37	1	3.78578793141823e-37	1	3.99633245654225e-38	1	3.99633245654225e-38
<https://identifiers.org/wikipathways/WP4534_r103303>	WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	46	1	7.71885354719821e-82	1	1.89030197868283e-81	1	8.55860154471169e-83	1	1.70853479837002e-80	1	7.71885354719821e-82	1	1.82040584964353e-81	1	5.05229141584095e-84	1	5.05229141584095e-84
<https://identifiers.org/wikipathways/WP4535_r109210>	WP4535	Envelope proteins and their potential roles in EDMD physiopathology	46	1	7.71885354719821e-82	1	1.89030197868283e-81	1	8.55860154471169e-83	1	1.70853479837002e-80	1	7.71885354719821e-82	1	1.82040584964353e-81	1	5.05229141584095e-84	1	5.05229141584095e-84
<https://identifiers.org/wikipathways/WP4536_r110928>	WP4536	Genes related to primary cilium development (based on CRISPR)	103	2	1.14663115924306e-149	2	8.18523189381562e-149	2	9.15832298517454e-152	2	1.02225009972842e-146	2	1.14663115924306e-149	2	7.53581443798284e-149	2	1.81924018971921e-154	2	1.81924018971921e-154
<https://identifiers.org/wikipathways/WP4537_r103300>	WP4537	Hippo-Yap signaling pathway	23	3	1.02588399104799e-40	3	1.53381190980192e-40	3	3.82234006566423e-41	3	4.12352073693678e-40	3	1.02588399104799e-40	3	1.50807681064421e-40	3	1.07390210501487e-41	3	1.07390210501487e-41
<https://identifiers.org/wikipathways/WP4538_r104390>	WP4538	Regulatory circuits of the STAT3 signaling pathway	78	11	2.86076390327226e-100	11	1.07268207233586e-99	11	1.11330663760455e-101	11	2.75980384282575e-98	11	2.86076390327226e-100	11	1.01467585857755e-99	11	1.70535919624358e-103	11	1.70535919624358e-103
<https://identifiers.org/wikipathways/WP4539_r113659>	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	50	4	1.43243511033012e-79	4	3.57712855949593e-79	4	1.51386016570436e-80	4	3.392030724695e-78	4	1.43243511033012e-79	4	3.44203175018817e-79	4	8.40103041926485e-82	4	8.40103041926485e-82
<https://identifiers.org/wikipathways/WP4540_r120395>	WP4540	Hippo signaling regulation pathways	98	4	5.49584614030639e-139	4	3.44098956774588e-138	4	6.06133208758648e-141	4	3.11527328190578e-136	4	5.49584614030639e-139	4	3.18549745134122e-138	4	1.82603569709661e-143	4	1.82603569709661e-143
<https://identifiers.org/wikipathways/WP4541_r116745>	WP4541	Hippo-Merlin signaling dysregulation	120	7	1.28925890810764e-155	7	1.15046146973313e-154	8	1.0174551947722e-155	7	2.48363172657957e-152	7	1.28925890810764e-155	8	1.68542605315903e-152	7	5.81185148745906e-161	8	1.05485104497389e-158
<https://identifiers.org/wikipathways/WP4542_r120673>	WP4542	Leukocyte-intrinsic Hippo pathway functions	36	3	1.08953142878727e-61	3	2.10815106718978e-61	3	2.15500121621144e-62	3	1.06813435354904e-60	3	1.08953142878727e-61	3	2.05041746949914e-61	3	2.68020185168943e-63	3	2.68020185168943e-63
<https://identifiers.org/wikipathways/WP4545_r121824>	WP4545	Oxysterols derived from cholesterol	52	8	3.47962675989209e-73	8	8.35647156733721e-73	8	4.04797927494244e-74	8	7.1988883931392e-72	8	3.47962675989209e-73	8	8.05409924088742e-73	8	2.54204163135627e-75	8	2.54204163135627e-75
<https://identifiers.org/wikipathways/WP4549_r119333>	WP4549	Fragile X syndrome	112	3	9.31367858144053e-157	3	7.71693777632754e-156	3	5.15530871163077e-159	3	1.38894108187392e-153	3	9.31367858144053e-157	3	7.0603052879439e-156	3	6.37865347968557e-162	3	6.37865347968557e-162
<https://identifiers.org/wikipathways/WP455_r117740>	WP455	GPCRs, class A rhodopsin-like	262	24	3.17662293150392e-245	24	2.58170617916498e-243	24	6.3250267853889e-250	24	1.24485656814745e-238	24	3.17662293150392e-245	24	2.14592882410017e-243	24	5.37817047827355e-256	24	5.37817047827355e-256
<https://identifiers.org/wikipathways/WP4553_r103606>	WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	35	1	1.4775310940972e-65	1	2.91583826720587e-65	1	2.78423929743081e-66	1	1.55071770259734e-64	1	1.4775310940972e-65	1	2.83363387161291e-65	1	3.25346182530885e-67	1	3.25346182530885e-67
<https://identifiers.org/wikipathways/WP4558_r107928>	WP4558	Overview of interferons-mediated signaling pathway	37	4	1.00781657162822e-60	4	1.95003973715057e-60	4	1.99337612499558e-61	4	9.88024277032849e-60	4	1.00781657162822e-60	4	1.89663615928667e-60	4	2.47918671281273e-62	4	2.47918671281273e-62
<https://identifiers.org/wikipathways/WP4559_r104316>	WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	50	8	2.01257045766088e-70	8	4.64776739311383e-70	8	2.57761033242654e-71	8	3.63692076261626e-69	8	2.01257045766088e-70	8	4.48697148659762e-70	8	1.83205860567914e-72	8	1.83205860567914e-72
<https://identifiers.org/wikipathways/WP4561_r107544>	WP4561	Cell migration and invasion through p75NTR	30	4	8.03994848623267e-50	4	1.35445162822396e-49	4	2.23457820073927e-50	4	4.88279333426579e-49	4	8.03994848623267e-50	4	1.32505618387185e-49	4	4.30579481181752e-51	4	4.30579481181752e-51
<https://identifiers.org/wikipathways/WP4564_r117803>	WP4564	Neural crest cell migration during development	39	6	4.97861386384343e-59	6	9.63319630152386e-59	6	9.84727805747842e-60	6	4.88083992854237e-58	6	4.97861386384343e-59	6	9.36938262687621e-59	6	1.2247182361295e-60	6	1.2247182361295e-60
<https://identifiers.org/wikipathways/WP4565_r117804>	WP4565	Neural crest cell migration in cancer	42	6	1.84283535368343e-63	6	3.78287441674128e-63	6	3.15232418155733e-64	6	2.21629693656142e-62	6	1.84283535368343e-63	6	3.67013974869263e-63	6	3.25214091205834e-65	6	3.25214091205834e-65
<https://identifiers.org/wikipathways/WP4566_r104315>	WP4566	Translation inhibitors in chronically activated PDGFRA cells	46	3	1.97648963929551e-76	3	4.65467959230847e-76	3	2.41252713209502e-77	3	3.82177023442999e-75	3	1.97648963929551e-76	3	4.48994607587281e-76	3	1.61174158915029e-78	3	1.61174158915029e-78
<https://identifiers.org/wikipathways/WP4571_r120383>	WP4571	Urea cycle and related diseases	9	3	2.04073304917885e-14	3	2.30407393299993e-14	3	1.5150436552057e-14	3	3.10548642133046e-14	3	2.04073304917885e-14	3	2.29233841211879e-14	3	1.03306613398358e-14	3	1.03306613398358e-14
<https://identifiers.org/wikipathways/WP4582_r108125>	WP4582	Cancer immunotherapy by CTLA4 blockade	16	2	7.91466562220127e-31	2	1.04956889587477e-30	2	3.95883221281062e-31	2	2.10106256340779e-30	2	7.91466562220127e-31	2	1.03717938108367e-30	2	1.62453037899804e-31	2	1.62453037899804e-31
<https://identifiers.org/wikipathways/WP4583_r106803>	WP4583	Biomarkers for urea cycle disorders	12	3	1.54726088666146e-20	3	1.85579174670717e-20	3	9.9028027405835e-21	3	2.90218665027597e-20	3	1.54726088666146e-20	3	1.84164938792615e-20	3	5.57955429536818e-21	3	5.57955429536818e-21
<https://identifiers.org/wikipathways/WP4584_r119306>	WP4584	Biomarkers for pyrimidine metabolism disorders	19	2	2.59104804299277e-36	2	3.64866617571116e-36	2	1.11835853716887e-36	2	8.46601476768587e-36	2	2.59104804299277e-36	2	3.59649853484725e-36	2	3.79651583371506e-37	2	3.79651583371506e-37
<https://identifiers.org/wikipathways/WP4585_r108119>	WP4585	Cancer immunotherapy by PD-1 blockade	25	6	6.23224524561654e-37	6	9.13384992287064e-37	6	2.43865296189377e-37	6	2.33803625784323e-36	6	6.23224524561654e-37	6	8.98813779143953e-37	6	7.2971648035761e-38	6	7.2971648035761e-38
<https://identifiers.org/wikipathways/WP4586_r119267>	WP4586	Metabolism of alpha-linolenic acid	6	2	1.75065742290272e-10	2	1.89832651339864e-10	2	1.43512690601699e-10	2	2.31669287031253e-10	2	1.75065742290272e-10	2	1.89186962049593e-10	2	1.11157916016632e-10	2	1.11157916016632e-10
<https://identifiers.org/wikipathways/WP4595_r121755>	WP4595	Urea cycle and associated pathways	24	5	1.49573885894794e-37	5	2.19212398148898e-37	5	5.852767108545e-38	5	5.61128701882362e-37	5	1.49573885894794e-37	5	2.15715306994547e-37	5	1.75131955285824e-38	5	1.75131955285824e-38
<https://identifiers.org/wikipathways/WP4629_r119264>	WP4629	Aerobic glycolysis	13	1	6.88044495868306e-28	1	8.76539966469129e-28	1	3.7977218804357e-28	1	1.58987404173068e-27	1	6.88044495868306e-28	1	8.67656115457625e-28	1	1.76885829938359e-28	1	1.76885829938359e-28
<https://identifiers.org/wikipathways/WP4630_r120771>	WP4630	Measles virus infection	150	16	7.91782775142292e-167	16	1.03900383886399e-165	16	1.41299076777994e-169	16	5.77262391278589e-163	16	7.91782775142292e-167	16	9.32398544524321e-166	16	4.05109367780714e-173	16	4.05109367780714e-173
<https://identifiers.org/wikipathways/WP465_r122957>	WP465	Tryptophan metabolism	56	7	8.30302649042474e-81	7	2.19835737643715e-80	7	7.60024887306863e-82	7	2.40666856715887e-79	7	8.30302649042474e-81	7	2.11013500834097e-80	7	3.50491887888621e-83	7	3.50491887888621e-83
<https://identifiers.org/wikipathways/WP4655_r105163>	WP4655	Cytosolic DNA-sensing pathway	74	11	2.10956324660791e-95	11	7.32464551739204e-95	11	9.9179670926645e-97	11	1.56030331777585e-93	11	2.10956324660791e-95	11	6.950999632699e-95	11	1.93839422706794e-98	11	1.93839422706794e-98
<https://identifiers.org/wikipathways/WP4656_r120396>	WP4656	Joubert syndrome	76	4	2.44562516848383e-113	4	1.00918938378745e-112	4	7.52068781621369e-115	4	3.28458420844332e-111	4	2.44562516848383e-113	4	9.50779708841533e-113	4	8.50395873643309e-117	4	8.50395873643309e-117
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	154	6	2.14480595781719e-191	6	3.6272312530983e-190	6	2.04908027033961e-194	6	3.75223776494737e-187	6	2.14480595781719e-191	6	3.22054168835729e-190	6	2.61936997107222e-198	6	2.61936997107222e-198
<https://identifiers.org/wikipathways/WP4658_r119261>	WP4658	Small cell lung cancer	96	10	2.85138652946854e-123	10	1.53541600260165e-122	10	4.55684555513433e-125	10	9.60272955158973e-121	10	2.85138652946854e-123	10	1.43045115663684e-122	10	2.21527923487114e-127	10	2.21527923487114e-127
<https://identifiers.org/wikipathways/WP4659_r116555>	WP4659	Gastrin signaling pathway	114	9	5.70956532753828e-145	9	4.39155954765406e-144	10	5.16540406028026e-145	9	6.58610262277587e-142	9	5.70956532753828e-145	10	5.14690778985026e-142	9	5.94803828329745e-150	10	8.58896728108168e-148
<https://identifiers.org/wikipathways/WP4666_r119241>	WP4666	Hepatitis B infection	152	21	1.74299541984259e-159	21	2.16543867148457e-158	22	2.24386039942355e-160	21	1.05212796151314e-155	21	1.74299541984259e-159	22	1.15358823771807e-156	21	1.21448381904685e-165	22	8.11496006363058e-164
<https://identifiers.org/wikipathways/WP4673_r119920>	WP4673	Male infertility	145	11	5.8460226275198e-172	11	7.67134641314572e-171	11	1.04326290748541e-174	11	4.26213995476789e-168	11	5.8460226275198e-172	11	6.88424042588679e-171	11	2.9910710424848e-178	11	2.9910710424848e-178
<https://identifiers.org/wikipathways/WP4674_r117748>	WP4674	Head and neck squamous cell carcinoma	74	2	5.14868456522926e-116	2	2.12460922902615e-115	2	1.58330269815032e-117	2	6.91491412303836e-114	2	5.14868456522926e-116	2	2.00164149229794e-115	2	1.79030710240699e-119	2	1.79030710240699e-119
<https://identifiers.org/wikipathways/WP4685_r119240>	WP4685	Melanoma	68	2	1.57802672954986e-108	2	5.8044977891467e-108	2	6.43795038838199e-110	2	1.42462675315999e-106	2	1.57802672954986e-108	2	5.49504960329548e-108	2	1.04803110211091e-111	2	1.04803110211091e-111
<https://identifiers.org/wikipathways/WP4688_r120418>	WP4688	Serine metabolism	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP4698_r119119>	WP4698	Vitamin D-sensitive calcium signaling in depression	37	4	1.00781657162822e-60	4	1.95003973715057e-60	4	1.99337612499558e-61	4	9.88024277032849e-60	4	1.00781657162822e-60	4	1.89663615928667e-60	4	2.47918671281273e-62	4	2.47918671281273e-62
<https://identifiers.org/wikipathways/WP47_r120579>	WP47	Hedgehog signaling pathway	16	1	1.30820919375229e-33	1	1.7699306844431e-33	1	6.22947633801837e-34	1	3.72198859771085e-33	1	1.30820919375229e-33	1	1.74756424782419e-33	1	2.39960174150376e-34	1	2.39960174150376e-34
<https://identifiers.org/wikipathways/WP4707_r116586>	WP4707	Aspirin and miRNAs	11	4	4.66889840702315e-16	4	5.37878040386231e-16	4	3.2987886396007e-16	4	7.6182762343076e-16	4	4.66889840702315e-16	4	5.34684532088774e-16	4	2.11064774773761e-16	4	2.11064774773761e-16
<https://identifiers.org/wikipathways/WP4718_r119764>	WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	47	17	2.36041463696566e-48	17	4.30440817324506e-48	17	5.40020173104922e-49	17	1.8853611000619e-47	17	2.36041463696566e-48	17	4.19697702083461e-48	17	8.10018192662357e-50	17	8.10018192662357e-50
<https://identifiers.org/wikipathways/WP4719_r116307>	WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	30	4	8.03994848623267e-50	4	1.35445162822396e-49	4	2.23457820073927e-50	4	4.88279333426579e-49	4	8.03994848623267e-50	4	1.32505618387185e-49	4	4.30579481181752e-51	4	4.30579481181752e-51
<https://identifiers.org/wikipathways/WP4720_r120365>	WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP4721_r116526>	WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	29	4	3.27225903389671e-48	4	5.40426199661349e-48	4	9.54909751115912e-49	4	1.85546146702101e-47	4	3.27225903389671e-48	4	5.29139102759483e-48	4	1.95913663937698e-49	4	1.95913663937698e-49
<https://identifiers.org/wikipathways/WP4722_r117144>	WP4722	Glycerolipids and glycerophospholipids	22	2	1.33810955354085e-41	2	2.00062423017644e-41	2	4.98566095521432e-42	2	5.378505309048e-41	2	1.33810955354085e-41	2	1.96705670953592e-41	2	1.40074187610636e-42	2	1.40074187610636e-42
<https://identifiers.org/wikipathways/WP4723_r120315>	WP4723	Omega-3 / omega-6 fatty acid synthesis	14	4	5.84235438531927e-22	4	7.14974805039589e-22	4	3.55906417611807e-22	4	1.17481754971137e-21	4	5.84235438531927e-22	4	7.08925948820973e-22	4	1.88191045544294e-22	4	1.88191045544294e-22
<https://identifiers.org/wikipathways/WP4724_r117812>	WP4724	Omega-9 fatty acid synthesis	14	5	1.40800740686195e-19	5	1.68877048950349e-19	5	9.01155049393085e-20	5	2.64098985175113e-19	5	1.40800740686195e-19	5	1.67590094301279e-19	5	5.07739440878505e-20	5	5.07739440878505e-20
<https://identifiers.org/wikipathways/WP4725_r117175>	WP4725	Sphingolipid metabolism overview	23	1	4.1593488803679e-46	1	6.47152535400269e-46	1	1.40526691654229e-46	1	1.91886861866513e-45	1	4.1593488803679e-46	1	6.35228451833433e-46	1	3.48111932731623e-47	1	3.48111932731623e-47
<https://identifiers.org/wikipathways/WP4726_r120323>	WP4726	Sphingolipid metabolism: integrated pathway	26	1	3.58211169556295e-51	1	5.91599561752989e-51	1	1.04533087150073e-51	1	2.03115650467544e-50	1	3.58211169556295e-51	1	5.79243681181707e-51	1	2.14464875684401e-52	1	2.14464875684401e-52
<https://identifiers.org/wikipathways/WP474_r117098>	WP474	Endochondral ossification	64	10	6.82529167350365e-85	10	1.99151290224317e-84	10	4.92046362640715e-86	10	2.76783880392269e-83	10	6.82529167350365e-85	10	1.90379536821287e-84	10	1.66824221093771e-87	10	1.66824221093771e-87
<https://identifiers.org/wikipathways/WP4746_r120402>	WP4746	Thyroid hormones production and peripheral downstream signaling effects	95	5	3.30966330157202e-133	5	1.92196118904582e-132	5	4.39270701357318e-135	5	1.44665729759177e-130	5	3.30966330157202e-133	5	1.78489581106305e-132	5	1.68048676150781e-137	5	1.68048676150781e-137
<https://identifiers.org/wikipathways/WP4747_r116543>	WP4747	Netrin-UNC5B signaling pathway	52	10	5.93037428190737e-69	10	1.3695421251709e-68	11	8.96252296653586e-68	10	1.07167931805089e-67	10	5.93037428190737e-69	11	1.45918488245483e-66	10	5.39846602473464e-71	11	6.77752870923482e-69
<https://identifiers.org/wikipathways/WP4754_r115147>	WP4754	IL-18 signaling pathway	185	52	1.96956741254036e-140	52	2.53785896299907e-139	56	1.54562808747581e-137	52	1.34842771071971e-136	52	1.96956741254036e-140	56	7.4646206240473e-134	52	1.11690144353694e-146	56	5.9245329552497e-141
<https://identifiers.org/wikipathways/WP4756_r120634>	WP4756	Renin-angiotensin-aldosterone system (RAAS)	44	5	1.11601485047381e-68	5	2.43005274887284e-68	5	1.65158407369769e-69	5	1.64567176742868e-67	5	1.11601485047381e-68	5	2.35179341179107e-68	5	1.41396983853971e-70	5	1.41396983853971e-70
<https://identifiers.org/wikipathways/WP4758_r108284>	WP4758	Nephrotic syndrome	49	2	2.76799055136268e-83	2	7.04852918127253e-83	2	2.78838403506562e-84	2	7.01194981849107e-82	2	2.76799055136268e-83	2	6.77676472555475e-83	2	1.45472388212376e-85	2	1.45472388212376e-85
<https://identifiers.org/wikipathways/WP4760_r108400>	WP4760	PKC-gamma calcium signaling pathway in ataxia	22	2	1.33810955354085e-41	2	2.00062423017644e-41	2	4.98566095521432e-42	2	5.378505309048e-41	2	1.33810955354085e-41	2	1.96705670953592e-41	2	1.40074187610636e-42	2	1.40074187610636e-42
<https://identifiers.org/wikipathways/WP4767_r116441>	WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	27	5	1.45993145700914e-42	5	2.27150539925493e-42	5	4.9324868770634e-43	5	6.73522885151469e-42	5	1.45993145700914e-42	5	2.22965186593537e-42	5	1.22187288388797e-43	5	1.22187288388797e-43
<https://identifiers.org/wikipathways/WP477_r117044>	WP477	Cytoplasmic ribosomal proteins	88	1	1.50960638845394e-135	1	8.28401884507322e-135	1	2.30294705335914e-137	1	5.4268441174904e-133	1	1.50960638845394e-135	1	7.71157274537463e-135	1	1.05439808320783e-139	1	1.05439808320783e-139
<https://identifiers.org/wikipathways/WP4784_r111633>	WP4784	Proteoglycan biosynthesis	18	2	1.65281590953014e-34	2	2.28137653512886e-34	2	7.49300219903135e-35	2	5.03950668539615e-34	2	1.65281590953014e-34	2	2.25065092522815e-34	2	2.70951340553558e-35	2	2.70951340553558e-35
<https://identifiers.org/wikipathways/WP4786_r117852>	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	33	4	1.43879790709798e-54	4	2.57236069136279e-54	4	3.45562304816e-55	4	1.07323783950125e-53	4	1.43879790709798e-54	4	2.51024706933987e-54	4	5.51789752620045e-56	4	5.51789752620045e-56
<https://identifiers.org/wikipathways/WP4787_r118872>	WP4787	Osteoblast differentiation and related diseases	118	10	4.76424457967196e-147	10	3.87480792259436e-146	10	2.76046686997334e-149	10	6.66354740371307e-144	10	4.76424457967196e-147	10	3.54787100412551e-146	10	3.6232039618945e-152	10	3.6232039618945e-152
<https://identifiers.org/wikipathways/WP4788_r117658>	WP4788	Autosomal recessive osteopetrosis pathways	11	2	3.86815221665368e-21	2	4.63947936676791e-21	2	2.47570068514584e-21	2	7.25546662568996e-21	2	3.86815221665368e-21	2	4.60412346981535e-21	2	1.39488857384204e-21	2	1.39488857384204e-21
<https://identifiers.org/wikipathways/WP4790_r116413>	WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	23	5	7.56594572817839e-36	5	1.0869281408216e-35	5	3.10928252641458e-36	5	2.64899508013633e-35	5	7.56594572817839e-36	5	1.07048721096044e-35	5	9.9095498032562e-37	5	9.9095498032562e-37
<https://identifiers.org/wikipathways/WP4792_r119117>	WP4792	Purine metabolism	15	1	9.8933320277515e-32	1	1.31196111984346e-31	1	4.94854026601329e-32	1	2.62632820425974e-31	1	9.8933320277515e-32	1	1.29647422635458e-31	1	2.03066297374753e-32	1	2.03066297374753e-32
<https://identifiers.org/wikipathways/WP4799_r120793>	WP4799	Downregulation of ACE2 by SARS-CoV-2 spike protein	5	2	3.49839708343393e-08	2	3.71755608873899e-08	2	3.01376650263572e-08	2	4.31677104834896e-08	2	3.49839708343393e-08	2	3.70806445617204e-08	2	2.48808468683897e-08	2	2.48808468683897e-08
<https://identifiers.org/wikipathways/WP4803_r110008>	WP4803	Ciliopathies	184	6	1.57734749919731e-218	6	4.55361339399627e-217	6	4.03462784598638e-222	6	1.74512420746589e-213	6	1.57734749919731e-218	6	3.95321103538053e-217	6	9.37654447465134e-227	6	9.37654447465134e-227
<https://identifiers.org/wikipathways/WP4804_r117680>	WP4804	Cholesterol biosynthesis with skeletal dysplasias	7	1	1.70061087431572e-15	1	1.92006161083328e-15	1	1.26253637933808e-15	1	2.58790535110871e-15	1	1.70061087431572e-15	1	1.91028201009899e-15	1	8.60888444986317e-16	1	8.60888444986317e-16
<https://identifiers.org/wikipathways/WP4806_r116801>	WP4806	EGFR tyrosine kinase inhibitor resistance	85	8	6.58325892420467e-115	8	2.98849243073866e-114	8	1.60116765978452e-116	8	1.22925211247703e-112	8	6.58325892420467e-115	8	2.80425390618552e-114	8	1.33796108736541e-118	8	1.33796108736541e-118
<https://identifiers.org/wikipathways/WP4808_r117708>	WP4808	Endochondral ossification with skeletal dysplasias	64	10	6.82529167350365e-85	10	1.99151290224317e-84	10	4.92046362640715e-86	10	2.76783880392269e-83	10	6.82529167350365e-85	10	1.90379536821287e-84	10	1.66824221093771e-87	10	1.66824221093771e-87
<https://identifiers.org/wikipathways/WP481_r120562>	WP481	Insulin signaling	161	9	3.1899162511978e-191	9	5.79739216276913e-190	9	2.5522667166189e-194	9	7.15387219118288e-187	9	3.1899162511978e-191	9	5.13183052474725e-190	9	2.59394513497707e-198	9	2.59394513497707e-198
<https://identifiers.org/wikipathways/WP4814_r116554>	WP4814	Somatic sex determination	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP4815_r110276>	WP4815	Glycosaminoglycan degradation	17	3	4.48497718591407e-30	3	5.94755707662364e-30	3	2.24333825392603e-30	3	1.19060211926442e-29	3	4.48497718591407e-30	3	5.87734982614075e-30	3	9.20567214765547e-31	3	9.20567214765547e-31
<https://identifiers.org/wikipathways/WP4816_r116440>	WP4816	TGF-beta receptor signaling in skeletal dysplasias	59	9	1.80671411095863e-80	9	4.87758667421471e-80	9	1.57654728569797e-81	9	5.60125919600259e-79	9	1.80671411095863e-80	9	4.67801275137446e-80	9	6.83593759501518e-83	9	6.83593759501518e-83
<https://identifiers.org/wikipathways/WP4818_r117691>	WP4818	Conversion of angiotensinogen to angiotensin II 	5	1	5.83552474300908e-11	1	6.32775504466212e-11	1	4.78375635338997e-11	1	7.7223095677084e-11	1	5.83552474300908e-11	1	6.30623206831977e-11	1	3.70526386722106e-11	1	3.70526386722106e-11
<https://identifiers.org/wikipathways/WP4823_r119116>	WP4823	Genes controlling nephrogenesis	44	2	3.54622343977955e-76	2	8.1895377174818e-76	2	4.54184455737906e-77	2	6.40838863947174e-75	2	3.54622343977955e-76	2	7.90620939447187e-76	2	3.22815489305172e-78	2	3.22815489305172e-78
<https://identifiers.org/wikipathways/WP4829_r109219>	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	38	3	1.01337010648812e-64	3	2.03963612123948e-64	3	1.81935265012597e-65	3	1.13854260566676e-63	3	1.01337010648812e-64	3	1.98049174324169e-64	3	1.99754031719836e-66	3	1.99754031719836e-66
<https://identifiers.org/wikipathways/WP4838_r110282>	WP4838	Regucalcin in proximal tubule epithelial kidney cells	44	1	5.72895547621907e-79	1	1.34918249052417e-78	1	6.99283226694249e-80	1	1.10775948824061e-77	1	5.72895547621907e-79	1	1.30143364518056e-78	1	4.67171475116012e-81	1	4.67171475116012e-81
<https://identifiers.org/wikipathways/WP4842_r119114>	WP4842	Mammalian disorder of sexual development	25	2	1.02447016757832e-46	2	1.62601139547809e-46	2	3.29616946804295e-47	2	5.06297788566005e-46	2	1.02447016757832e-46	2	1.59471577866131e-46	2	7.66766371655566e-48	2	7.66766371655566e-48
<https://identifiers.org/wikipathways/WP4844_r120398>	WP4844	Influence of laminopathies on Wnt signaling	39	3	3.21051455345549e-66	3	6.59037354832987e-66	3	5.49185397483849e-67	3	3.86114448878298e-65	3	3.21051455345549e-66	3	6.39397168761802e-66	3	5.6657507178718e-68	3	5.6657507178718e-68
<https://identifiers.org/wikipathways/WP4846_r122702>	WP4846	SARS-CoV-2 and COVID-19 pathway	50	1	1.79008269548222e-87	1	4.73952660826039e-87	1	1.63856805765084e-88	1	5.18863303736319e-86	1	1.79008269548222e-87	1	4.54932447574204e-87	1	7.55639481747852e-90	1	7.55639481747852e-90
<https://identifiers.org/wikipathways/WP4853_r122756>	WP4853	Linoleic acid metabolism affected by SARS-CoV-2	13	3	1.66924411009121e-22	3	2.04278515725596e-22	3	1.01687547889088e-22	3	3.35662157060388e-22	3	1.66924411009121e-22	3	2.02550271091708e-22	3	5.37688701555125e-23	3	5.37688701555125e-23
<https://identifiers.org/wikipathways/WP4856_r113654>	WP4856	Intracellular trafficking proteins involved in CMT neuropathy	27	1	7.92113151352982e-53	1	1.33443510169847e-52	1	2.20155487757565e-53	1	4.81063382686287e-52	1	7.92113151352982e-53	1	1.30547407278014e-52	1	4.24216237617488e-54	1	4.24216237617488e-54
<https://identifiers.org/wikipathways/WP4861_r118973>	WP4861	Endoplasmic reticulum stress response in coronavirus infection	54	2	3.51182123505478e-90	2	9.85677385025037e-90	2	2.78516628572798e-91	2	1.24534205380881e-88	2	3.51182123505478e-90	2	9.43802202001087e-90	2	1.06778451639166e-92	2	1.06778451639166e-92
<https://identifiers.org/wikipathways/WP4864_r116596>	WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	32	5	1.30534024522798e-50	5	2.24309852286836e-50	5	3.45549738914007e-51	5	8.49032600804866e-50	5	1.30534024522798e-50	5	2.19258671292888e-50	5	6.25380447045821e-52	5	6.25380447045821e-52
<https://identifiers.org/wikipathways/WP4868_r120021>	WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	42	6	1.84283535368343e-63	6	3.78287441674128e-63	6	3.15232418155733e-64	6	2.21629693656142e-62	6	1.84283535368343e-63	6	3.67013974869263e-63	6	3.25214091205834e-65	6	3.25214091205834e-65
<https://identifiers.org/wikipathways/WP4871_r120412>	WP4871	Kisspeptin/kisspeptin receptor system in the ovary	39	3	3.21051455345549e-66	3	6.59037354832987e-66	3	5.49185397483849e-67	3	3.86114448878298e-65	3	3.21051455345549e-66	3	6.39397168761802e-66	3	5.6657507178718e-68	3	5.6657507178718e-68
<https://identifiers.org/wikipathways/WP4872_r110081>	WP4872	MAP3K1 role in promoting and blocking gonadal determination	17	3	4.48497718591407e-30	3	5.94755707662364e-30	3	2.24333825392603e-30	3	1.19060211926442e-29	3	4.48497718591407e-30	3	5.87734982614075e-30	3	9.20567214765547e-31	3	9.20567214765547e-31
<https://identifiers.org/wikipathways/WP4874_r121708>	WP4874	CAMKK2 pathway	47	1	2.92333695985744e-83	1	7.30026236631828e-83	1	3.08951054225378e-84	1	6.92251168305118e-82	1	2.92333695985744e-83	1	7.02455459222067e-83	1	1.71449600393159e-85	1	1.71449600393159e-85
<https://identifiers.org/wikipathways/WP4875_r116427>	WP4875	Disruption of postsynaptic signaling by CNV	33	3	4.6981156150138e-57	3	8.56739614109177e-57	3	1.07484387190047e-57	3	3.75257985839593e-56	3	4.6981156150138e-57	3	8.35356761843552e-57	3	1.61224178997824e-58	3	1.61224178997824e-58
<https://identifiers.org/wikipathways/WP4876_r120600>	WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	8	2	6.8024434972629e-15	2	7.68024644333305e-15	2	5.05014551735233e-15	2	1.03516214044349e-14	2	6.8024434972629e-15	2	7.64112804039599e-15	2	3.44355377994527e-15	2	3.44355377994527e-15
<https://identifiers.org/wikipathways/WP4877_r119237>	WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	42	8	4.98266481084408e-59	8	9.83305514595394e-59	8	9.38926512457242e-60	8	5.22947135200969e-58	8	4.98266481084408e-59	8	9.55583800253578e-59	8	1.09716200323328e-60	8	1.09716200323328e-60
<https://identifiers.org/wikipathways/WP4879_r120399>	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	59	6	4.69592218634653e-87	6	1.3438675002467e-86	6	3.55070473657759e-88	6	1.78082348568978e-85	6	4.69592218634653e-87	6	1.28572466146049e-86	6	1.28011050140807e-89	6	1.28011050140807e-89
<https://identifiers.org/wikipathways/WP4880_r119113>	WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	43	4	1.26819869372024e-69	4	2.76142357826464e-69	4	1.87680008374733e-70	4	1.87008155389624e-68	4	1.26819869372024e-69	4	2.67249251339897e-69	4	1.60678390743155e-71	4	1.60678390743155e-71
<https://identifiers.org/wikipathways/WP4883_r120620>	WP4883	SARS-CoV-2 and ACE2 receptor: molecular mechanisms	7	2	1.02121683002659e-12	2	1.12995625797539e-12	2	7.96660455362328e-13	2	1.44922699662088e-12	2	1.02121683002659e-12	2	1.12515610394831e-12	2	5.78947479253297e-13	2	5.78947479253297e-13
<https://identifiers.org/wikipathways/WP4884_r120646>	WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	32	2	4.27101419546713e-58	2	7.78854194644705e-58	3	4.18863399776977e-56	2	3.41143623490541e-57	4	5.33663223723615e-53	3	3.04272372041197e-55	2	1.46567435452564e-59	3	6.68836063781861e-57
<https://identifiers.org/wikipathways/WP4891_r120510>	WP4891	COVID-19 adverse outcome pathway	15	10	1.46034006693801e-10	10	1.61583744890481e-10	11	1.30596548447547e-08	10	2.07239460516785e-10	10	1.46034006693801e-10	11	1.7216013546513e-08	10	8.27894895332217e-11	11	1.01153703575135e-08
<https://identifiers.org/wikipathways/WP49_r120703>	WP49	IL-2 signaling pathway	42	5	8.97484750170509e-66	5	1.87891113414302e-65	5	1.46279544387808e-66	5	1.15532420672184e-64	5	8.97484750170509e-66	5	1.82140930456217e-65	5	1.41808470002543e-67	5	1.41808470002543e-67
<https://identifiers.org/wikipathways/WP4900_r110333>	WP4900	Purinergic signaling	33	1	1.87387198116355e-62	1	3.55492140741808e-62	1	3.89047138332856e-63	1	1.71589650353045e-61	1	1.87387198116355e-62	1	3.46043844642363e-62	1	5.15019179344245e-64	1	5.15019179344245e-64
<https://identifiers.org/wikipathways/WP4905_r115772>	WP4905	1q21.1 copy number variation syndrome	38	2	2.46962657958111e-67	2	5.06951811409979e-67	2	4.22450305756807e-68	2	2.97011114521763e-66	2	2.46962657958111e-67	2	4.91843975970617e-67	2	4.35826978297812e-69	2	4.35826978297812e-69
<https://identifiers.org/wikipathways/WP4906_r115773>	WP4906	3q29 copy number variation syndrome	75	2	3.04535758984371e-117	2	1.28091392425211e-116	2	8.93511680671717e-119	2	4.36915382668814e-115	2	3.04535758984371e-117	2	1.20580812789033e-116	2	9.50942157794063e-121	2	9.50942157794063e-121
<https://identifiers.org/wikipathways/WP4912_r115852>	WP4912	SARS coronavirus and innate immunity	32	3	1.74399746314906e-55	3	3.11801295922765e-55	3	4.18863399776977e-56	3	1.30089435091059e-54	3	1.74399746314906e-55	3	3.04272372041197e-55	3	6.68836063781861e-57	3	6.68836063781861e-57
<https://identifiers.org/wikipathways/WP4917_r119111>	WP4917	Proximal tubule transport	57	5	1.02755889337704e-86	5	2.8840920285832e-86	5	8.14939655203978e-88	5	3.64387084944463e-85	5	1.02755889337704e-86	5	2.7615652430552e-86	5	3.12433749496217e-89	5	3.12433749496217e-89
<https://identifiers.org/wikipathways/WP4919_r111814>	WP4919	Neuroinflammation	18	1	2.72741899262395e-37	1	3.84070123759073e-37	1	1.17721951280935e-37	1	8.91159449230089e-37	1	2.72741899262395e-37	1	3.78578793141823e-37	1	3.99633245654225e-38	1	3.99633245654225e-38
<https://identifiers.org/wikipathways/WP4925_r112845>	WP4925	Unfolded protein response	25	6	6.23224524561654e-37	6	9.13384992287064e-37	6	2.43865296189377e-37	6	2.33803625784323e-36	6	6.23224524561654e-37	6	8.98813779143953e-37	6	7.2971648035761e-38	6	7.2971648035761e-38
<https://identifiers.org/wikipathways/WP4928_r120795>	WP4928	MAPK pathway in congenital thyroid cancer	16	1	1.30820919375229e-33	1	1.7699306844431e-33	1	6.22947633801837e-34	1	3.72198859771085e-33	1	1.30820919375229e-33	1	1.74756424782419e-33	1	2.39960174150376e-34	1	2.39960174150376e-34
<https://identifiers.org/wikipathways/WP4932_r118797>	WP4932	7q11.23 copy number variation syndrome	117	8	2.7866149278001e-150	8	2.30887654285934e-149	8	1.5424474967257e-152	8	4.15565548965568e-147	8	2.7866149278001e-150	8	2.11241476052395e-149	8	1.90846729896585e-155	8	1.90846729896585e-155
<https://identifiers.org/wikipathways/WP4940_r115775>	WP4940	15q11.2 copy number variation syndrome	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP4941_r120578>	WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	36	1	4.32448125101619e-67	1	8.70399482748012e-67	1	7.76395156526037e-68	1	4.85864554338592e-66	1	4.32448125101619e-67	1	8.45160061127313e-67	1	8.52435412744685e-69	1	8.52435412744685e-69
<https://identifiers.org/wikipathways/WP4947_r118070>	WP4947	Nitric oxide metabolism in cystic fibrosis	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP4949_r115778>	WP4949	16p11.2 proximal deletion syndrome	82	1	1.69756520538939e-128	1	8.31500068865451e-128	1	3.42457016123494e-130	1	4.12188861203676e-126	1	1.69756520538939e-128	1	7.77747869680984e-128	1	2.24838604522362e-132	1	2.24838604522362e-132
<https://identifiers.org/wikipathways/WP4950_r115784>	WP4950	16p11.2 distal deletion syndrome	34	3	1.302903188503e-58	3	2.42338992343692e-58	3	2.83952538031202e-59	3	1.1143031893927e-57	3	1.302903188503e-58	3	2.36094180404662e-58	3	4.00118400432549e-60	3	4.00118400432549e-60
<https://identifiers.org/wikipathways/WP496_r119106>	WP496	Steroid biosynthesis	11	2	3.86815221665368e-21	2	4.63947936676791e-21	2	2.47570068514584e-21	2	7.25546662568996e-21	2	3.86815221665368e-21	2	4.60412346981535e-21	2	1.39488857384204e-21	2	1.39488857384204e-21
<https://identifiers.org/wikipathways/WP4961_r120610>	WP4961	STING pathway in Kawasaki-like disease and COVID-19	21	3	2.99049238267922e-37	3	4.29615865937391e-37	3	1.22896542546029e-37	3	1.04703362851237e-36	3	2.99049238267922e-37	3	4.23117474687918e-37	3	3.91681810405387e-38	3	3.91681810405387e-38
<https://identifiers.org/wikipathways/WP4963_r122690>	WP4963	p53 transcriptional gene network	98	11	1.92208767189955e-123	11	1.05475245850058e-122	11	2.93219886597894e-125	11	6.90966218434715e-121	11	1.92208767189955e-123	11	9.81866466531149e-123	11	1.34249932466429e-127	11	1.34249932466429e-127
<https://identifiers.org/wikipathways/WP4969_r120081>	WP4969	RAS and bradykinin pathways in COVID-19	31	7	1.76795480945675e-44	7	2.86240596837775e-44	7	5.4172030180805e-45	7	9.35921270557774e-44	7	1.76795480945675e-44	7	2.80496638372797e-44	7	1.18343048084881e-45	7	1.18343048084881e-45
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	37	5	2.47519749991895e-58	5	4.69569568705854e-58	5	5.13892365023855e-59	5	2.26652769151335e-57	5	2.47519749991895e-58	5	4.57089314388086e-58	5	6.80288833995811e-60	5	6.80288833995811e-60
<https://identifiers.org/wikipathways/WP4970_r113773>	WP4970	Galanin receptor pathway	20	1	7.03810869070189e-41	1	1.03149067451954e-40	1	2.7539841466897e-41	1	2.64035715171446e-40	1	7.03810869070189e-41	1	1.01503532370858e-40	1	8.24072818020991e-42	1	8.24072818020991e-42
<https://identifiers.org/wikipathways/WP500_r121748>	WP500	Glycogen synthesis and degradation	45	2	1.28901498214926e-77	2	3.03566060367946e-77	3	6.81276683606839e-76	2	2.49245884854125e-76	2	1.28901498214926e-77	3	1.18593140917077e-74	2	1.051135819011e-79	3	4.84223233957741e-77
<https://identifiers.org/wikipathways/WP5027_r120060>	WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	17	1	1.83646212170015e-35	1	2.53486281680987e-35	1	8.3255579989238e-36	1	5.59945187266235e-35	1	1.83646212170015e-35	1	2.50072325025348e-35	1	3.01057045059511e-36	1	3.01057045059511e-36
<https://identifiers.org/wikipathways/WP5033_r118996>	WP5033	Genes associated with the development of rheumatoid arthritis	18	4	2.01823973366131e-29	4	2.67640068448066e-29	4	1.0095022142667e-29	4	5.3577095366899e-29	4	2.01823973366131e-29	4	2.64480742176335e-29	4	4.142552466445e-30	4	4.142552466445e-30
<https://identifiers.org/wikipathways/WP5036_r119016>	WP5036	Angiotensin II receptor type 1 pathway	28	6	6.81301346604271e-42	6	1.06003585298564e-41	6	2.3018272092963e-42	6	3.14310679737348e-41	6	6.81301346604271e-42	6	1.04050420410317e-41	6	5.70207345814394e-43	6	5.70207345814394e-43
<https://identifiers.org/wikipathways/WP5037_r120417>	WP5037	Riboflavin and CoQ disorders	18	1	2.72741899262395e-37	1	3.84070123759073e-37	1	1.17721951280935e-37	1	8.91159449230089e-37	1	2.72741899262395e-37	1	3.78578793141823e-37	1	3.99633245654225e-38	1	3.99633245654225e-38
<https://identifiers.org/wikipathways/WP5038_r121595>	WP5038	Mitochondrial immune response to SARS-CoV-2	48	2	7.01600870365788e-82	2	1.75206296791631e-81	2	7.41482530140899e-83	2	1.6614028039322e-80	2	7.01600870365788e-82	2	1.68589310213287e-81	2	4.11479040943586e-84	2	4.11479040943586e-84
<https://identifiers.org/wikipathways/WP5039_r120358>	WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	86	26	3.03728600023897e-82	26	9.95320926838207e-82	27	8.02321349119298e-82	26	1.83957823623182e-80	26	3.03728600023897e-82	27	4.32043009723843e-80	26	3.8640600944869e-85	27	2.00215558229151e-83
<https://identifiers.org/wikipathways/WP5043_r120456>	WP5043	Pentose phosphate pathway in senescent cells	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP5044_r119244>	WP5044	Kynurenine pathway and links to cell senescence	23	6	1.52958202804674e-33	6	2.15392926572814e-33	6	6.60204323108693e-34	6	4.99777071785719e-33	6	1.52958202804674e-33	6	2.12313296840489e-33	6	2.24120984716979e-34	6	2.24120984716979e-34
<https://identifiers.org/wikipathways/WP5046_r118987>	WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	28	4	1.37660552460482e-46	4	2.22879218894818e-46	4	4.21806686613612e-47	4	7.28748486529965e-46	4	1.37660552460482e-46	4	2.18406726207967e-46	4	9.21469784865575e-48	4	9.21469784865575e-48
<https://identifiers.org/wikipathways/WP5049_r120508>	WP5049	Glycolysis in senescence	12	2	3.85210179251818e-23	2	4.71411959366764e-23	2	2.34663572051742e-23	2	7.74604977831665e-23	2	3.85210179251818e-23	2	4.67423702519325e-23	2	1.24082008051183e-23	2	1.24082008051183e-23
<https://identifiers.org/wikipathways/WP5050_r119012>	WP5050	TCA cycle in senescence	10	2	4.23386842622816e-19	2	4.97689604798731e-19	2	2.84705578791774e-19	2	7.40717183695431e-19	2	4.23386842622816e-19	2	4.94315437986536e-19	2	1.70937254321734e-19	2	1.70937254321734e-19
<https://identifiers.org/wikipathways/WP5052_r118777>	WP5052	Nephrogenesis	19	1	4.27213197525602e-39	1	6.13736951339129e-39	1	1.75566489351466e-39	1	1.49576232644626e-38	1	4.27213197525602e-39	1	6.04453535268456e-39	1	5.5954544343627e-40	1	5.5954544343627e-40
<https://identifiers.org/wikipathways/WP5053_r118778>	WP5053	Development of ureteric collection system	61	4	2.10857543178176e-94	4	6.52062617365999e-94	4	1.31778436687814e-95	4	1.04525704630921e-92	4	2.10857543178176e-94	4	6.21820494347395e-94	4	3.71686069482968e-97	4	3.71686069482968e-97
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	109	30	3.16246418046982e-101	30	1.49129038958221e-100	31	3.01648935169852e-101	30	6.73452197749783e-99	30	3.16246418046982e-101	31	5.63803979545285e-99	30	5.1877604275121e-105	31	2.37298202781041e-103
<https://identifiers.org/wikipathways/WP5061_r115541>	WP5061	Fatty acid transporters	25	3	4.15934888036791e-44	3	6.4715253540027e-44	3	1.40526691654231e-44	3	1.91886861866512e-43	3	4.15934888036791e-44	3	6.35228451833438e-44	3	3.48111932731617e-45	3	3.48111932731617e-45
<https://identifiers.org/wikipathways/WP5063_r118833>	WP5063	FOXP3 in COVID-19	17	5	3.27509180033313e-25	5	4.17233024039302e-25	5	1.80771561508741e-25	5	7.56780043863799e-25	5	3.27509180033313e-25	5	4.13004310957823e-25	5	8.41976550506588e-26	5	8.41976550506588e-26
<https://identifiers.org/wikipathways/WP5064_r120384>	WP5064	7-oxo-C and 7-beta-HC pathways	29	4	3.27225903389671e-48	4	5.40426199661349e-48	4	9.54909751115912e-49	4	1.85546146702101e-47	4	3.27225903389671e-48	4	5.29139102759483e-48	4	1.95913663937698e-49	4	1.95913663937698e-49
<https://identifiers.org/wikipathways/WP5065_r118890>	WP5065	SARS-CoV-2 altering angiogenesis via NRP1	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP5066_r116631>	WP5066	FOXA2 pathway	21	5	2.19824515967505e-32	5	3.03423079172138e-32	5	9.96569292471177e-33	5	6.70254389157685e-32	5	2.19824515967505e-32	5	2.99336573055345e-32	5	3.60365282936237e-33	5	3.60365282936237e-33
<https://identifiers.org/wikipathways/WP5072_r115764>	WP5072	Modulators of TCR signaling and T cell activation	64	4	2.67306193577839e-98	4	8.75964424557203e-98	4	1.44870365803973e-99	4	1.61898041895655e-96	4	2.67306193577839e-98	4	8.33303819465104e-98	4	3.4006912603292e-101	4	3.4006912603292e-101
<https://identifiers.org/wikipathways/WP5074_r120388>	WP5074	Kallmann syndrome	25	1	1.68083702637952e-49	1	2.72135798406373e-49	1	5.15026479381707e-50	1	8.89802791855898e-49	1	1.68083702637952e-49	1	2.66674879374807e-49	1	1.1251157324366e-50	1	1.1251157324366e-50
<https://identifiers.org/wikipathways/WP5076_r118892>	WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	5	1	5.83552474300908e-11	1	6.32775504466212e-11	1	4.78375635338997e-11	1	7.7223095677084e-11	1	5.83552474300908e-11	1	6.30623206831977e-11	1	3.70526386722106e-11	1	3.70526386722106e-11
<https://identifiers.org/wikipathways/WP5083_r120385>	WP5083	Neuroinflammation and glutamatergic signaling	140	16	3.09978835103665e-157	16	3.38786973348235e-156	16	8.6778446414874e-160	16	1.20236451978449e-153	16	3.09978835103665e-157	16	3.06372170342702e-156	16	4.45164029613553e-163	16	4.45164029613553e-163
<https://identifiers.org/wikipathways/WP5085_r119785>	WP5085	Vasopressin-regulated water reabsorption	44	3	1.46222613166909e-73	3	3.31130308376853e-73	3	1.96510474515933e-74	3	2.4693657557431e-72	3	1.46222613166909e-73	3	3.19937940162955e-73	3	1.48602730243474e-75	3	1.48602730243474e-75
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	438	46	1.06224113855868e-321	46	1.06417787589038e-318	46	0	46	2.1266092028737e-311	46	1.06224113855868e-321	46	7.97421952387772e-319	46	0	46	0
<https://identifiers.org/wikipathways/WP5088_r119639>	WP5088	Prostaglandin signaling	35	14	2.3208431795506e-36	14	3.5397856838512e-36	15	7.01001878682552e-35	14	9.99432434895954e-36	14	2.3208431795506e-36	15	2.76575254764906e-34	14	2.1722354829188e-37	15	1.96949350451307e-35
<https://identifiers.org/wikipathways/WP5090_r118898>	WP5090	Complement system in neuronal development and plasticity	113	16	6.93451955640301e-130	16	4.59318628589578e-129	16	6.65883907144968e-132	16	4.77420005771641e-127	16	6.93451955640301e-130	16	4.24209166829759e-129	16	1.67769901133864e-134	16	1.67769901133864e-134
<https://identifiers.org/wikipathways/WP5092_r119997>	WP5092	Interactions of natural killer cells in pancreatic cancer	38	11	7.80006063535954e-47	11	1.34036352234001e-46	11	2.06483246488065e-47	10	4.88680712497397e-48	10	7.01559010539299e-49	10	1.20099850778475e-48	11	3.73696086132236e-48	11	3.73696086132236e-48
<https://identifiers.org/wikipathways/WP5095_r120801>	WP5095	Overview of proinflammatory and profibrotic mediators	130	41	9.5506515918851e-106	41	5.44259176619624e-105	42	4.25203030856665e-106	41	3.91145383888863e-103	41	9.5506515918851e-106	42	1.51874227380517e-103	41	5.39278845689331e-110	42	1.83354807534378e-108
<https://identifiers.org/wikipathways/WP5097_r119075>	WP5097	CCL18 signaling pathway	131	9	1.95525439910623e-162	9	2.05987929241649e-161	9	5.9919233249716e-165	9	6.6809392178012e-159	9	1.95525439910623e-162	9	1.86567119838652e-161	9	3.45479902004392e-168	9	3.45479902004392e-168
<https://identifiers.org/wikipathways/WP5098_r119538>	WP5098	T-cell activation SARS-CoV-2	92	11	1.11277961928667e-116	11	5.45060847813886e-116	11	2.24485743943206e-118	11	2.70196021094341e-114	11	1.11277961928667e-116	11	5.09825469782809e-116	11	1.4738509952196e-120	11	1.4738509952196e-120
<https://identifiers.org/wikipathways/WP51_r116716>	WP51	Regulation of actin cytoskeleton	151	5	6.47607763829591e-191	5	1.05640624859256e-189	5	6.76206375812291e-194	5	1.00036917810187e-186	5	6.47607763829591e-191	5	9.39384008611908e-190	5	9.69665922228475e-198	5	9.69665922228475e-198
<https://identifiers.org/wikipathways/WP5101_r119172>	WP5101	Congenital generalized lipodystrophy (CGL)	20	2	4.27213197525603e-38	2	6.13736951339127e-38	2	1.75566489351474e-38	2	1.49576232644626e-37	2	4.27213197525603e-38	2	6.04453535268457e-38	2	5.59545443436273e-39	2	5.59545443436273e-39
<https://identifiers.org/wikipathways/WP5102_r119174>	WP5102	Familial partial lipodystrophy (FPLD)	31	1	2.66938387216694e-59	1	4.86783871652947e-59	1	6.10706745397997e-60	1	2.13214764681587e-58	1	2.66938387216694e-59	1	4.74634523774754e-59	1	9.1604647157851e-61	1	9.1604647157851e-61
<https://identifiers.org/wikipathways/WP5104_r120389>	WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP5108_r120390>	WP5108	Familial  hyperlipidemia type 1	18	4	2.01823973366131e-29	4	2.67640068448066e-29	4	1.0095022142667e-29	4	5.3577095366899e-29	4	2.01823973366131e-29	4	2.64480742176335e-29	4	4.142552466445e-30	4	4.142552466445e-30
<https://identifiers.org/wikipathways/WP5109_r120391>	WP5109	Familial hyperlipidemia type 2	16	6	4.67388350825541e-21	6	5.71979844031666e-21	6	2.84725134089446e-21	6	9.39854039769084e-21	6	4.67388350825541e-21	6	5.67140759056783e-21	6	1.50552836435435e-21	6	1.50552836435435e-21
<https://identifiers.org/wikipathways/WP5110_r120392>	WP5110	Familial hyperlipidemia type 3	13	3	1.66924411009121e-22	3	2.04278515725596e-22	3	1.01687547889088e-22	3	3.35662157060388e-22	3	1.66924411009121e-22	3	2.02550271091708e-22	3	5.37688701555125e-23	3	5.37688701555125e-23
<https://identifiers.org/wikipathways/WP5111_r119173>	WP5111	Familial hyperlipidemia type 4	22	4	1.64477081047357e-36	4	2.36288726265565e-36	4	6.75930984003172e-37	4	5.7586849568181e-36	4	1.64477081047357e-36	4	2.32714611078356e-36	4	2.15424995722963e-37	4	2.15424995722963e-37
<https://identifiers.org/wikipathways/WP5112_r119153>	WP5112	Familial hyperlipidemia type 5	15	3	2.40815573553907e-26	3	3.06788988264195e-26	3	1.32920265815249e-26	3	5.56455914605738e-26	3	2.40815573553907e-26	3	3.03679640410163e-26	3	6.1910040478426e-27	3	6.1910040478426e-27
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	41	10	2.44098260914448e-53	10	4.54020890460939e-53	11	6.22420882479349e-52	10	2.08764145381125e-52	10	2.44098260914448e-53	11	4.83738621472934e-51	10	7.49619822618375e-55	11	9.33617415442872e-53
<https://identifiers.org/wikipathways/WP5114_r119169>	WP5114	Nucleotide excision repair in xeroderma pigmentosum 	61	1	2.56630370178409e-102	1	8.40979670273769e-102	1	1.39084452576778e-103	1	1.55432067872168e-100	1	2.56630370178409e-102	1	8.0002286815006e-102	1	3.26487256175998e-105	1	3.26487256175998e-105
<https://identifiers.org/wikipathways/WP5115_r120811>	WP5115	Network map of SARS-CoV-2 signaling pathway	285	57	2.00011856372015e-210	57	1.37218154432121e-208	58	1.54796694668012e-213	57	4.3721353017567e-204	59	1.18271534611313e-207	58	2.77275305162799e-207	58	2.39040379496445e-219	58	2.39040379496445e-219
<https://identifiers.org/wikipathways/WP5117_r119395>	WP5117	Cohesin complex - Cornelia de Lange syndrome	36	1	4.32448125101619e-67	1	8.70399482748012e-67	2	5.01163073537547e-65	1	4.85864554338592e-66	1	4.32448125101619e-67	2	5.1005409689033e-64	1	8.52435412744685e-69	2	5.85623128555592e-66
<https://identifiers.org/wikipathways/WP5121_r119472>	WP5121	Sphingolipid metabolism in senescence	30	1	1.05483717529179e-57	1	1.88589493501673e-57	1	2.53344798252201e-58	1	7.86831260631412e-57	1	1.05483717529179e-57	1	1.84035708895885e-57	1	4.0453794180355e-59	1	4.0453794180355e-59
<https://identifiers.org/wikipathways/WP5122_r119484>	WP5122	Prostaglandin and leukotriene metabolism in senescence 	32	4	5.33663223723615e-53	4	9.35403887768288e-53	4	1.3455986717835e-53	4	3.71730560772709e-52	4	5.33663223723615e-53	4	9.13577797053705e-53	4	2.287419338134e-54	4	2.287419338134e-54
<https://identifiers.org/wikipathways/WP5124_r119432>	WP5124	Alzheimer's disease	267	21	2.76482379934598e-254	21	2.57101779258451e-252	21	3.94795922110172e-259	21	1.72316193550909e-247	21	2.76482379934598e-254	21	2.12498790755225e-252	21	2.18094566893091e-265	21	2.18094566893091e-265
<https://identifiers.org/wikipathways/WP5130_r122780>	WP5130	Th17 cell differentiation pathway	71	14	9.7263687712514e-86	14	3.00781341888709e-85	14	6.07863324216765e-87	14	4.82152800412794e-84	14	9.7263687712514e-86	14	2.868313528833e-85	14	1.7145015181522e-88	14	1.7145015181522e-88
<https://identifiers.org/wikipathways/WP5133_r121511>	WP5133	Non-classical role of vitamin D	8	3	2.7232448800709e-12	3	3.01321668793437e-12	3	2.12442788096621e-12	3	3.86460532432234e-12	3	2.7232448800709e-12	3	3.00041627719549e-12	3	1.54385994467547e-12	3	1.54385994467547e-12
<https://identifiers.org/wikipathways/WP5143_r120629>	WP5143	GDNF signaling	135	1	7.80118942436635e-186	1	1.02369816748863e-184	2	9.67562220519944e-186	1	5.68758680197084e-182	1	7.80118942436635e-186	2	5.99887126148355e-182	1	3.99141660422545e-192	2	2.93967832901218e-189
<https://identifiers.org/wikipathways/WP5144_r120537>	WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	57	7	3.80138562212213e-82	7	1.02626020030236e-81	7	3.31710708855214e-83	7	1.17852326742313e-80	7	3.80138562212213e-82	7	9.84269193743318e-82	7	1.43830364360338e-84	7	1.43830364360338e-84
<https://identifiers.org/wikipathways/WP5149_r120374>	WP5149	Lipid metabolism in senescent cells	20	3	1.72736536199518e-35	3	2.43244411714078e-35	3	7.45572358112573e-36	3	5.64400984512382e-35	3	1.72736536199518e-35	3	2.39766568989821e-35	3	2.53101055581004e-36	3	2.53101055581004e-36
<https://identifiers.org/wikipathways/WP5154_r122424>	WP5154	Docosahexaenoic acid (DHA) oxylipin metabolism	2	1	0.00167224080267564	1	0.00170648464163818	1	0.00159108989657917	1	0.00179372197309415	1	0.00167224080267564	1	0.00170502983802214	1	0.00149253731343287	1	0.00149253731343287
<https://identifiers.org/wikipathways/WP516_r117755>	WP516	Hypertrophy model	20	5	1.26765470874595e-30	5	1.71506283322539e-30	5	6.03636257153971e-31	5	3.60660695118182e-30	5	1.26765470874595e-30	5	1.69338975614165e-30	5	2.32521408751714e-31	5	2.32521408751714e-31
<https://identifiers.org/wikipathways/WP5171_r122629>	WP5171	Leukotriene metabolic pathway	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP5173_r122082>	WP5173	Disorders of galactose metabolism 	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP5174_r121476>	WP5174	Ulcerative colitis signaling	22	6	8.06023225214193e-32	6	1.11255129029784e-31	6	3.65408740572762e-32	6	2.45759942691151e-31	6	8.06023225214193e-32	6	1.09756743453627e-31	6	1.32133937076618e-32	6	1.32133937076618e-32
<https://identifiers.org/wikipathways/WP5176_r122283>	WP5176	Disorders of bile acid synthesis and biliary transport	20	3	1.72736536199518e-35	3	2.43244411714078e-35	3	7.45572358112573e-36	3	5.64400984512382e-35	3	1.72736536199518e-35	3	2.39766568989821e-35	3	2.53101055581004e-36	3	2.53101055581004e-36
<https://identifiers.org/wikipathways/WP5178_r122450>	WP5178	Disorders of fructose metabolism	14	3	1.93776264853043e-24	3	2.41954248744363e-24	4	3.55906417611807e-22	3	4.17712906564039e-24	3	1.93776264853043e-24	4	7.08925948820973e-22	3	5.5760309790902e-25	4	1.88191045544294e-22
<https://identifiers.org/wikipathways/WP5179_r121899>	WP5179	Biosynthesis and turnover of 1-deoxy-sphingoid bases	10	1	7.03300403027945e-22	1	8.4354170304871e-22	1	4.50127397299248e-22	1	1.31917575012545e-21	1	7.03300403027945e-22	1	8.37113358148251e-22	1	2.5361610433492e-22	1	2.5361610433492e-22
<https://identifiers.org/wikipathways/WP5180_r122423>	WP5180	DYRK1A	62	1	1.26680596744124e-103	1	4.23220288611813e-103	1	6.54763558068344e-105	1	8.20152187921243e-102	1	1.26680596744124e-103	1	4.02282383011389e-103	1	1.44587213449374e-106	1	1.44587213449374e-106
<https://identifiers.org/wikipathways/WP5181_r122326>	WP5181	Roles of ceramides in the development of insulin resistance	23	2	2.53096379370388e-43	2	3.86026487366263e-43	2	8.97965559670545e-44	2	1.08991737540181e-42	2	2.53096379370388e-43	2	3.7923138574457e-43	2	2.36890170223869e-44	2	2.36890170223869e-44
<https://identifiers.org/wikipathways/WP5182_r122168>	WP5182	Pro-survival signaling of neuroprotectin D1	16	3	3.18961024574711e-28	3	4.14579713870529e-28	3	1.67590563675648e-28	3	7.89999523841327e-28	3	3.18961024574711e-28	3	4.10031581988407e-28	3	7.32663200928115e-29	3	7.32663200928115e-29
<https://identifiers.org/wikipathways/WP5183_r122816>	WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	33	5	3.52217727657584e-52	5	6.17366565927073e-52	5	8.8809512337712e-53	5	2.45342170109985e-51	5	3.52217727657584e-52	5	6.02961346055439e-52	5	1.50969676316841e-53	5	1.50969676316841e-53
<https://identifiers.org/wikipathways/WP5187_r122433>	WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	12	1	6.38822851163882e-26	1	7.97651369486906e-26	1	3.70423949568648e-26	1	1.37707551614519e-25	1	6.38822851163882e-26	1	7.90234492847556e-26	1	1.83825197112865e-26	1	1.83825197112865e-26
<https://identifiers.org/wikipathways/WP5188_r122585>	WP5188	Retinol metabolism	19	2	2.59104804299277e-36	2	3.64866617571116e-36	2	1.11835853716887e-36	2	8.46601476768587e-36	2	2.59104804299277e-36	2	3.59649853484725e-36	2	3.79651583371506e-37	2	3.79651583371506e-37
<https://identifiers.org/wikipathways/WP5190_r122630>	WP5190	Creatine pathway	5	2	3.49839708343393e-08	2	3.71755608873899e-08	2	3.01376650263572e-08	2	4.31677104834896e-08	2	3.49839708343393e-08	2	3.70806445617204e-08	2	2.48808468683897e-08	2	2.48808468683897e-08
<https://identifiers.org/wikipathways/WP5191_r122556>	WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	14	2	4.81631147107814e-27	2	6.13577976528392e-27	2	2.65840531630502e-27	2	1.11291182921147e-26	2	4.81631147107814e-27	2	6.07359280820331e-27	2	1.23820080956851e-27	2	1.23820080956851e-27
<https://identifiers.org/wikipathways/WP5192_r122557>	WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	14	1	7.97402561436775e-30	1	1.03644928467633e-29	1	4.18976409189123e-30	1	1.97499880960331e-29	1	7.97402561436775e-30	1	1.02507895497102e-29	1	1.83165800232028e-30	1	1.83165800232028e-30
<https://identifiers.org/wikipathways/WP5193_r122440>	WP5193	Cholesterol synthesis disorders	18	9	3.41944655952186e-18	9	4.1012997602228e-18	9	2.18851940566893e-18	9	6.41383249710995e-18	9	3.41944655952186e-18	9	4.07004514731678e-18	9	1.23308149927637e-18	9	1.23308149927637e-18
<https://identifiers.org/wikipathways/WP5194_r122165>	WP5194	Synthesis of ceramides and 1-deoxyceramides	22	1	2.20083808148162e-44	1	3.35675206405441e-44	1	7.80839617104804e-45	1	9.47754239479835e-44	1	2.20083808148162e-44	1	3.29766422386575e-44	1	2.05991452368579e-45	1	2.05991452368579e-45
<https://identifiers.org/wikipathways/WP5195_r122514>	WP5195	Disorders in ketolysis	5	2	3.49839708343393e-08	2	3.71755608873899e-08	2	3.01376650263572e-08	2	4.31677104834896e-08	2	3.49839708343393e-08	2	3.70806445617204e-08	2	2.48808468683897e-08	2	2.48808468683897e-08
<https://identifiers.org/wikipathways/WP5198_r121825>	WP5198	Inflammatory bowel disease signaling	43	17	1.23561334058603e-42	17	2.08157863682553e-42	17	3.43419443562872e-43	17	7.50408363122526e-42	17	1.23561334058603e-42	17	2.03640247275416e-42	17	6.61732786026943e-44	17	6.61732786026943e-44
<https://identifiers.org/wikipathways/WP5200_r122392>	WP5200	Dravet syndrome	20	1	7.03810869070189e-41	1	1.03149067451954e-40	1	2.7539841466897e-41	1	2.64035715171446e-40	1	7.03810869070189e-41	1	1.01503532370858e-40	1	8.24072818020991e-42	1	8.24072818020991e-42
<https://identifiers.org/wikipathways/WP5205_r122560>	WP5205	Clock-controlled autophagy in bone metabolism	80	7	3.48621167550297e-111	7	1.46634243969727e-110	7	1.02285881426359e-112	7	5.0016441857164e-109	7	3.48621167550297e-111	7	1.38036412797206e-110	7	1.08860308040212e-114	7	1.08860308040212e-114
<https://identifiers.org/wikipathways/WP521_r111034>	WP521	Amino acid conjugation of benzoic acid	4	1	1.39935883337357e-08	1	1.48702243549559e-08	1	1.20550660105429e-08	1	1.72670841933958e-08	1	1.39935883337357e-08	1	1.48322578246882e-08	1	9.9523387473559e-09	1	9.9523387473559e-09
<https://identifiers.org/wikipathways/WP5211_r122576>	WP5211	Glucose metabolism in triple-negative breast cancer cells	8	3	2.7232448800709e-12	3	3.01321668793437e-12	3	2.12442788096621e-12	3	3.86460532432234e-12	3	2.7232448800709e-12	3	3.00041627719549e-12	3	1.54385994467547e-12	3	1.54385994467547e-12
<https://identifiers.org/wikipathways/WP5213_r122577>	WP5213	Amino acid metabolism in triple-negative breast cancer cells	9	2	5.09334371675252e-17	2	5.86776044057711e-17	2	3.59867851592803e-17	2	8.31084680106283e-17	2	5.09334371675252e-17	2	5.83292216824115e-17	2	2.30252481571377e-17	2	2.30252481571377e-17
<https://identifiers.org/wikipathways/WP5218_r122962>	WP5218	Extrafollicular B cell activation by SARS-CoV-2	76	15	5.80416074776281e-90	15	1.93908037217352e-89	15	2.99994872180952e-91	14	4.79300317244797e-90	14	6.92620614291549e-92	14	2.2404561316111e-91	15	6.62459327237252e-93	15	6.62459327237252e-93
<https://identifiers.org/wikipathways/WP5220_r122761>	WP5220	Metabolic reprogramming in pancreatic cancer	43	4	1.26819869372024e-69	4	2.76142357826464e-69	4	1.87680008374733e-70	4	1.87008155389624e-68	4	1.26819869372024e-69	4	2.67249251339897e-69	4	1.60678390743155e-71	4	1.60678390743155e-71
<https://identifiers.org/wikipathways/WP5221_r122738>	WP5221	2q11.2 copy number variation syndrome	65	4	1.38335211644584e-99	4	4.6215655516408e-99	4	7.15001805410642e-101	4	8.95606189209997e-98	4	1.38335211644584e-99	4	4.39292362248437e-99	4	1.57889237086714e-102	4	1.57889237086714e-102
<https://identifiers.org/wikipathways/WP5222_r122737>	WP5222	2q13 copy number variation syndrome	68	9	4.33652609275228e-92	9	1.3939068038036e-91	10	3.24078645676443e-91	9	2.45696465811029e-90	9	4.33652609275228e-92	10	1.63365877405782e-89	9	6.14998612842616e-95	10	8.59768060753981e-93
<https://identifiers.org/wikipathways/WP5223_r122632>	WP5223	2q21.1 copy number variation syndrome	42	1	4.63708075582151e-76	1	1.05009611535998e-75	1	6.23183322989205e-77	1	7.83096962709211e-75	1	4.63708075582151e-76	1	1.01460234723982e-75	1	4.71256015571277e-78	1	4.71256015571277e-78
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	172	5	2.8466180000835e-210	5	6.76398117499939e-209	6	2.79040635827719e-211	5	1.60932382227699e-205	5	2.8466180000835e-210	6	1.32123098951652e-206	5	5.08826327770832e-218	6	1.27715408270479e-215
<https://identifiers.org/wikipathways/WP524_r117113>	WP524	G13 signaling pathway	38	2	2.46962657958111e-67	2	5.06951811409979e-67	2	4.22450305756807e-68	2	2.97011114521763e-66	2	2.46962657958111e-67	2	4.91843975970617e-67	2	4.35826978297812e-69	2	4.35826978297812e-69
<https://identifiers.org/wikipathways/WP530_r117693>	WP530	Cytokines and inflammatory response	30	12	1.94479195876585e-32	12	2.79389938015734e-32	12	7.99226940312471e-33	12	6.80912144462319e-32	12	1.94479195876585e-32	12	2.7516387172642e-32	12	2.54720473351882e-33	12	2.54720473351882e-33
<https://identifiers.org/wikipathways/WP534_r117147>	WP534	Glycolysis and gluconeogenesis	46	8	8.48430361236095e-65	8	1.81147414288743e-64	9	1.89449424213688e-63	8	1.16897061429753e-63	8	8.48430361236095e-65	9	2.35894188384895e-62	8	1.20038464453603e-66	9	1.83658850614009e-64
<https://identifiers.org/wikipathways/WP536_r116854>	WP536	Calcium regulation in cardiac cells	152	10	1.04795857200384e-180	10	1.59021389812684e-179	10	1.30759412768268e-183	10	1.26134618374141e-176	10	1.04795857200384e-180	10	1.41836429878574e-179	10	2.36066109943652e-187	10	2.36066109943652e-187
<https://identifiers.org/wikipathways/WP545_r116815>	WP545	Complement activation	22	4	1.64477081047357e-36	4	2.36288726265565e-36	4	6.75930984003172e-37	4	5.7586849568181e-36	4	1.64477081047357e-36	4	2.32714611078356e-36	4	2.15424995722963e-37	4	2.15424995722963e-37
<https://identifiers.org/wikipathways/WP554_r121084>	WP554	ACE inhibitor pathway	17	2	1.11197781468943e-32	2	1.50444108177663e-32	2	5.29505488731549e-33	2	3.16369030805419e-32	2	1.11197781468943e-32	2	1.48542961065056e-32	2	2.03966148027819e-33	2	2.03966148027819e-33
<https://identifiers.org/wikipathways/WP558_r119232>	WP558	Complement and coagulation cascades	60	12	1.27191030944116e-75	12	3.30261393711079e-75	12	1.22134401610621e-76	12	3.44663809723778e-74	12	1.27191030944116e-75	12	3.17267502810973e-75	12	5.9905558361058e-78	12	5.9905558361058e-78
<https://identifiers.org/wikipathways/WP560_r117838>	WP560	TGF-beta receptor signaling	55	9	3.95484079114852e-75	9	9.87617089266688e-75	9	4.17964897135383e-76	9	9.36513031418311e-74	9	3.95484079114852e-75	9	9.50317921691755e-75	9	2.31945849066287e-77	9	2.31945849066287e-77
<https://identifiers.org/wikipathways/WP58_r113950>	WP58	Monoamine GPCRs	34	2	3.18558236797802e-61	2	6.04336639261088e-61	2	6.61380135165845e-62	2	2.91702405600181e-60	2	3.18558236797802e-61	2	5.88274535892017e-61	2	8.75532604885219e-63	2	8.75532604885219e-63
<https://identifiers.org/wikipathways/WP581_r117099>	WP581	EPO receptor signaling	26	5	6.58050586363016e-41	5	1.00366886715228e-40	5	2.33471045514337e-41	5	2.83378517604471e-40	5	6.58050586363016e-41	5	9.8600160293586e-41	5	6.15914442582064e-42	5	6.15914442582064e-42
<https://identifiers.org/wikipathways/WP585_r107188>	WP585	Interferon type I signaling pathways	54	6	2.34749203502002e-80	6	6.09544545284832e-80	6	2.25416472258062e-81	6	6.3612625991037e-79	6	2.34749203502002e-80	6	5.85562464814629e-80	6	1.10564259179408e-82	6	1.10564259179408e-82
<https://identifiers.org/wikipathways/WP61_r120637>	WP61	Notch signaling pathway	60	7	4.02507615972549e-86	7	1.15188642878293e-85	7	3.04346120278082e-87	7	1.52642013059118e-84	7	4.02507615972549e-86	7	1.10204970982331e-85	7	1.09723757263553e-88	7	1.09723757263553e-88
<https://identifiers.org/wikipathways/WP619_r120967>	WP619	Type II interferon signaling	37	19	3.97367451720632e-30	19	5.70860380233936e-30	19	1.63301154751778e-30	19	1.39126615816698e-29	19	3.97367451720632e-30	19	5.62225517339636e-30	19	5.20454771219549e-31	19	5.20454771219549e-31
<https://identifiers.org/wikipathways/WP623_r107189>	WP623	Oxidative phosphorylation	62	1	1.26680596744124e-103	1	4.23220288611813e-103	1	6.54763558068344e-105	1	8.20152187921243e-102	1	1.26680596744124e-103	1	4.02282383011389e-103	1	1.44587213449374e-106	1	1.44587213449374e-106
<https://identifiers.org/wikipathways/WP673_r118930>	WP673	ErbB signaling pathway	92	1	3.71868750411533e-140	1	2.20055433912769e-139	1	4.71206725390485e-142	1	1.73470429531468e-137	1	3.71868750411533e-140	1	2.04200291801882e-139	1	1.69803210271715e-144	1	1.69803210271715e-144
<https://identifiers.org/wikipathways/WP678_r116938>	WP678	Arachidonate epoxygenase / epoxide hydrolase	7	1	1.70061087431572e-15	1	1.92006161083328e-15	1	1.26253637933808e-15	1	2.58790535110871e-15	1	1.70061087431572e-15	1	1.91028201009899e-15	1	8.60888444986317e-16	1	8.60888444986317e-16
<https://identifiers.org/wikipathways/WP688_r117673>	WP688	Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)	5	3	1.39702656865128e-05	3	1.45480361605985e-05	3	1.26477734227278e-05	3	1.6072777536686e-05	3	1.39702656865128e-05	3	1.45232524533404e-05	3	1.11300321657928e-05	3	1.11300321657928e-05
<https://identifiers.org/wikipathways/WP69_r120966>	WP69	T-cell receptor signaling pathway	89	8	1.46208502295192e-119	8	7.16157349014888e-119	8	2.94952601932062e-121	8	3.55011494510008e-117	8	1.46208502295192e-119	8	6.69861462925352e-119	8	1.93649796314095e-123	8	1.93649796314095e-123
<https://identifiers.org/wikipathways/WP690_r117170>	WP690	Polyol pathway	4	2	8.38215941190768e-06	2	8.72882169635909e-06	2	7.58866405363668e-06	2	9.6436665220116e-06	2	8.38215941190768e-06	2	8.71395147200427e-06	2	6.67801929947566e-06	2	6.67801929947566e-06
<https://identifiers.org/wikipathways/WP691_r114497>	WP691	Tamoxifen metabolism	21	9	1.55566860515823e-23	9	1.98185686418669e-23	9	8.58664917166504e-24	9	3.59470520835303e-23	9	1.55566860515823e-23	9	1.96177047704968e-23	9	3.9993886149063e-24	9	3.9993886149063e-24
<https://identifiers.org/wikipathways/WP692_r117833>	WP692	Sulfation biotransformation reaction	18	2	1.65281590953014e-34	2	2.28137653512886e-34	2	7.49300219903135e-35	2	5.03950668539615e-34	2	1.65281590953014e-34	2	2.25065092522815e-34	2	2.70951340553558e-35	2	2.70951340553558e-35
<https://identifiers.org/wikipathways/WP694_r106139>	WP694	Arylamine metabolism	7	1	1.70061087431572e-15	1	1.92006161083328e-15	1	1.26253637933808e-15	1	2.58790535110871e-15	1	1.70061087431572e-15	1	1.91028201009899e-15	1	8.60888444986317e-16	1	8.60888444986317e-16
<https://identifiers.org/wikipathways/WP696_r106311>	WP696	Benzo(a)pyrene metabolism	9	1	8.46773685245642e-20	1	9.95379209597464e-20	1	5.69411157583549e-20	1	1.48143436739087e-19	1	8.46773685245642e-20	1	9.88630875973075e-20	1	3.41874508643468e-20	1	3.41874508643468e-20
<https://identifiers.org/wikipathways/WP697_r106826>	WP697	Estrogen metabolism	18	5	4.88010367599307e-27	5	6.3430696222191e-27	5	2.56413562423745e-27	5	1.20869927147724e-26	5	4.88010367599307e-27	5	6.27348320442271e-27	5	1.12097469742e-27	5	1.12097469742e-27
<https://identifiers.org/wikipathways/WP698_r106827>	WP698	Glucuronidation	26	2	2.18508813429337e-48	2	3.53776537928285e-48	2	6.69534423196219e-49	2	1.15674362941265e-47	2	2.18508813429337e-48	2	3.46677343187244e-48	2	1.4626504521676e-49	2	1.4626504521676e-49
<https://identifiers.org/wikipathways/WP699_r106828>	WP699	Aflatoxin B1 metabolism	8	1	1.13185415927834e-17	1	1.30394676457269e-17	1	7.99706336872898e-18	1	1.84685484468063e-17	1	1.13185415927834e-17	1	1.29620492627582e-17	1	5.11672181269725e-18	1	5.11672181269725e-18
<https://identifiers.org/wikipathways/WP702_r106643>	WP702	Metapathway biotransformation Phase I and II	190	22	1.01118651847812e-191	22	2.44579328695215e-190	22	4.0003846233084e-195	22	6.07789720033161e-187	22	1.01118651847812e-191	22	2.13915651664777e-190	22	1.63476095983559e-199	22	1.63476095983559e-199
<https://identifiers.org/wikipathways/WP704_r117787>	WP704	Methylation pathways	9	2	5.09334371675252e-17	2	5.86776044057711e-17	2	3.59867851592803e-17	2	8.31084680106283e-17	2	5.09334371675252e-17	2	5.83292216824115e-17	2	2.30252481571377e-17	2	2.30252481571377e-17
<https://identifiers.org/wikipathways/WP706_r117178>	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	166	14	1.57497063617924e-185	14	2.86237057770679e-184	16	1.04017101466848e-184	14	3.53211111165114e-181	14	1.57497063617924e-185	16	1.84927744728618e-180	14	1.28071933484601e-192	16	1.18551386129192e-188
<https://identifiers.org/wikipathways/WP707_r116541>	WP707	DNA damage response	68	4	2.08938629126027e-103	4	7.39556867812949e-103	4	9.36915993012963e-105	4	1.65164102627607e-101	4	2.08938629126027e-103	4	7.01262661065358e-103	4	1.72280592720507e-106	4	1.72280592720507e-106
<https://identifiers.org/wikipathways/WP710_r116542>	WP710	DNA damage response (only ATM dependent)	114	9	5.70956532753828e-145	9	4.39155954765406e-144	10	5.16540406028026e-145	9	6.58610262277587e-142	9	5.70956532753828e-145	10	5.14690778985026e-142	9	5.94803828329745e-150	10	8.58896728108168e-148
<https://identifiers.org/wikipathways/WP716_r116512>	WP716	Vitamin A and carotenoid metabolism	43	6	6.43197404288865e-65	6	1.3465529794692e-64	6	1.0483367347793e-65	6	8.27982348150647e-64	6	6.43197404288865e-65	6	1.3053433349362e-64	6	1.01629403501825e-66	6	1.01629403501825e-66
<https://identifiers.org/wikipathways/WP722_r120570>	WP722	Serotonin HTR1 group and FOS pathway	34	1	5.18824489898692e-64	1	1.00388146056658e-63	1	1.02619105533878e-64	1	5.08635406451927e-63	1	5.18824489898692e-64	1	9.76389271190069e-64	1	1.27628659604261e-65	1	1.27628659604261e-65
<https://identifiers.org/wikipathways/WP727_r116775>	WP727	Monoamine transport	32	5	1.30534024522798e-50	5	2.24309852286836e-50	5	3.45549738914007e-51	5	8.49032600804866e-50	5	1.30534024522798e-50	5	2.19258671292888e-50	5	6.25380447045821e-52	5	6.25380447045821e-52
<https://identifiers.org/wikipathways/WP733_r120590>	WP733	Serotonin receptor 2 and STAT3 signaling	4	2	8.38215941190768e-06	2	8.72882169635909e-06	2	7.58866405363668e-06	2	9.6436665220116e-06	2	8.38215941190768e-06	2	8.71395147200427e-06	2	6.67801929947566e-06	2	6.67801929947566e-06
<https://identifiers.org/wikipathways/WP75_r119233>	WP75	Toll-like receptor signaling pathway	104	19	1.13161513945988e-114	19	5.97936226182687e-114	20	1.27030829237882e-114	19	3.57001030324204e-112	19	1.13161513945988e-114	20	3.50390628543065e-112	19	9.77995523047953e-119	20	6.96332812410137e-117
<https://identifiers.org/wikipathways/WP98_r117172>	WP98	Prostaglandin synthesis and regulation	46	6	3.11761233533167e-69	6	6.92294135723479e-69	6	4.39657797396357e-70	6	4.91990259759865e-68	6	3.11761233533167e-69	6	6.6944614444548e-69	6	3.53748799344597e-71	6	3.53748799344597e-71
